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West Nile virus (WNV) is a mosquito-borne flavivirus and has the potential to cause 
fatal meningoencephalitis in infected victims. This re-emerging virus has recently 
caused large epidemics in the western hemisphere. Despite advances in WNV 
research, the mechanisms of cytopathology are still not known. Previous studies on 
WNV-host interactions have been limited. This area of research will be significant, as 
elucidations of these mechanisms will have direct implications in inhibiting the 
replication of the virus within the host. A screening of the global genomic expression 
was therefore carried out.  
 
The initial studies on different human host cells have found that HeLa cells (cervical 
adenocarcinoma) were not as permissive as A172 cells (glial blastoma) to WN 
(Sarafend)V infection. An attempt to study the global transcriptomic profiles on host 
cells was subsequently carried out on two fronts: between virus-infected cells and 
mock-infected control cells, and between permissive cell lines and less-permissive 
cell lines. A time sequence study of the host response during the different phases of 
the virus infection was also carried out in A172 cells. Five time-points (1.5 h, 6 h, 12 
h, 18 h, and 24 h) were carried out to cover the full spectrum of the virus replication 
cycle: from early to late phases of infection. 
 
In the comparison between A172 and HeLa cells during a WNV infection, greater 
cytopathic effects accompanied with high virus titers were observed in the infected 
A172 cells. The intracellular levels of viral protein and RNA were quantified using 
immuofluorescence microscopy and quantitative PCR, respectively. Both virus 
components were consistently higher in A172 cells, and is therefore more permissive 
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to the virus infection. High-density microarray studies were utilized to elucidate the 
differences in host responses between the two types of cells. Four functional classes 
of genes belonging to cytoskeletal structure and functions, hexose metabolism, protein 
biosynthesis and RNA processing were found to be significantly differentially 
regulated between the two cell types. These classes of host responses could be 
responsible for the levels of permissiveness in the two cell lines.  
 
In the time sequence study in WNV-infected A172 cells, differentially expressed 
genes during the course of the West Nile infection were clustered into 6 groups based 
on their gene expression patterns. Some of the functional groups that were 
differentially expressed at certain time points correlated with the stages in the virus 
replication cycle. These included the genes involved in the mitochondria, cellular 
transport and the endoplasmic reticulum. Further analysis is needed to understand the 











The Human Genome Project was launched about 10 years ago and the full sequence 
was recently published. This project has paved the way to the revolution in the life 
sciences that we are experiencing today. Its focus has started to shift gradually 
towards functional genomics, which deals with the functional analysis of genes and 
their products.  
 
Techniques of functional genomics include methods for gene expression profiling at 
the transcript levels, protein levels, and bioinformatics. Among the techniques of 
functional genomics, both DNA microarrays and proteomics hold great promise for 
the study of complex biological systems with applications in molecular medicine 
(Celis et al., 2000). These technologies are complementary, allowing high-throughput 
screening. In combination are expected to generate a vast amount of gene and protein 
expression data that may lead to a better understanding of the regulatory events 
involved in normal and disease processes. This could help to identify new networks 
of disease-associated alterations in humans.  
 
Although much has been learned about the molecular biology of flaviviruses, there 
are still many unanswered questions. Since West Nile virus (WNV) alternates 
between insect vectors and vertebrates in nature, any cellular proteins that this virus 
uses during replication would be expected to be evolutionarily conserved. Of 
particular interest will be the identification of the cell protein(s) used for virus 
attachment and entry, and the elucidation of the molecular mechanisms involved in 
virus replication.  Viruses use cell proteins during many stages of their replication 
cycles, including attachment, entry, translation, transcription/replication, and 
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assembly. Viruses also interact with cell proteins to alter the intracellular environment 
or cell architecture so that it is more favourable for virus replication. The replication 
can also inactivate intracellular defence mechanisms, such as apoptosis and interferon 
pathways. Mutations in the cell proteins involved can cause disruptions of these 
critical host-virus interactions. These virus-host interactions may thus represent novel 
targets for the development of new anti-viral agents.  
 
Flavivirus-host interaction studies have not been extensive, and therefore, not well 
understood. Using West Nile (Sarafend) virus as a model for this study, an attempt 
was therefore made to elucidate the mechanisms of these virus-host interactions on a 
global scale.  
Literature Review 
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1.0     LITERATURE REVIEW 
1.1     Introduction to West Nile Virus  
West Nile virus (WNV) is a mosquito-borne virus that was first isolated and 
identified as a distinct pathogen in 1937 from the blood of a febrile adult woman 
participating in a malaria study in the West Nile region of Uganda (Smithburn et al., 
1940). It was then classified as a flavivirus by a cross-neutralisation test (Calisher et 
al., 1989; Wengler et al., 1999). In the recent 76th Report of the International 
Committee on Taxonomy of Viruses (ICTV), they have assigned members of the 
genus into species (Heinz et al., 2000; Mackenzie et al., 2002).  There are currently 
27 mosquito-borne species, 12 tick-borne species and 14 species with no known 
vector.  The appearance of the WNV in the United States in 1999 has increased 
interest not only in this virus, but also other flaviviruses, including dengue, yellow 
fever, Japanese encephalitis and tick-borne encephalitis viruses (TBEV).  
 
1.2   West Nile Virus Epidemiology 
The WNV isolates are grouped into two genetic lineages (1 and 2) on the basis of 
signature amino acid substitutions or deletions in their envelope protein (Berthet et al., 
1997).  All WNV isolates that are associated with human diseases have been found in 
lineage 1, while lineage 2 viruses are mainly restricted to endemic enzootic infection 
in Africa (Jia et al., 1999; Lanciotti et al., 2002).  Due to antigenic cross-reactivity 
between different flaviviruses, techniques such as in situ hybridization and sequence 
analyses of real-time polymerase chain reaction (PCR) products are required to 
unequivocally identify WNV as the causative agent in infections (Briese et al., 2002; 
Lanciotti et al., 2002). 
Literature Review 
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In recent times, outbreaks have increased in frequency (Romania and Morocco in 
1996; Tunisia in 1997; Italy in 1998; Russia and the United States in 1999; and Israel, 
France, and the United States in 2000) as well as the severity of the disease amongst 
those who developed clinical symptoms (Petersen and Roehrig, 2001). The WNV 
outbreaks in the USA have coincided with the emergence of a new variant of WNV 
designated “Isr98/NY99” that circulated in North America and the Middle East 
(Lanciotti et al., 2002). This strain is characterized by a high avian death rate and an 
apparent increase in human disease severity (Solomon et al., 2003). 
 
This is consistent with the hypothesis that some changes in the neurovirulent 
properties of the virus had occurred (Ceccaldi et al., 2004). In 2002, 39 states 
reported 4156 human WNV illness cases (O’Leary et al., 2004), and the numbers 
increased to 9862 cases with 264 deaths in 2003 (CDC, 2004).  The increased 
neurovirulence of Isr98/NY99 is accompanied by several novel modalities of 
transmission to humans, including transplacental transmission to the foetus, 
transmission via breast milk, blood transfusion, or laboratory contamination through 
percutaneous inoculation (Peterson and Roehrig, 2001; Hayes and O’Leary, 2004).  
 
Wild bird species develop high levels of viremia after WNV infection and are able to 
sustain viremic levels of WNV of at least 105 PFU/ml of serum (the minimum level 
estimated to be required to infect a feeding mosquito) for days to weeks. They are the 
main reservoir hosts in endemic regions for the virus, which can initiate epizootics 
outside the endemic areas (Bernard et al., 2001; Petersen and Roehrig, 2001). The 
WNV has been isolated from Culex, Aedes Anopheles, Minomyia, and Mansonia 
mosquitoes in Africa, Asia, and the United States, but Culex species are the most 
Literature Review 
 7
susceptible to infection with WNV (Burke and Monath, 2001; Ilkal et al., 1997). Also 
Culex mosquitoes feed on wild bird species and they could have high levels of 
viremia (Turell et al., 2000). Natural vertical transmission of WNV in Culex 
mosquitoes in Africa has been reported and is expected to enhance virus maintenance 
in nature (Miller et al., 2000). Humans and horses are incidental hosts with low 
viremic levels and do not play a role in the transmission cycle. 
 
Fever is the most common symptom observed in humans. The course of the fever is 
sometimes biphasic, and a rash on the chest, back, and upper extremities often 
develops during or just after the fever (Burke and Monath, 2001). Symptoms also 
include headaches, muscle weakness and disorientation. A portion of infected 
individuals develop encephalitis, meningoencephalitis, pan-meningo-
polioencephalitis (Omalu et al., 2003) or hepatitis. The brainstem, particularly the 
medulla, is the primary central nervous system (CNS) target. Humans aged 60 and 
older have an increased risk of developing fatal disease (George et al., 1984; 
Sampson et al., 2000; Chowers et al., 2001). Flacid paralysis and muscle weakness, 
similar to polio-like syndrome, have also been reported in the absence of fever or 
meningo-encephalitis (Li et al., 2003; Arturo et al., 2003).  
 
Histopathological studies after autopsy revealed that, although WNV could be 
detected in all major organs (spleen, liver, kidney, heart, etc.), most of the brains 
(88%) were also positive for viral antigens, including glial cells and neurones (Steele 
et al., 2000). Neuropathogenicity was also observed in infected animals whereby 
poliomyeloencephalitis was characterized by T-lymphocytes and, to a lesser extent, 
macrophage infiltrates within the CNS, with multifocal glial nodules and some 
Literature Review 
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nueronophagia (Cantile et al., 2001). A Parkinson’s disease-like syndrome, in which 
patients have mask-like faces, tremors and cogwheel rigidity is common in Japanese 
encephalitis (Misra and Kalita, 1997), correlating with the damage of the basal 
ganglia and thalamus.  As high levels of WNV-reactive serum IgM antibodies could 
be detected in confirmed human cases of WNV encephalitis as late as 1.5 years after 
onset (Roehrig et al., 2003) and also in animal studies (Xiao et al., 2001), there is a 
possibility of viral persistence within the CNS. 
 
1.3   Virus Morphology  
West Nile virus belongs to the flavivirus family of viruses. The virions are small 
(~50nm in diameter), spherical, enveloped, and have a buoyant density of ~1.2g/cm3. 
The WNV genome is a single-stranded RNA of positive polarity (mRNA sense) and 
is 11,029 bases in length, containing a single open reading frame (ORF) of 10,301 
bases. The virus contain three structural proteins: a nucleocapsid protein (C protein, 
14kDa), a lipid membrane protein (M protein, 8kDa), and a large envelope 
glycoprotein (E protein, 55kDa) carrying the majority of flavivirus antigenic and 
functional determinants (Heinz and Roehrig, 1990). The spherical nucleocapsid is 
~25nm in diameter and is composed of multiple copies of the C protein. Cryo-
electron microscopy data revealed that the virion envelope and capsid have 
icosahedral symmetry (Heinz et al., 2000). The two viral envelope proteins, E and M, 
are both Type I integral membrane proteins with C-terminal membrane anchors 
(Mukhopadhyay et al., 2003). Figure 1-1 shows the structure of the virus particle and 






The recent determination of the structure of the entire virion of dengue virus type 2 
by cryoelectron microscopy at a resolution of 24 Å has increased our understanding 
of the structure of the flavivirus virion. The structure has provided insights into the 
functions of its component parts (Kuhn et al., 2002), especially with the elucidation 
of the crystal structure of surface glycoprotein E of TBEV by X-ray crystallography 
at 2 Å resolution (Rey et al., 1995). The E glycoprotein is the principal stimulus for 
the development of neutralizing antibodies and contains a fusion peptide responsible 
Figure 1-1. The immature and 
mature flavivirus virions. The 
heterodimers of prM and E are 
shown on the left (immature 
virion) and the homodimers of E, 
following cleavage of prM, on the 
right (mature virion). The 
icosahedral nucleocapsid consists 
of viral C protein and genomoic 
RNA, and is surrounded by a lipid 
bilayer in which the viral E and 
prM/M proteins are embedded. 
Viral maturation is triggered by 
the cleavage of prM to pr and M 
proteins by the host protease 
furin. (Shi, 2002) 
Figure 1-2. Structural arrangement of flavivirus envelope protein. (a) Diagrams of the 
flavivirus ectodomain and transmembrane domain proteins. The volume occupied by the 
ectodomain of an E monomer is pink (domain I), yellow (domain II) and lilac (domain III). (b) 
Homodimer arrangement of the E protein on the surface of the flavivirus particle (Zhang et al., 
2003). (c) Structure of the whole WNV with the homodimer E proteins arranged in a herringbone 




for inserting the virus into the host cell membrane. Generally, the E proteins of most 
flaviviruses are glycosylated, and the glycosylation of certain amino acid residues 
have been postulated to contribute to the pathogenecity of the virus (Beasley et al., 
2004). Varying N-glycosylation sites could also be important in epitope definition 
(Seligman and Bucher, 2003).   
 
1.4   Virus Assembly and Maturation 
WNV replicates in a wide variety of cell cultures, including primary chicken, duck 
and mouse embryo cells and continuous cell lines from monkeys, humans, pigs, 
rodents, amphibians, and insects, but does not cause obvious cytopathology in many 
cell lines (Brinton, 1986). It was demonstrated that although embryonic stem (ES) 
cells were relatively resistant to WNV infection before differentiation, they became 
permissive for WNV infection once differentiated, and die by the process of apoptosis 
(Shrestha et al., 2003). Since flaviviruses are transmitted between insect and 
vertebrate hosts during their natural transmission cycle, it is likely that the cell 
receptor(s) they utilize is a highly conserved protein (Brinton, 2002). The receptor for 
WNV was found to be a 105-kDa protease-sensitive, N-linked glycoprotein in Vero 
and murine neuroblastoma 2A cells (Chu and Ng, 2003a), and was recently 
determined to be the αVβ3-integrin receptor (Chu and Ng, in press).  
 
The pathway for flavivirus entry into host cells is through clathrin-mediated 
endocytosis, which is triggered by an internalization signal (di-leucine or YXXΦ) in 
the cytoplasmic tail of the receptor.  Clathrin is assembled on the inside face of the 
plasma membrane to form an electron dense coat known as clathrin-coated pit.  
Clathrin interacts with a number of accessory protein molecules (Eps15, ampiphysin 
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and AP2 adapter protein) as well as the dynamin GTPase responsible for releasing the 
internalized vesicle from the plasma membrane (Marsh and McMahon, 1999).   
 
This is followed by low-pH fusion of the viral membrane with the lysosomal vesicle 
membrane, releasing the nucleocapsid into the cytoplasm [(Heinz and Allison, 2000) 
(Fig. 1-3A)]. The reduced pH causes the conformational rearrangement of the E 
proteins, allowing the interactions of the virus E proteins with the lysosomal 
membrane to form hemifusion pores for the release of viral nucleocapsids into the 
cytoplasm for uncoating and replication (Modis et al., 2004).  
 
The RNA genome is released and translated into a single polyprotein (Fig. 1-3B). The 
viral serine protease, NS2B-NS3, and several cell proteases then cleave the 
polyprotein at multiple sites to generate the mature viral proteins (Fig. 1-3C). The 
viral RNA-dependent RNA polymerase (RdRp), NS5, in conjunction with other viral 
nonstructural proteins and possibly cell proteins, copies complementary minus strands 
from the genomic RNA template (Fig. 1-3D), and these minus-strand RNAs in turn 
serve as templates for the synthesis of new genomic RNAs (Fig. 1-3E). Upon WNV 
infection, extensive reorganization and proliferation of both smooth and rough 
endoplasmic reticula were observed (Ko et al., 1979; Murphy, 1980; Westaway and 
Ng, 1980; Lindenbach and Rice, 1999). There were also induction of unique sets of 
membranous structures, but their functions during infection mostly remained elusive 
(Westaway et al., 2002).  One of such generic flavivirus-induced features, in both 
vertebrate and invertebrate cells, is the formation of vesicles packets that contains bi-
layered membrane vesicles of 50-100 nm in size. These vesicles enclosed 
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distinctively single or double-stranded ‘thread-like’ structures during early stages of 
infection (Ng, 1987).  
 
Flavivirus assembly occurs in association with the ER membranes (Fig. 1-2F, G). 
Intracellular immature virions, which contain heterodimers of E and prM, accumulate 
in vesicles and are then transported through the host secretory pathway [(Heinz et al., 
1994; Wengler, 1989) (Fig. 1-2H)]. It has been shown by electron microscopy that 
mature virions can be found within the lumen of endoplasmic reticulum (Matsumura 
et al., 1977; Sriurairatna and Bhamarapravati, 1977; Hase et al., 1989; Ng, 1987) at 
the perinuclear area of the cytoplasm (Murphy, 1980; Westaway and Ng, 1980). The 
glycosylated and hydrophilic N-terminal portion of prM is cleaved in the trans-Golgi 
network by cellular furin or a related protease (Stadler et al., 1997). The C-terminal 
portion (M) remains inserted in the envelope of the mature virion (Murray et al., 
1993). The prM-E interaction may maintain the E protein in a stable, fusion-inactive 
conformation during the assembly and release of new virions (Heinz and Allison, 
2000).  
 
Assembly of WN (Sarafend) virus [WN(S)V] is, however, slightly different from the 
process shown above, which is generally true for other flaviviruses. With the use of 
cryo-immunoelectron microscopy, the precursor of nucleocapsid particles from 
WN(S)V was observed to be closely associated with the envelope proteins at the host 
cell’s plasma membrane (Ng et al., 2001). Instead of maturing within the 
endoplasmic reticulum, WN(S)V was found to mature (cis-mode) at the plasma 
membrane (Ng et al., 1994). This contrasts with the trans-mode of maturation (Fig. 1-
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2I) observed for most flavivirus where mature virus particles are released from cells 
by exocytosis (Mason, 1989; Nowak et al., 1989). 
 
 
Egress of WNV had been observed to occur predominantly at the apical surface of 
polarized Vero cells, suggesting the involvement of a microtubule-dependent, 
polarized sorting mechanism for WNV proteins (Chu and Ng, 2002a). A recent study 
has shown that both E and C proteins were strongly associated and transported along 
the microtubules to the plasma membrane for assembly (Chu and Ng, 2002b). It was 
also observed in the same study that the association of E protein and microtubules 
was sensitive to high salt extraction but resistant to Triton X-100 and octyl glycoside 
extraction. This suggested that virus E protein and possibly also C protein associate 
effectively with the microtubules through an ionic interaction (Chu and Ng, 2002b).  
Figure 1-3. The Flavivirus replication cycle. A. Attachment and entry of the virion. B. Uncoating and 
translation of the virion RNA. C. Proteolytic processing of the polyprotein. D. Synthesis of the minus-
strand RNA from the virion RNA. E. Synthesis of nascent genome RNA from the minus-strand RNA. 
F. Transport of structural proteins to cytoplasmic vesicle membranes. G. Encapsidation of nascent 
genome RNA and budding of nascent virions. H. Movement of nascent virions to the cell surface. I. 
Release of nascent virions. SHA, slowly sedimenting hemagglutinin, a subviral particle that is also 
sometimes released. (Brinton, 2002) 
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1.5   Virus-Host Interactions 
Infection and replication of viruses in vertebrate cells result in the alteration of 
expression of many cellular genes and these differentially expressed genes can be 
identified using a variety of techniques such as high-density DNA microarrays, 
differential display or subtraction hybridization (Manger and Relman, 2000). Such 
changes in host gene expression could be a cellular antivirus response, a virus-
induced response that is beneficial or even essential for virus survival or a non-
specific response that neither promotes nor prevents virus infection (Saha and 
Rangarajan, 2003).  
 
Infection of diploid vertebrate cells with WNV has been reported to increase cell 
surface expression of MHC-1, which resulted from increased MHC-1 mRNA 
transcription activated by NF-κB (Kesson and King, 2001). Activation of NF-κB 
appeared to be mediated via virus-induced phosphorylation of inhibitor κB. Increased 
MHC-1 expression allows intracellular virus antigens to be presented, thus increasing 
the cell’s susceptibility to virus-specific cytotoxic T-cell (CTL) lysis (Douglas et al., 
1994). This increase may also enhance tissue damage and immunopathology in an 
infected host (King et al., 1993).  
 
West Nile virus infection has also been reported to induce expression of non-
conserved polymorphic intracellular adhesion molecule-1 [(ICAM-1)(CD54)] and its 
receptor, the integrin lymphocyte related antigen-1 [(LFA-1)(CD11a/CD18)] in 
infected cells (Shen et al., 1995). The binding of ICAM-1 to its ligand has been found 
to increase the avidity of cellular conjugation between T cells and their target cells. 
This facilitates the interaction of antigen-targeted immune cells, and hence 
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contributing to more efficient antiviral responses. WNV-specific, interferon-
independent induction of ICAM-1 was observed within 2 h after infection in 
quiescent but not replicating fibroblasts. The increase in MHC-1 and ICAM-1 
expressions were found to be cell-cycle dependent, with up-regulation in G0 phase 
compared to G1 phase (Douglas et al., 1994; Shen et al., 1995). E-selectin (ELAM-1, 
CD62E), which is a rolling receptor for leukocyte adhesion, was found to increase 
maximally 2 h post-infection (p.i.), but declined to baseline levels within 24 h p.i. 
(Shen et al., 1997).  
 
Another common outcome of virus-host interaction is the physiological process of 
cell death. Apoptosis, which is an active and highly conserved process of cellular 
self-destruction with distinctive morphological and biochemical features, was 
observed in WNV-infected K562 and Neuro-2a cells and was shown to be bax 
dependent (Parquet et al., 2001). Apoptosis has also been shown to be a major 
pathway of death in mouse neuronal cells infected with dengue virus (Despres et al., 
1996). Virus replication appears to be required since UV-inactivated virus failed to 
induce apoptosis. Apoptosis of cells might also be triggered by the M ectodomain 
(proapoptotic sequence) of WNV and similarly found in Dengue virus M protein 
(Catteau et al., 2003). Since the introduction of WNV C protein into the nuclei of host 
cells has been shown to induce apoptosis, it could contribute to the pathogenesis of 
flavivirus infection (Yang et al., 2002a). However, others found that neurons of mice 
infected with Murray Valley Encephalitis (MVE) virus do not show evidence of 
apoptosis, and the severity of the disease may be more linked to neutrophil infiltration 




It was also reported that human umbilical vein endothelial cells (HUVEC) infected 
with WNV showed an increase in nitrite secretion and a rearrangement of zonula 
occludens-1 (ZO-1) and β-catenin (Wen et al., 2001). It was thus postulated that 
WNV may modulate its entry into the CNS by altering cellular junctions of 
endothelial cells and leukocyte diapedesis across the endothelial cells.   
 
The role of host genetic factors often has a part to play in the outcome of WNV 
infection. It was found that WNV replication was less efficient in cells that produce 
the normal copy of Oas1b as compared to those expressing the inactive mutated form 
(Lucas et al., 2003).  Variation in the response of individuals to flavivirus infection 
has also been observed in humans as well as in other host species. In mice, the alleles 
of a single Mendelian dominant gene, Flv, can determine whether an infection is 
lethal (Brinton, 1986) and segregates as a Mendelian dominant trait (Sangster et al., 
1993). The Flv resistance allele functions intracellularly to reduce the amount of virus 
produced, and the lower production of virus results in a slower spread of the virus in 
the host, both of which serve to give the host defence systems sufficient time to 
effectively eliminate the infection. Most of the currently used inbred mouse strains 
are susceptible. However BRVR, BSVR, C3H.RV, Det, PRI, and most wild Mus 
musculus domesticus are resistant.  
 
As the severity of WNV infection varies between different individuals, it will be of 
interest to the study the role of host genetic factors and polymorphisms in WNV 
pathogenesis (Ceccaldi et al., 2004). Other aspects of the host immune response may 
be critical in determining the outcome of human flavivirus infection. A role for innate 
immunity in JEV infection is suggested by the elevated IFNα levels found in plasma 
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and CSF (Burke and Morill, 1987). The humoral immune response to JEV, and to 
WNV infection is characterized by early production of IgM antibodies in both serum 
and CSF, followed by production of IgG (Martin et al., 2002).  
 
1.6   Neutralization of West Nile Virus Infection 
The mouse model was used to point out the role of humoral immune response in 
limiting the spread of WNV infection in the CNS after primary replication in the 
lymph nodes (Diamond et al., 2003a), and the role of CD8+ T cells in both recovery 
and immunopathology (Wang et al., 2003). Recently, this model of infection has 
demonstrated that passive transfer of immune antibodies could improve the clinical 
outcome even after WNV had reached the CNS, although antibodies by themselves 
could not completely eliminate virus reservoirs host tissues (Engle and Diamond, 
2003). Diamond and colleagues (2003b) have recently demonstrated the role of 
specific anti-WNV neutralizing IgM in preventing CNS infection and viral-induced 
death.  
 
1.7   Global Genomic Analyses of Infected Host Cells 
Within the past 5 years, increasing sophistication in infectious diseases research has 
caused an entirely new paradigm for fighting infectious disease to emerge. The 
unraveling of the genetic code of disease-causing microorganisms has allowed new 
methods to disrupt the disease process, which involve analysis of biological systems 
and molecular structures, thus producing a ‘global picture’ (Huang et al., 2002). DNA 
microarrays lead the way in this area. This new technology allows researchers to 
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study how the entire genetic code of the invading microorganism interacts with the 
human cells it infects. 
 
1.7.1   Microarrays 
Microarrays consist of DNA molecules or probes, synthesized or attached to specific 
locations on a solid support, such as a coated glass surface. Arrays allow the 
identification of the sequence, and the abundance of each detected nucleic acid 
interrogated by the microarray. This is achieved by amplifying and labelling target 
nucleic acids from experimental samples and then monitoring the amount of label 
hybridized to each probe location (Schena, 2003). 
 
The major types of DNA microarrays currently in use can be distinguished by the 
lengths of their probes and by the method of probe deposition onto hybridization 
substrates. Microarrays that carry sequences of more than ~100bp are commonly 
created using PCR products or cDNA clones, and are referred to as cDNA arrays. 
Microarrays that possess shorter DNA sequences are termed oligonucleotide 
microarrays (Southern, 2001). 
 
Detection can be done by using radioisotopes like 32P, which gives precise 
quantification but has a wide shine and thus lower resolution. A common method is 
by using fluorescent labels like Cy5 and Cy3 that enables double labelling and high-
resolution imaging (Southern, 2001), which is detected by using scanning confocal 
microscopy. In order to measure relative gene expression by using cDNA microarrays, 
RNA is prepared from the two samples to be compared, and labelled cDNA is made 
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by reverse transcription, incorporating either Cy3 (green) or Cy5 (red) fluorescent dye. 
The two labelled cDNAs are mixed and hybridized to the microarray, and the slide is 
scanned. In cases where the green Cy3 and red Cy5 signals are overlaid, yellow spots 
indicate equal intensity for the dyes. With the use of image analysis software, signal 
intensities are determined for each dye at each element of the array, and the logarithm 
of the ratio of Cy5 intensity to Cy3 intensity is calculated. Positive log (Cy5/Cy3) 
ratios indicate relative excess of the transcript in the Cy5-labelled sample, and 
negative log (Cy5/Cy3) ratios indicate relative excess of the transcript in the Cy3-
labelled sample (Schena, 2003).  
 
1.7.2   Microarray Applications 
Gene expression microarray is a relatively new technology, yet it has already become 
a widely used tool in biology. The key fundamental issue of infectious diseases is 
how to globally and integratively understand the interactions between microbial 
pathogens and their hosts during infection (Huang et al., 2002). Microarrays are 
ideally suited in this global approach. 
 
1.7.2.1   Expression Analyses: Gene Function and Elucidation of Regulatory 
Circuitry 
Generally, gene expression experiments are designed to provide clues to gene product 
function, regulatory circuitry, and biochemical pathways. A gene is usually 
transcribed only when and where its function is required, determining the locations 
and conditions under which a gene is expressed. This allows inferences about its 
function towards pathogenesis. Experiments usually consist of comparing expression 
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levels in a disease tissue versus an unaffected tissue, or investigating cellular response 
in the presence and absence of an infectious agent (Warrington et al., 2000). 
 
The first application of global gene expression methods to pathogenesis used 
oligonucleotide arrays to monitor gene expression in primary human foreskin 
fibroblasts infected by human cytomegalovirus (CMV) and Toledo virus (Zhu et al., 
1998). The transcript abundance of 258 out of 6,600 human genes changed by more 
than fourfold, compared to uninfected cells, at either 8 or 24 h after infection. Some 
of these changes, such as induction of cytokines, stress inducible proteins, and many 
interferon-inducible genes, were consistent with induction of cellular immune 
responses (Zhu et al., 1998).  
 
With probe microarrays, the questions addressed are broader because thousands of 
genes are queried simultaneously, compared to the conventional methods of 
expression analyses of one or two genes per experiment. Large-scale analysis of the 
genome enables the elucidation of the expression patterns of the whole genome in a 
single experiment (Huang et al., 2002).  
 
1.7.2.2   Expression Analyses: Pathogenesis 
In addition to the simple observation of up and down regulation/expression of host 
genes, microarrays can also be used to ask very specific questions about the clinical 
manifestation of a disease and the role in pathogenesis of individual virulence factors 
(Huang et al., 2002). 
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Transcription profiling of macrophages and epithelial cells infected by Salmonella 
confirmed increased expression of many proinflammatory cytokines and chemokines, 
signaling molecules, transcription activators and identified several genes previously 
unrecognized to be regulated by infection (Cummings and Relman, 2000). The 
macrophage study demonstrated that exposure to purified Salmonella lipo-
polysaccharide (LPS) resulted in a very similar response profile to whole cells. The 
activation of macrophages with gamma interferon before infection modified the 
response. In epithelial cells, over-expression of κB (an inhibitor of NF-κB) blocked 
induction of gene expression for a number of regulated genes, underscoring the 
importance of NF-κB in the proinflammatory response (Detweiler et al., 2001). 
 
These data will help to identify genes with a critical role in pathogen progression and 
multiplication in the human host. Through the use of microarrays for monitoring gene 
expression profiles, infectomes of microbial and host cells during infection provide 
global and accurate information for building a comprehensive framework to interpret 
pathogenic processes (Huang et al., 2002). 
 
Global changes in gene expression of virus-infected cells in culture have been 
reported for several viruses such as human cytomegalovirus (Zhu et al., 1998), herpes 
simplex virus (Mossman et al., 2001), influenza virus (Geiss et al., 2001a), Kaposi’s 
sarcoma associated virus (Renne et al., 2001), human papillomavirus (Chang and 
Laimins, 2000) and human immunodeficiency virus type 1 (Geiss et al., 2001b). 
Studies on neurotropic viruses include rabies virus (Prosniak et al., 2001) and Sindbis 
virus (Johnston et al., 2001).  
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A virus-host interaction study on dengue virus, which is another flavivirus, was 
recently carried out using Affymetrix microarrays on human umbilical vein 
endothelial cells (Warke et al., 2003). They found 269 genes that were induced and 
126 genes that were repressed. Broad functional responses that were activated 
included the stress, defense, immune, cell adhesion, wounding, inflammatory, and 
antiviral pathways. In another study, a microarray study was conducted on the 
pathogenic WNV (NY strain) which was observed to evade the host cell innate 
antiviral response (Fredericksen et al., 2004). However, this was carried out on 293 
cells (human epithelial kidney) which do not represent the natural CNS hosts. 
Nevertheless, Fredericksen and colleagues (2004) reported that the WNV was able to 
replicate efficiently despite the activation of IFN-β and several IFN-stimulated genes 
late in infection through the IFN regulatory factor 3 (IRF-3) pathway.  
 
1.7.2.3   Expression Analyses: Time-Course Study 
A similar experimental design has been used to examine the global effects of HIV-1 
infection on cultured CD4-positive T cells. One study concluded that HIV-1 infection 
resulted in differential expression of 20 of the 1,506 human genes monitored and that 
most of these changes occurred only after 3 days in culture (Corbeil et al., 1999). In 
contrast, the preliminary results of an independent study using a similar design 
indicated that substantial HIV-induced transcription changes began very early after 
inoculation (Geiss et al., 2000). The latter study confirmed activation of nuclear 




A time-course study of Cryptococcus neoformans infection of human brain 
microvascular endothelial cells (HBMEC) was done using oligonucleotide 
microarrays to monitor the infectomes of 12,558 human genes. An ontology (gene 
functional classification) analysis revealed gene expression patterns of different 
subsets of genes within the same functional class. For example, among the 7 time-
point samples, the changes in expression profiles of the 29 MHC class II-related 
genes suggested that C. neoformans may contain superantigens stimulating the 
immune system (Huang et al., 2002). 
 
1.7.3   Microarray Data Management and Manipulations 
Microarray experiments churn out massive amounts of data in a single experiment 
and analyzing the data has proven to be more complex than carrying out the 
experiment itself. This is made especially more daunting as a standardized approach 
to analyzing microarray data is not present (Nadon and Shoemaker, 2002). 
Microarray data are cumbersome with hands-on data transformation, leading to 
human errors which often have dramatic consequences and thus, altering results 
(Grant et al., 2003). Data loading and storage usually involves several parsing and 
data transportation steps, each of which can corrupt the data from their original state. 
Data integrity management is therefore important in preventing data corruption. 
 
1.7.3.1   Identification of Differentially Regulated Genes 
To identify genes that are up- or down-regulated in the sample compared to control, 
scaling of the data is first required (Knudsen, 2002). Normalization is carried out to 
ensure that the expression levels in the sample are comparable to the expression 
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levels in the control. There are a number of reasons why data must be normalized. 
This includes the unequal quantities of starting RNA, differences in labelling or 
detection efficiencies between the fluorescent dyes used, and systematic biases in the 
measured expression levels (Quackenbush, 2002). The log2 (ratio) values can have a 
systematic dependence on intensity, which most commonly appears as a deviation 
from zero for low-intensity spots. Locally weighted linear regression (lowess) 
analysis has been proposed as a normalization method that can remove such 
systematic biases or intensity-dependent effects in the log2 (ratio) values. Lowess uses 
a weight function that deemphasies the contributions of data from array elements that 
are far from each point (Yang et al., 2002b). 
 
Duplication is essential for identifying and reducing the variation in any experimental 
assay. Duplication in a two-colour spotted array experiment can be carried out by a 
dye-reversal or flip-dye analysis for each RNA sample (Churchill, 2002). This 
process may help to compensate for any biases that may occur during labelling or 
hybridization; for example, if some genes preferentially label with the red or green 
dye. Experimental variation during duplication will lead to a distribution of the 
measured values for the log of the product ratios, log2(T1i*T2i). The consistent array 
elements between a flip-dye duplicates are expected to have a value for log2(T1i*T2i) 
close to zero. Inconsistent measurements have a value ‘far’ from zero and can be 
eliminated from further consideration. The stringency of this elimination can be 
chosen based on the number of standard deviation of the mean. Averaging over the 




Differentially regulated genes or genes exhibiting the most significant variation are 
often identified using a fixed fold-change cut-off (generally twofold) from the 
log2(ratio) figures. Another more sophisticated approach involves calculating the 
mean and standard deviation of the distribution of values and defining a global fold-
change difference and confidence; this is essentially equivalent to using a Z-score for 
the data set. Using a sliding window to determine the local structure of the data set, 
one can calculate the mean and standard deviation within a window surrounding each 
data point. An intensity-dependent Z-score threshold is defined to identify differential 
expression, where Z simply measures the number of standard deviations a particular 
data point is from the mean (Yang et al., 2002c). Differentially expressed genes at the 
95% confidence level would be those with a value of more than 1.96 standard 
deviations from the local mean. At higher intensities, this allows smaller changes to 
be identified, while applying more stringent criteria at intensities where the data are 
naturally more variable at the lower intensity regions. 
 
1.7.3.2   Identification of Gene Expression Patterns 
The data from expression arrays is often of a high dimensionality. A 10 array 
experiment with 15,000 genes will constitute a matrix of 10 x 15,000. To facilitate a 
visual analysis of the data, a reduction of the dimensionality of the matrix is 
necessary (Knudsen, 2002). Since visual analysis is traditionally performed in two 
dimensions, clustering algorithms can help in this process by grouping significantly 
changed genes into clusters that behave similarly under different conditions. 
 
The object of hierarchical clustering algorithm is to compute a dendrogram that 
assembles all elements into a single tree. For any set of n genes, an upper-diagonal 
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similarity matrix is computed, which contains similarity scores for all pairs of genes. 
The matrix is scanned to identify the highest value, representing the most similar pair 
of genes. A node is created joining these two genes, and a gene expression profile is 
computed for the node by averaging observation for the joined elements. The 
similarity matrix is updated with this new node replacing the two joined elements, and 
the process is repeated n-1 times until only a single element remains (Eisen et al., 
1998). A graphical representation of the primary data is obtained by representing each 
data point with a colour that quantitatively and qualitatively reflects the original 
experimental observations. The end product is a representation of complex gene 
expression data that, through statistical organization and graphical display, allows 
biologists to assimilate and explore the data in a natural intuitive manner. 
Relationships among objects (genes) are represented by a tree whose branch lengths 
reflect the degree of similarity between the objects. Such methods are useful in their 
ability to represent varying degrees of similarity and more distant relationships among 
groups of closely related genes (Eisen et al., 1998).  
 
Hierarchical clustering fails when the number of genes reaches several thousands. 
Calculating the distances between all of them becomes time consuming. Removing 
genes that show no significant change in any experiment is one way to reduce the 
problem. Another way is to use a faster algorithm, like K-means clustering (Knudsen, 
2002).   
 
In K-means clustering, the number of clusters can be decided by the user, and the 
algorithm then randomly assigns each gene to one of the K clusters. The distance 
between each gene and the centre of each cluster (centroid) is calculated, and the 
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genes are continually shifted to the closest cluster. The centroids will be recalculated 
after each step and the algorithm will stop after the cluster centroids no longer change 
(Soukas et al., 2000). The Figures of Merit (FOM) algorithm can be used to 
determine the appropriate number of clusters for K-means clustering. A FOM is an 
estimate of the predictive power of a clustering algorithm. It is computed by 
removing each experiment in turn from the data set, clustering genes based on the 
remaining data, and calculating the fit of the withheld experiment to the clustering 
pattern obtained from the other experiments. The lower the adjusted FOM value is, 
the higher the predictive power of the algorithm (Yeung et al., 2001).  
 
Another method of clustering is the Self Organizing Tree Algorithm (SOTA). This 
involves the use of unsupervised neural network, which grows by adopting the 
topology of a binary tree. The result of the algorithm is a hierarchical cluster obtained 
with the accuracy and robustness of a neural network. Since SOTA runtimes are 
approximately linear with the number of items to be classified, it is especially suitable 
for dealing with huge amounts of data (Herrero et al., 2001).  
 
The t-test is used to determine if genes are significantly different from a pre-defined 
mean value. Each gene whose mean log2 expression ratio over all experiments is 
significantly different from the mean value of zero (i.e. no change in expression) is 
assigned to one cluster. T-values are calculated for each gene, and p-values are 
computed either from the theoretical t-distribution, or from permutations of the data 





1.7.3.3   Quantitative Real-Time PCR (qRT-PCR) to Quantify Transcript Levels 
The two commonly used methods to analyze data from qRT-PCR experiments are 
absolute quantification and relative quantification. Absolute quantification determines 
the input copy number, usually by relating the PCR signal to a standard curve. This is 
performed when it is necessary to determine the absolute transcript copy number. 
Relative quantification relates the PCR signal of the target transcript in a treatment 
group to that of another sample such as an untreated control, and is sufficient when 
only the relative change in gene expression is needed. The 2-∆∆CT method of analysis 
is often used to calculate the relative changes in gene expression (Livak and 
Schmittgen, 2001).  
 
Standard curves derived from serial dilutions of samples provide a useful tool to 
evaluate the consistency of the PCR reactions. This will help to test the response of 
the reagent system to different starting quantities that may be found in the test 
samples. The assay should return predictable and consistent results based on the 
inputs, similar to a mathematical formula. R2 is the correlation coefficient squared and 
is a measure of how closely the calculated CT values fit the expected values. R2 is a 
positive number, and the closer to 1.00, the better the fit (BioRad, 2004). If the points 
on a standard curve do not fall on a straight line, it might be the result of some kind of 
inhibitor present in the test sample, and is representative of standard curves with R2 
values above 1.00. The inhibitor is diluted out at lower concentrations, so it does not 
affect the kinetics of the experiment at these concentrations, which may be introduced 
during the various steps of the cDNA isolation process (BioRad, 2004). 
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1.8   Objectives 
 
There are three general aims of this study: 
a. To optimize the techniques for genomic microarray studies that are tailored for 
virus-host interactions, as well as subsequent downstream confirmatory tests. 
b. To identify groups of cellular genes that might be important for the pathogenesis 
of WNV infection by comparative analysis of permissive and less permissive cells. 
c. To carry out a time-course study from early- to late-phase infection to determine 
the changes in gene regulation in response to virus replication. 
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2.0   MATERIALS AND METHODS 
 
2.1   Cell Culture 
2.1.1   Tissue Culture Techniques 
All solutions and media for cell culture were made using type 1 grade reagent water 
(NANOpure, Barnstead, USA). The chemicals used were also of ultrapure grade. 
Glass bottles were used for storage of the media. These have screw-capped lids with 
non-toxic plastic blue washer. All cell culture and media preparations were done 
under aseptic conditions in a laminar flow hood (Gelman Sciences, Australia) or in a 
biohazard hood (Gelman Sciences, Australia). Cells used in this study were grown in 
sterile 75cm2 plastic tissue culture flasks from Nunc (Denmark). 
 
2.1.2   Cell Lines 
Two human cell lines were used in this study. They were the HeLa cell line and the 
neuroblastoma cell line, A172. HeLa cells were derived from cervical 
adenocarcinoma cells obtained from a 31 years old Negroid woman. A172 cells were 
derived from the glioblastoma brain tumour cells of a 53 year old male (Giard et al., 
1973). The passage number of the cell lines used in this study was between 50 and 80. 
Vero cells, a continuous cell line that was derived from African green monkey kidney 
cells, were used for propagation of the WN virus. The passage number of the Vero 
cell line used was between 50 and 80.  
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2.1.3   Media for Cell Culture 
Dulbecco’s Modified Eagle’s media [(DMEM) (Sigma, USA – Appendix 1a)] was 
used as the growth media to culture both HeLa and A172 cells and Medium 199 
[(M199)(Sigma, USA – Appendix 1b)] was used to culture Vero cells. The media was 
prepared to manufacturer’s specifications, which was supplemented with 10% foetal 
calf serum (FCS). Sodium bicarbonate was added as a buffering agent, and the pH of 
the media was adjusted to 7.2.  
 
2.1.4   Regeneration, Cultivation and Propagation of Cell Lines 
Cells in cryo-vials were stored in liquid nitrogen. To revive the cells, each vial of the 
desired cell line was retrieved from liquid nitrogen storage and immediately thawed 
in a 37°C water bath. When thawed, the cells were transferred into a 75 cm2 culture 
flask and 15 ml of DMEM was added. The growth media was needed to dilute the 
toxic effects of dimethysulphoxide (DMSO), which was present in the preserving 
medium. The cells in the flasks were then incubated at 37°C. The growth media was 
decanted after 12 h and replaced with fresh media, after which the cells were allowed 
to grow to confluency for about 3-4 days.  
 
When the cells were confluent, the medium was discarded and the cell monolayer was 
rinsed once with 10ml PBS (Appendix 1c). This was followed by the addition of 3ml 
trypsin-versene solution (Appendix 1d) and incubated at 37°C for about 2 min. It was 
then observed under microscope to ensure that the cells have rounded up. The flask 
was tapped gently to dislodge the cell monolayer. Five ml of growth medium was 
immediately added to inactivate the enzymatic effect of the trypsin-versene solution. 
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The cell aggregates were resuspended by pipetting up and down for a few times. The 
suspension of HeLa or A172 cells was split into a ratio of 1:4 for seeding into 75 cm2 
culture flasks, and topped up to 17 ml with growth media. The cells were cultivated at 
37°C, in a humidified 5% CO2 incubator (Lunaire, USA). The monolayer reached 
confluency in about 3 days and was used for subsequent experiments.  
 
2.1.5   Cultivation of Cells on Coverslips 
Cells were grown on coverslips for immunofluorescence microscopy. Glass 
coverslips of diameter 13 mm (ARH, UK) were washed with 90% ethanol for 30 min 
and then boiled in double-distilled water for about 10 min. The coverslips were then 
left to air dry. Dry sterilisation was done in a hot air oven at 160°C (Jouan, USA) for 
2 h. The individual coverslips were subsequently placed aseptically in a 24-well 
tissue culture tray (Nunc, Denmark). Cells from a confluent cell monolayer in a 75 
cm2 flask were used. The monlayer was trypsinized (Section 2.1.4) and resuspended 
in 30 ml of DMEM. Two ml of the cell suspension were dispensed into each well. 
The trays were then left at 37°C in the 5% CO2 incubator (Lunaire, USA) until they 
were 50 to 70% confluent. 
 
2.2   Infection of Cells 
2.2.1   Virus Strains 
The virus used in this study was West Nile (Sarafend) virus [WN(S)V] – a gift from 
Emeritus Professor Westaway, Sir Albert Sakzewski Virus Research Laboratory, 
Queensland, Australia. The virus stock was propagated in Vero cells throughout the 
study, and introduced into the human cell lines, HeLa and A172, for infection studies. 
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The virus was not ‘adapted’ to the human cell lines prior to infection, so as to ensure 
that a base level of comparison can be obtained by using the same virus stock. This 
was also to prevent any form of attenuation to the virus when grown in HeLa cells 
(Dunster et al., 1990).  
 
2.2.2   Infection of Cell Monolayers and Production of Virus Pool 
A confluent cell monolayer of about 3 days old from a 75 cm2 culture flask was used 
for infection. The growth medium was discarded and the monolayer was washed with 
5 ml of virus diluent (Appendix 2a). A volume of 1 ml of virus suspension with 
multiplicity of infection (MOI) = 10 was inoculated onto the cell monolayer. The 
flask was incubated at 37°C for 1 h and rocked every 15 min to ensure even infection 
of the cell monolayer. After 1 h of virus adsorption, 10 ml of maintenance medium 
(Appendix 2b, c) was added to the flask. The infected cells were then incubated at 
37°C for 24 h. Mock-infected controls on HeLa and A172 cells were prepared in the 
above manner; with 1 ml of virus diluent (Appendix 2a) used instead of virus 
suspension. 
 
At the end of the incubation period, the maintenance medium containing extracellular 
virus particles was then harvested. The supernatant was first spun on a bench top 
centrifuge (Sigma Model 3K15, USA) at 1,000 rpm for 10 min at 4°C to remove cell 
debris. One ml of this supernatant was aliquoted into sterile cryo-vials, sealed and 
frozen immediately in cold ethanol (-80°C). The vials were subsequently stored at -
80°C.   
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2.2.3   Plaque Assay 
Virus stock was diluted in ten-fold serial dilutions using virus diluent (Appendix 2a) 
from 10-1 to 10-8 dilutions. Aliquots containing 0.1 ml of the appropriate dilutions 
were inoculated onto a day-old confluent Vero cell monolayer grown in a 24-well 
culture plate (Nunc, Denmark).  The virus was allowed to adsorb to the cells at 37°C 
for 1 h, with gentle rocking at 15 min intervals. Following that, the excess inoculate 
were removed and the wells washed gently with virus diluent. One ml of overlay 
media (Appendix 2d) was added to each well. The plate was placed in a humidified 
37°C, 5% CO2 incubator (Lunaire, USA). After about 4 days of incubation, the 
overlay media was decanted and then stained with 1% crystal violet solution 
(Appendix 2e) for 1 h at room temperature. Thereafter, the plate was rinsed twice 
with water and dried. The number of plaques obtained was then counted.  
 
The virus was plaqued on Vero cells, even though they had been passaged in HeLa 
and A172 cells, so that a basal level of comparison can be obtained. It had also been 
reported that HeLa cell plaque assays were unreliable (Dunster et al., 1990).  
 
2.3   Light Microscopy 
When the monolayers reached 70% confluency, the cells were infected with WN(S) 
virus as before (Section 2.2.2). The flasks were incubated for 24 h until cytopathic 
effects (CPE) was observed. The flasks were then visualised under an optical 
microscope (IX81, Olympus, Japan) that was linked to a digital camera. Pictures of 
the virus-infected and mock-infected control cells were taken under phase-contrast at 
magnifications of 100x and 400x.  
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2.4   Genomic Expression Studies 
Microarray assays are essentially miniaturized hybridization assays for studying 
thousands of nucleic acid fragments simultaneously. Figure 2-1 shows the key 
components of a basic microarray experiment. 
Figure 2-1. The main steps in a microarray experiment involves probe preparation, 
hybridization, scanning and data analysis.  (Amersham Biosciences, 2002) 
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2.4.1   Microarrays 
Microarrays consist of a collection of nucleic acid sequences immobilized onto a 
solid support so that each unique sequence forms a tiny feature, called a ‘spot’ or 
‘target’. Agilent’s Human 1A Oligo Microarrays (Agilent Technologies, USA) were 
used for this study. It comprised of 22,575 (60-mer) oligonucleotide probes 
representing 17,803 well-characterized, full length, human genes from the Incyte 
Genomics Foundation Database. One thousand and seventy-five of the probes were 
quality control features consisting of negative controls, performance controls, oligo 
synthesis controls, microarray 
location controls and feature 
morphology controls.  
 
2.4.2   Probe Labelling 
Total cellular RNA was the 
starting material for this 
microarray experiment, which 
was subsequently converted to 
a labelled population of cDNA, 
known as the ‘probe’. These 
probes frequently consisted of 
several thousands of different 
labelled fluorescent cyanine 
dyes (Cy3 and Cy5) coupled 
to the nucleic acid fragments. 
Figure 2-2. The main steps involved in probe labelling.  
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These fluorescent dyes are compatible with current microarray formats, with high 
spectral separation, high incorporation rates with a variety of enzymes, and fluoresce 
brightly when dry. Fluorescence has the advantage of permitting the detection of two 
or more different signals in one experiment. It has also increased the accuracy and 
throughput of microarray analysis over filter-based macroarrays, in which only one 
radioactively labelled sample can be conveniently analyzed at a time (Amersham 
Biosciences, 2002). CyDyes should be protected from light during all handling and 
storage. Figure 2-2 shows the main steps involved in probe labelling.  
 
However, it should be noted that CyDyes exhibit different quantum yields during 
incorporation. Cy5 also has the disadvantage that it sometimes gives high background 
levels on glass surfaces and is more sensitive to photobleaching than Cy3 [(Bilban et 
al., 2002) (See also Section 4.2.1.2)]. 
 
2.4.2.1   Total RNA Isolation from Cell Culture 
RNA is prone to disintegration from ubiquitous ribonucleases (RNase), therefore it is 
important to stabilize RNA and adopt proper RNA handling techniques. A cell 
monolayer was first scrapped off using a cell scrapper (Nunc, Denmark) and pelleted 
in RNase-free eppendorf tubes by centrifugation at 500 x g for 5min. The supernatant 
was then discarded and the cells were washed with PBS (Appendix 1c) to remove all 
media. The cells were resuspended in 100 µl of PBS and 1 ml of RNAlater RNA 
Stabilization Reagent (Ambion Inc, USA) was added, which protects RNA in cells by 
preventing unwanted changes in the gene-expression patterns due to RNA 
degradation or new induction of genes. The cell sample can then be stored at 4°C. 
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Total RNA isolation was carried out using QIAGEN RNeasy Mini Kit (QIAGEN 
GmbH, Germany) according to the manufacturer’s recommended protocol. Briefly, 
the cells were pelleted at 3000 x g to remove the RNAlater RNA Stabilization 
Reagent. A higher centrifugal force was necessary to pellet the cells since the 
stabilization reagent has a higher density that most cell-culture media. After the lysis 
of cells to release RNA, homogenization of the sample is required to reduce the 
viscosity of the cell lysates by shearing the high-molecular weight genomic DNA and 
other high-molecular weight cellular components to create a homogeneous lysate. 
Homogenization would disrupt the cells and thus increase the yield of RNA and this 
was carried out using QIAshredder (QIAGEN GmbH, Germany) according to the 
manufacturer’s protocol. RNA was eluted out in 60 µl of RNase-free water and stored 
at -20°C for later use.  
 
2.4.2.2   RNA Quantification and Quality Determination 
RNA concentration, of an appropriately diluted sample in DEPC water (Appendix 3a), 
can be determined by measuring the absorbance at 260 nm (A260) in a 
spectrophotometer (Shimadzu-UV 1601, Australia). An absorbance of 1 unit at 260 
nm corresponds to 40 µg of RNA per ml. Cuvettes (Hellma GmbH, Germany) used 
for measurement had to be RNase-free. The purity of RNA was determined by taking 
the ratio of the readings at 260 nm and 280 nm (A260/A280). Pure RNA has an 
A260/A280 ratio of 1.9-2.1.  
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2.4.2.3   Determination of RNA Integrity 
The integrity and size distribution of total RNA extracted was checked by denaturing 
formaldehyde-agarose (FA) gel (Appendix 3b) electrophoresis. The respective 
ribosomal bands (1.9kb and 5.0kb for 18S and 28S rRNA, respectively) should 
appear as sharp bands on stained gels. Degraded RNA samples (smearing of the 
ribosomal bands) should not be used to proceed with microarray analysis. Prior to 
running the gel, equilibrate the gel in 1 X FA gel running buffer (Appendix 3c) for at 
least 30 min. Two µl of RNA sample was mixed with 8 µl of RNA loading buffer 
(Appendix 3d) and mixed. Ten µl of each mixture was incubated for 5 min at 65°C, 
and then chilled on ice.  The equilibrated FA gel was electrophoresied at 100V for 1.5 
h. The gel was subsequently visualized under UV and images captured using 
ChemiGenius2 (Syngene, UK).  
 
2.4.2.4   Reverse Transcription and Labelling 
mRNA has to be reverse-transcribed into labelled cDNA for use on microarrays. In 
the initial phase of microarray experiments, CyScribe First-Strand cDNA Labelling 
Kit (Amersham Biosciences, USA) was used to incorporate Cy3-dCTP and Cy5-
dCTP (both from Amersham Biosciences, USA) into cDNA probes in first-strand 
cDNA synthesis reactions. This labelling kit was used in microarray experiments for 
the comparison between A172 and HeLa cells after 24 h p.i. with WN(S)V. Twenty-
five µg of total RNA from each infected and mock-infected cell lines was used as the 
starting sample. Priming with anchored oligo(dT) will direct the start of the synthesis 
of cDNA from the 5’ end of the poly-A-tail by the reverse transcriptase. The labelled 
cDNA obtained using this method undergoes no amplification in amount.  
 
Materials & Methods 
 40
The fluorescent cDNA probes require purification from the RNA template, and 
unincorporated fluorescent nucleotides have to be removed, in order to maximize 
hybridization signal and minimize non-specific hybridization background on 
microarrays. The RNA template was degraded with alkaline hydrolysis treatment 
with the addition of 2 µl of 2.5 M NaOH (Appendix 3e) into each microcentrifuge 
tube containing the labelling reactions and incubated at 37°C. Ten µl of 2 M HEPES 
free acid (Appendix 3f) was added to each reaction tube after 15 min to neutralize the 
reaction mixture.  
 
After neutralization, the labelling reactions were ready for purification. This was 
carried out using CyScribe GFX Purification Kit (Amersham Biosciences, USA) 
according to the manufacturer’s protocol, which achieved 50% or higher of cDNA 
recovery and removed unincorporated nucleotides from the labelled cDNA. The 
purified labelled cDNA was eluted out in 120 µl of Elution Buffer.  
 
2.4.2.5   Quantification of cDNA Yield and Incorporation of Fluorescent 
Nucleotides 
The yield of fluorescent probe is determined not only by the success of the labelling 
step and by the amount of template RNA used in the reaction, but also by the 
recovery of labelled material from the purification system. In order to produce 
reproducible and high-quality microarray results, it is imperative to use balanced and 
optimal amounts of fluorescently-labelled samples in hybridizations. Quantifying the 
amount of Cy3 and Cy5 incorporation into cDNA is therefore necessary.  
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Absorbance of the purified sample was measured against blank (ddH20) at 550 nm for 
Cy3 and at 650 nm for Cy5 in a 100 µl cuvette (Hellma GmbH, Germany). The 
amount of Cy3 and Cy5 incorporated into cDNA was calculated as follows: 
pmol CyDye in sample = (A/E) x Z x 106 
where A = absorbance of Cy3 (at 550 nm) or Cy5 (at 650 nm), E = extinction 
coefficient for Cy3 (150,000 lmol-1cm-1) or Cy5 (250,000 lmol-1cm-1), Z = volume of 
purified cDNA in µl (=120 µl).  
 
2.4.3   Microarray Hybridization 
In microarray hybridization, the labelled fragments in the probe are expected to form 
duplexes with their immobilized complementary targets. This requires the nucleic 
acids to be single-stranded and accessible to each other. The number of duplexes 
formed during hybridization reflects the relative number of each specific fragment in 
the probe. Hybridization should be carried out under stringent conditions (high 
temperature) that do not promote annealing of non-complementary fragments.  
 
Hybridization preparations were carried out according to Agilent Technologies (USA) 
Oligonucleotide Microarray Hybridization protocol in conjunction with Agilent’s In-
situ Hybridization Kit Plus (Agilent Technologies, USA). Equal amounts of Cy3 and 
Cy5 labelled cDNA (20-40 pmol each) were suspended in 100 µl of nuclease-free 
water (Gibco BRL, USA). The resuspended cDNA was heat denatured for 3 min at 
98°C, and then cooled to room temperature. Twenty-five µl of 10x Control Targets 
and 125 µl of 2x Hybridization Buffer were added to give a total volume of 250 µl, 
and immediately used for hybridization.  
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Lucidea SlidePro Hybridizer (Amersham BioSciences, USA), an automated 
instrument for performing hybridization, was initially used in the hybridization 
reactions for the comparison between A172 and HeLa cells. An automated system 
helps to minimize and control variations in environmental conditions during 
hybridization to produce a consistent fluorescent signal within and between slides. 
Variations are a common occurrence in manual hybridization methods due to probe 
depletion and target saturation. Pre-wash of the instrument was carried according to 
the manufacturer’s protocol before inserting the slide. Two hundred and fifty µl of the 
reaction mixture was injected into the chamber and allowed to hybridize to the target 
for 17 h at 60°C. After hybridization, the slides are washed in Wash Solution 1 
(Appendix 3g) for 10 min at room temperature to remove all unattached and loosely 
bound probe molecules, and subsequently in Wash Solution 2 (Appendix 3h) for 5 
min at 4°C. The slides were then dried immediately with an air-pump to prevent 
smearing. The hybridization, washing and drying steps were automatically performed 
by the Lucidea SlidePro. 
 
2.4.4   Scanning 
Scanning of the processed microarrays was performed on Axon’s GenePix 4000B 
Microarray Scanner (Axon Instruments, USA). It consists of a confocal microscope 
attached to a detector system and scanned with two different lasers that emit light at 
635 nm and 532 nm for Cy5 and Cy3, respectively, allowing high-resolution (5 µm) 
detection of the hybridization signals. Scanning was carried out according to the 
manufacturer’s user guide before undergoing data analysis.  
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2.4.5   Protocol from Agilent Technologies (USA)  
After the scanning of the initial lot of microarray slides that were labelled with 
Amersham’s CyScribe First-Strand cDNA Labelling Kit and hybridized on the 
Lucidea SlidePro Hybridizer, it was observed that the hybridization pattern on some 
of the slides were ‘patchy’. The amount of fluorescence from the spots was not 
evenly distributed across the whole microarray slide. This resulted in wastage of 
some microarray slides as they could not be reused. An alternative probe labelling 
and hybridization protocol was 
therefore utilized to optimize the 
results. These were carried out on 
the second phase of microarray 
experiments, which was a time-
series of virus infections (i.e. 1.5 h, 6 
h, 12 h, 18 h, 24 h p.i.) in A172 cells. 
 
Agilent Technologies Fluorescent 
Linear Amplification kit (Agilent 
Technologies, USA) was used for 
the probe labelling from total RNA 
(Section 2.4.2.1-3). Instead of 
labelled cDNA probes, this kit 
produces labelled cRNA probes 
from Cy3/5-CTP (Perkin Elmer, 
USA) as the end product, with an 
amplification of RNA from a smaller Figure 2-3. Procedural overview of the linear amplification labelling step.  
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amount of starting material. Only 5 µg of total RNA was required, compared to 25 µg 
above. 
 
Five µl of T7 promoter primer was added to 5 µg of total RNA. This was topped up 
with nuclease-free water (Gibco BRL, USA) to 9.5 µl. The primer and template was 
denatured at 65°C for 10 mins and chilled on ice. Reverse transcriptase (MMLV-RT) 
was then added and incubated at 40°C for 4 h, after which it was inactivated at 65°C 
for 15 min. Four µl of the respective Cy3/5-CTP dyes were added together with the 
T7 polymerase for the amplification step. The samples were then incubated at 40°C 
for 1 h. A workflow of this new labelling strategy is shown in Figure 2-3. 
 
Purification of the labelled products was carried out through the precipitation of 
labelled cRNA. This was achieved through the addition of 80 µl of 4.0 M LiCl and 
stored at -20°C overnight. The cRNA was pelleted through centrifugation at 
maximum speed for 20 min. The pellet was then rinsed with 70% ethanol, and the 
pellet was allowed to dry at room temperature for 10 min. Each pellet was 
resuspended in 100 µl of nuclease-free water (Gibco BRL, USA). The amount of 
incorporated CyDyes in the cRNA was again quantified as described in Section 
2.4.2.5 and equal amounts were combined. Ten µl of 25x Fragmentation Buffer was 
added and incubated at 60°C for 30 min in the dark. This prevents self-annealing of 
the RNA during long hybridization. Just before hybridization, 250 µl of 2x 
Hybridization Buffer was added to the mixture.  
 
Hybridization was carried out as described in Section 2.4.3, except that the automated 
Lucidea SlidePro Hybridizer was not used. Manual hybridization was carried out on 
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the SureHyb Chambers (Agilent Technologies, USA) instead, according to the 
manufacturer’s protocol. The hybridization mixture was dispensed on the microarray 
and enclosed inside the hybridization chamber. Care was taken to ensure that the 
bubbles within the chamber were free to move when rotated. The whole chamber was 
then mounted in a preheated hybridization oven (Labnet ProBlot 6TM, USA) at 60°C 
for 17 h with a rotational speed of 4 rpm. Washing of the slides was also carried out 
manually. After hybridization, the microarray was disassembled from the 
hybridization chamber and immersed in a 250 ml Pyrex beaker filled with Wash 
Solution 1 (Appendix 3g) under a magnetic stirrer (Stuart Scientific SB162, UK) for 
10 min. The microarray was then transferred to a second beaker filled with Wash 
Solution 2 (Appendix 3h) maintained at 4°C for 5 min. Finally, the microarray was 
carefully lifted out and a nitrogen-gas gun was used to dry the slide. The microarray 
slide was then immediately scanned (Section 2.4.4). 
 
2.4.6   Data Analysis 
Transforming images into gene expression matrix is a non-trivial process (Brazma 
and Vilo, 2000). The spots corresponding to genes on the microarray should be 
identified, their boundaries determined, the fluorescence intensity from each spot 
measured and compared to the background intensity. It should be noted that methods 
for the analysis of microarray data are still evolving, and there is currently no 
standard experimental design or method of data analysis for microarray experiments.  
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2.4.6.1   Image Analysis 
The first step in the microarray workflow was to locate the spots within the scanned 
image. The positions of the spot have to be accurately defined and measurement of 
fluorescence intensity for each spot was carried out by quantifying the intensities of 
pixels within (foreground) and outside (background) the spot. GenePix Pro 4.1 (Axon 
Instruments, USA) was able to automate the spotfinding process by aligning a grid of 
spots over the scanned image of the array. The file for the grid patterns with the 
corresponding gene annotations was supplied by Agilent.  
 
2.4.6.2   Quality Control Check 
Quality control spots were next checked using the software to ensure that the 
hybridization process occurred correctly. Negative control spots should not give any 
signal at all, while positive control spots consisting of housekeeping genes should 
usually show up, but may vary depending on experimental conditions. Control spots 
were identified according to the gene array list supplied by Agilent. The negative 
controls should have a signal-to-noise (SNR) ratio of less than 3 (SNR = [average 
signal – average background]/standard deviation of background). Any higher SNR 
than 3 suggests that the data obtained from the experiment may not be accurate.   
 
Bad spots are defined as having less than 55% of their pixels brighter than the median 
background intensity at both wavelengths. These bad spots are ‘flagged’ and removed 
from the list. 
 
A lower limit of detection was determined by calculating the standard deviation of the 
background subtracted by the median intensities of negative control spots. This 
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standard deviation was then multiplied by 3 to give the value of the lower limit of 
detection. Spots on the microarray whose pixel intensities fall below this lower limit 
were removed from the list. These spots were deemed to be below the threshold for 
reliable pixel intensity detection.  
 
2.4.6.3   Database Generation and Analysis 
The data for all remaining spots were exported as .txt files from GenePix Pro as tab-
limited format, and read with Excel XP. Normalization and analyses were performed 
using BRB ArrayTools 3.1 (National Cancer Institute, http://linus.nci.nih.gov/BRB-
ArrayTools.html), which encompasses the statistical software R within the Excel 
framework. The data was then logarithmic (base 2) transformed before Lowess (or 
intensity-dependent) normalization (Yang et al., 2002b) was carried out. This will 
reduce variability in the data across slides due to the differences in the signal intensity 
values between the 2 dyes. A logarithmic scale was used because transforming 
expression data to log scale removes much of the proportional relationship between 
random error and signal intensity. Distributions of replicated logged expression 
values and log ratios tend to be normal (Nadon and Shoemaker, 2002). Since the 
CyDyes were switched on the replicate microarrays, the calculation of the Log2 ratios 
had to be switched accordingly. This was performed to prevent CyDye bias during 
incorporation of dyes into certain genes. The virus sample is always compared against 
the control sample. Positive Log ratios would therefore, indicate that mRNA from the 
virus sample was in abundance, whereas negative Log ratios would indicate the 
reverse. The data was then screened for genes with at least a 2-fold change in 
expression values.  
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Software from The Institute of Genomic Research (TIGR) were used for the more 
advanced analysis carried out in the second part of this study. The 2 programmes used 
were MIDAS and MeV (Saeed et al., 2003). 
 
MIDAS was used to perform a number of transformations on the data to eliminate 
questionable or low quality data. It also adjusts the measured intensities to facilitate 
comparisons, and to select those genes that are significantly differentially expressed. 
Lowess normalization was first performed after importing the microarray data into 
the software, so that the raw data can be compared across the 2 channels. A flip-dye 
consistency checking was then carried out between the flip-dye pairs of experiments. 
Inconsistent spots whose intensities deviate by more than 2SD are removed from the 
list. Finally slice analysis was carried out to classify and filter spots based on their 
expression levels. Differentially regulated genes can be identified at a 95% 
confidence interval.  
 
To perform the clustering analyses to determine the trends in gene expressions, MeV 
was used to carry out clustering algorithms and to generate the graphical output. 
Various clustering methods were carried out to determine the best method. The 
functions of these different methods are highlighted in Section 1.7.3.2. Data 
generated by MIDAS was uploaded into MeV before starting the algorithms. 
Hierarchical clustering, K-means clustering, Self Organizing Tree Algorithm (SOTA), 
Figures of Merit (FOM) test, and t-tests were all carried out individually. The 
graphical outputs were then inspected and the most coherent clusters were selected. 
The genes in each cluster were subsequently analysed for any significance or 
relevance to the virus-host infection system being studied.   
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Up and down regulated genes or clusters of genes were then separately uploaded into 
EASE (Hosack et al., 2003). This software helps to classify the uploaded genes 
according to their biological themes or ontology groups. Genes from any functional 
groups which are significantly over-represented or predominate during the virus 
infection process are identified. For example, if there are 10 genes known to be 
involved in apoptosis, and 8 genes relating to apoptosis were found to be 
differentially regulated, EASE will identify the apoptosis ontology group to be highly 
over-represented. If only 1 gene relating to apoptosis was found, this ontology group 
will not be selected. Biological categories with Fisher’s exact test of P-values less 
than 0.05 were selected. 
 
2.5   Indirect Immunofluorescence Microscopy 
For immunofluorescence microscopy, the cells were cultivated as described in 
Section 2.1.5. When the monolayers reached confluency of about 70%, the cells were 
infected with WN(S)V as before (Section 2.2.2). Each coverslip in the 24-well tissue 
culture plate was infected with 50 µl of virus and incubated for 1 h at 37°C. After 1 h 
adsorption, the excess innocula were removed before 1.5 ml of DMEM was added. 
Mock-infected cells using virus diluent was used as controls. The plate was incubated 
at various time points until it is ready for immunofluorescence microscopy studies. 
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The antisera used and their sources are described as below: 
Table 2.1: Antibodies and their working dilution used in IFA. 
Type of antibody Name Dilution 
Mouse monoclonal anti-tubulinα antibody 
(Amersham Biosciences, UK) 
1:250 
  
Mouse monoclonal anti-actin antibody 
(Chemicon International, USA) 
1:250 
  
Rabbit polyclonal anti- WNV Envelope protein 





Sheep anti-mouse Ig, flourescein isothiocynate 
(FITC) linked (Amersham Biosciences, UK) 
1:500 
  
Donkey anti-rabbit Ig, Texas Red™ linked 






The infected and control cells were washed twice with cold PBS (Appendix 1c) and 
then fixed with cold methanol (Merck, Germany) for 10 min at -20°C. This was 
followed by a wash in cold PBS for 15 min. The cells were then blocked with cold 
0.1% BSA (Appendix 4a) in PBS to prevent non-specific attachment of antibodies.  
 
Primary antibodies were diluted as detailed above in Table 2.1. Fifty µl of the diluted 
antibodies was spotted on parafilm. Coverslips seeded with cells were then inverted 
over the drop of antibody and incubated for 1 h at 37°C in a humid chamber. After 
incubation, the excess antibodies were washed off thrice with cold 0.1% BSA in PBS 
for 5 min each at room temperature. Species-specific secondary antibodies were 
appropriately diluted in PBS as detailed in Table 2.1. Coverslips were similarly 
exposed to the secondary antibodies as above. After incubation, the coverslips were 
washed three times with cold PBS for 5 min each. For double immuno-labelling, 
secondary antibodies of different species specificity were added in succession. 
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A single drop of mountant (Appendix 4b) was placed on ethanol-cleaned glass slides 
and the coverslips inverted over the mountant. Excess mountant was blotted with lint-
free paper (Kimwipe, Kimberly Clark, Canada). Fluorescence was visualised under 
optical immunofluorescence microscopy (IX81, Olympus, Japan) using oil immersion 
objectives. FITC (480 nm) and Texas Red (543 nm) emit green and red fluorescence, 
respectively. When the two fluorescent stains are co-localized, yellow fluorescence 
would be detected. Where relevant, quantification of the fluorescent intensity was 
performed using the MetaMorph software (Universal Imaging Corporation, USA).  
 
2.6 Quantitative Real-Time PCR 
2.6.1   List of Oligonucleotides Synthesised During the Project 
Appendix 5 lists the oligonucleotides (Proligo, Singapore) that were synthesised and 
used in the quantitative analyses of RNA transcripts. (+) denotes sense orientation; (-) 
anti-sense orientation. Primers against target genes for qRT-PCR should optimally be 
in the range of 100-180 bp to allow for efficient thermal cycling and binding of the 
SYBR dye. As such, designing a primer based on the 60 bp oligonucleotide probes 
found on the microarray is insufficient. Sequences for the primers against target genes 
were primarily sourced from the online database ‘PrimerBank’ 
[(http://pga.mgh.harvard.edu/primerbank/) (Wang and Seed, 2003)].  PrimerBank is a 
public resource for PCR primers, which is designed for gene expression detection or 
quantification (real-time PCR). If primers for a particular gene of interest are not 
found in PrimerBank, then ‘Primer3’ [(http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi) (Rozen and Skaletsky, 2000)] was used as a tool to 
generate optimal primers based on target gene sequences.  
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2.6.2   Real-Time PCR 
New samples of total cellular RNA, different from the microarray batch, were 
extracted as described in Section 2.4.2.1. An additional DNase treatment step was 
included to remove all contaminating genomic DNA as qRT-PCR is a very sensitive 
quantification method. The qRT-PCR was performed in two steps; reverse 
transcription to cDNA and then followed by real-time PCR. For cDNA synthesis, 5 
µg of total RNA was reverse transcribed using 200U SuperScript III (Invitrogen, 
USA) in a total volume of 20 µl containing 500 µM dNTP mix, 5 mM MgCl2, 20 mM 
DTT, 40U RNaseOUT, primed with 2.5 µM oligo(dT). Reverse transcription was 
performed at 50°C for 50 min, followed by 85°C for 5 min, according to the 
manufacturer’s protocol.  
 
For the quantification of viral transcripts, the primer used was targeted against the 
WNV envelope (E) gene. Even though a similar SYBR green-based qPCR assay has 
been reportedly carried out (Papin et al., 2004), this was however on the E region of 
the WNV/NY99 strain. Due to strain variability, a different primer pair for the E gene 
was developed in this study. During reverse transcription, the WN(S)V E (-) primer 
(Appendix 5) was used, instead of oligo(dT), to target the E region specifically during 
the cDNA synthesis reaction. All the cDNAs were subsequently diluted 1:10 with 
sterile Nanopure H2O. 
 
For real-time PCR, 25 µl reaction mixture containing 2 µl of diluted cDNA, 12.5 µl of 
Platinum SYBR Green (Invitrogen, USA) and 0.2 µM of both forward and reverse 
primers (Proligo, USA) (Appendix 5) was used. A negative template control that 
contained all SYBR green reagents except DNA was performed in parallel. Reactions 
Materials & Methods 
 53
were cycled at 50°C for 2 min and then 95°C for 2 min, followed by 45 cycles of 
95°C for 15 s, 60°C for 30 s and 72°C for 30 s, followed by a melting curve analysis. 
These were performed on the iCycler iQ (Bio-Rad, USA). Each gene was quantified 
at least 3 times, with a triplicate sample each time. This was to increase the statistical 
power and to average the readings.  
 
A calibration curve containing 5 points ranging from 100 fg to 1 ng of cDNA was 
used as a standard. The hypoxanthine guanine phosphoribosyltransferase (HPRT1) 
gene was used as an internal control for normalization (Johnson et al., 2004; 
Vandesompele et al., 2002), as it is a putative housekeeping gene. Other common 
housekeeping genes, such as G6PH and GAPDH, were found to be differentially 
expressed during virus infection. The threshold cycle (CT) values were then translated 
into relative copy numbers of cDNA by using the 2-∆∆CT method of calculation (Livak 
and Schmittgen, 2001) as follows: 
 
Relative change = 2-∆∆CT 





3.0   RESULTS – Comparison between HeLa and A172 cells 
 
Numerous studies on WNV are carried out on non-human host cells (e.g. Vero, C6/36, 
etc.) in vitro, but few are done on human cell lines and thus, the virus-host 
interactions have not been clearly established hitherto. In this study, West Nile 
(Sarafend) [WN(S)] virus was used to infect human cells. HeLa (human cervical 
carcinoma) cells were initially used in this study as it was a readily available cell line 
in laboratories and is of human origins. Studies on infectivity rates were performed on 
HeLa cells, but were found to be relatively poor. A172 (human brain glioblastoma) 
cells were subsequently obtained and were found to be highly susceptibility to WN(S) 
virus infection. A global genomics method was therefore carried out to compare the 
infectomics between HeLa and A172 cells.  
 
3.1   West Nile (Sarafend) Virus [WN(S)V] Infection on HeLa Cells 
When WN(S)V was used to infect HeLa cells, it was found that cytopathic effects 
(CPE) were not extensive when compared to Vero cells, from which the virus stock 
was obtained. HeLa cells generally remained quite intact after initial infection and 
managed to continue propagating slowly in the maintenance medium (2% FCS).  
 
Figure 3-1 shows mock-infected (control) HeLa cells and Figure 3-2 shows WN(S) 
virus-infected HeLa cells. It was observed that HeLa formed a packed monolayer 
typical of epidermal cells. Virus-infected HeLa cells showed some signs of CPE with 
some cell-rounding and cell lysis. Loss of plasma membrane integrity can be seen in 
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some of the infected cells. Cell lysis or lifting of cells from the growing substrate 
were, however, less prominent when compared to A172 cells.  
     
[A]      [B] 
Figure 3-1. Normal epidermal cell morphology is observed for the mock-infected 
control HeLa cells when viewed under phase-contrast microscopy. The magnification 
is 100x and 400x in [A] and [B], respectively.  
 
 
     
[A]      [B] 
Figure 3-2. Prominent cell-rounding (arrow-1) is observed in the WN(S) virus-
infected HeLa cells. Some of the cells exhibit a loss of plasma membrane integrity or 
membrane blebbing (arrow-2), while others exhibit highly condensed nuclear material 
(arrow-3). The HeLa cells generally exhibit less severe CPE when compared to A172 






3.2   West Nile (Sarafend) Virus Infection on A172 Cells 
As WNV is known to cause encephalitis and targets the brainstem, WN(S) virus was 
therefore expected to show enhanced cytopathic effects on A172 cells, which is a 
brain glial blastoma cell line.  
 
Figure 3-3 shows mock-infected (control) A172 cells and Figure 3-4 shows WN(S) 
virus-infected A172 cells, where widespread CPE was found. Extensive lifting of 
infected cells and lysis of cells were observed in the virus-infected cells. Cell 
shrinkage and condensation were also readily observed, with many fragmented cells. 





     
[A]      [B] 
Figure 3-3.  Normal neuro-glial morphology is observed for the mock-infected A172 
cells when viewed under phase-contrast microscopy. The magnification is 100x and 
400x in [A] and [B], respectively. 
 
 
     
[A]      [B] 
Figure 3-4.   Extensive CPE with cell-lifting off the growing substrate are observed 
for WN(S)V-infected A172 cells. Cell shrinkage and condensation are observed 
(arrow-1). Most of the cells have lysed due to the aggressive virus infection (arrow-2). 
A172 cells exhibit much more severe CPE compared to HeLa cells (Figure 3-2). The 






3.3   Plaque Assay Studies 
The virus stock for this study was produced in Vero cells, which was the preferred 
cell line for growing WN(S)V with high titres of 108 PFU/ml. The virus was not 
adapted by passaging through the various cell lines to provide a basal level for 
comparison.  
 
The virus titre obtained from WN(S)V-infected HeLa cells was consistently around 
106 PFU/ml even after nearly 48 h of infection. In comparison, the virus titre obtained 
from WN(S)V-infected A172 cells was in the range of 108 PFU/ml after just 24 h of 
infection. The A172 cells were therefore more permissive to WN(S)V infection 
compared to HeLa cells. The virus titres in the HeLa cells were about 100-fold lower 
than that in infected-A172 cells. Figure 3-5 shows the histogram from the plaque 















Figure 3-5. WN(S)V titres obtained from three different cell lines. 
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3.4   Quantitative Real-Time PCR (qPCR) 
Another method was used to determine the efficiency of virus replication in the two 
different cell lines. qPCR is reported to be the most sensitive method to quantify the 
number of copies of viral genomic RNA within the cell, and has been used to quantify 
the virus yield in clinical settings. In this study, the target of the qPCR was against the 
WN(S)V envelope (E) gene, which forms the envelope protein of the virus. The 
procedure for this was described in Section 2.6.2.  
 
Figure 3-6 shows the standard curve obtained from a serial dilution of the WN(S)V E 
gene. The correlation coefficient of the standard curve has a value of R2 = 0.998, thus 
representing a closely fit curve encompassing the 6-fold dilution range. It can 
therefore be inferred that test results which fall within this range will be highly 
accurate. From the slope of the curve, a 10-fold dilution represented a CT change of 
4.07. Figure 3-7 shows the evenly-spaced amplification plot obtained for the dilution 
series. Figure 3-8 shows the amplification plot obtained for the WN(S)V E gene 
qPCR tests on A172 and HeLa cells from one set of experiment, and the 
corresponding dissociation curve (denoting specificity) is shown in Figure 3-9.  
 
Tables 3-1 and 3-2 give the data obtained for the qRT-PCR studies for the relative 
quantity of the E gene transcripts at 12 h and 24 h p.i., respectively. From the analysis, 
the amount of E gene transcripts are 8.18x and 4.48x more in A172 than HeLa cells, 




Figure 3-6. Standard curve for WN(S)V E gene. 
 
Figure 3-7. Amplification plot for dilution series of WN(S)V E gene target. The 
samples were ten-fold serially diluted, and were carried out in triplicates. Each line 













Figure 3-9. Dissociation (melt) curve for qRT-PCR. 
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Table 3-1.  Data from qRT-PCR on WN(S)V E gene at 12 hours p.i. 
Test number CT (HeLa) CT (A172) ∆CT Fold Change 
1 36.42 32.95 3.47 8.52 
2 31.03 26.89 4.14 10.17 
3 29.48 27.10 2.38 5.84 
Average    8.18 
 
Table 3-2.  Data from qRT-PCR on WN(S)V E gene at 24 hours p.i. 
Test number CT (HeLa) CT (A172) ∆CT Fold Change 
1 26.71 24.92 1.79 4.40 
2 35.14 32.95 2.19 5.38 
3 43 41.51 1.49 3.66 
Average    4.48 
 
 
3.5   Immunofluorescence Microscopy of West Nile (Sarafend) Virus 
Immunofluorescence (IF) microscopy was carried out to study if the distribution of 
virus proteins within the cell was the same between the two cell lines, in an attempt to 
understand the differences in the permissiveness of the two cell lines. Figures 3-10 
and 3-11 show the fluorescence images of the cells at 24 h p.i. It was observed that 
the fluorescence was much more intense in WN(S)V-infected A172 cells (Figure 3-10) 
than in HeLa cells (Figure 3-11). 
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[A]       [C] 
    
[B]       [D] 
Figure 3-10. [A] and [B] show WN(S)V-infected A172 cells at 24 h p.i., whereas the 
[C] and [D] shows mock-infected control A172 cells. The primary antibody is the 
anti-E protein antibody. Fluorescence staining is detected more strongly at the 
perinuclear region of the infected cell. Some bright speckles are seen at the plasma 
membrane. This represents the maturing virus particles. A slight polarization of the 
staining can be observed in the infected cell. [C] and [D] show negligible 




   
[A]       [C] 
   
[B]       [D] 
Figure 3-11.  [A] and [B] show WN(S)V-infected HeLa cells at 24 h p.i., [C] and [D] 
show mock-infected control HeLa cells. The primary antibody is the anti-E protein 
antibody. Fluorescence staining is detected mainly at the perinuclear region of the 
infected cell, but is less dispersed when compared to the A172 cells (Figure 3-10). 
Some speckles and polarized staining are also observed. The fluorescence intensity is 
much lesser compared to A172 cells (Figure 3-10). [C] and [D] show negligible 
fluorescence in the mock-infected cells.  
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As the MetaMorph software that was used to capture the IF images was able to 
quantify the amount of fluorescence in the images, the intensity of the fluorescence 
was measured in the two infected cell lines. Table 3-3 presents the data from this 
finding. From the intensity readings, A172 cells show 3.98x greater fluorescence 
compared to HeLa cells. This value corresponds closely to the value obtained from 
qPCR.  
 
Table 3-3.  Intensity of fluorescence within infected host cells 
Cell HeLa A172 
1 16.48 62.61 
2 16.07 65.28 
3 18.65 64.21 
4 15.71 67.04 
5 15.35 68.33 
6 16.95 64.53 
7 17.05 67.24 
8 15.34 64.68 
Average 16.45 65.49 





3.6   Global Genomics Studies on HeLa and A172 Cells 
As different rates of virus infection and replication was observed between the two cell 
lines, a global transcriptomic study was carried out to determine the host factors that 
may contribute to determine the efficacy of the virus infection in different hosts.  
  
3.6.1   Total RNA Isolation  
Total RNA had to be first extracted from the cells in order to carry out microarray 
experiments for transcriptomic studies. As RNase is ubiquitous anywhere, extra 
precautions are necessary when handling RNA. Total RNA isolation was carried out 
as described in Section 2.4.2.1.  
 
Microarray experiments were initially conducted according to the methods described 
in Sections 2.4.2 – 2.4.3. Essentially, these methods utilized Amersham’s probe 
labelling kits and automated hybridization workstation. Two sets of experiments were 
carried out for each cell line. Each set consisted of a virus-infected and mock-infected 
control samples. This was carried out in duplicates, but with a dye-swap between the 
virus-infected and control samples.  
 
The quantity and purity of eluted total RNA are shown in Table 3-4. The purity levels 
were in the range of 1.6 – 2.1 before proceeding with the labelling step. It was found 
that the yield of total RNA was markedly lower in the WNV-infected A712 cell 
samples, compared to the rest of the samples. The explanation for this could be that 
the cytopathic effects in infected A172 cells were more advanced compared to 
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infected HeLa cells (Section 3.2). Nevertheless, the amount of RNA harvest from 
each batch was sufficient to proceed with the probe labelling.  
 
Table 3-4: Quantity and purity of RNA samples.  











HWNC1 Cy5 0.811 0.447 1.62 97.3 1.81 





HWNC2 Cy3 0.260 0.151 0.867 52.0 1.72 





AWNC1 Cy5 0.484 0.269 1.312 78.72 1.86 





AWNC2 Cy3 0.498 0.285 1.870 112.2 1.90 
Sample: H – HeLa, A – A172, WNV – Virus infected sample, WNC – Control sample. 
A260/A280: UV Absorbance readings. 
Concentration = A260 X 40 X dilution factor (50) 
Yield = Concentration X volume (60) 
Purity = A260/A280 
 
3.6.2   Integrity of Isolated Total RNA 
After the extracted samples had been quantified, it was crucial for the integrity of 
RNA to be determined. Electrophoresis of samples on denaturing formaldehyde-
agarose (FA) gel will elucidate if the RNA samples had degraded. Figure 3-12 shows 
a representative FA gel image from the HeLa cell samples. Intact total RNA samples 
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will give two sharp ribosomal bands for 18S (1.9kb) and 28S (5.0kb) rRNA (Figure 
3-12). mRNA appeared as a very faint smear in between these two bands. Degraded 
RNA samples will give indistinct small fragments that will produce inconsistencies in 
cDNA synthesis and thus, generate inaccurate microarray results. After the RNA 
integrity had been verified to be intact, the RNA samples were then reverse 
transcribed, labelled, and purified, as described in Sections 2.4.2.4.  The CyDye used 



























3.6.3   Quantification of Incorporated Fluorescent Nucleotides 
After the RNA had been reverse transcribed into labelled cDNA probes, it was crucial 
to quantify the amount of incorporated fluorescent nucleotides, and combine equal 
amounts of the labelled probe for microarray hybridization. The procedure for 
fluorescent nucleotide quantification is described in Section 2.4.2.5. Figure 3-13 
Figure 3-12. Diagram shows the intact ribosomal 28S and 18S RNA bands from HeLa 
cell samples. The faint smear represents mRNA. 3µg of total RNA was loaded per lane.  
L-R: HWNV1, HWNC1, HWNV2, HWNC2. 
Results 
 69
shows the general experimental strategy for RNA labelling. Briefly, total RNA was 
reverse transcribed to produce labelled cDNA. The RNA template was subsequently 
degraded. The labelled cDNA from control and virus-infected samples were 
combined in equal amounts and allowed to hybridize onto a microarray.  Table 3-5 
shows the quantity of purified cDNA probes harvested by UV spectrometry.  
 
Table 3-5: Quantity of incorporated fluorescent nucleotides. 
Sample Cy3 (A550) Cy5 (A650) Quantity of CyDye (pmol) 






H24WNC1 --- 0.041 19.7 






H24WNC2 0.031 --- 24.8 






A24WNC1 --- 0.045 19.2 






A24WNC2 0.034 --- 27.24 








Figure 3-13. RNA labelling strategy. Total RNA from control and virus-infected 
samples are separately reverse transcribed with MMLV-RT using oligo-dT as 
primers. This is carried out in the presence of CyDye-labelled nucleotides (dCTP). 
The RNA template is then degraded with RNase, leaving the labelled cDNA probes, 
which have to be purified from unlabelled probes. Equal amounts of labelled cDNA 
probes are combined and allow to hybridize onto a microarray. The CyDyes used are 
switched across different sets of experiments as shown in Table 3-4. This is to 
prevent CyDye bias.  
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3.6.4   Microarray Images 
After microarray hybridization (on Amersham’s Lucidea SlidePro) and scanning were 
carried out, the image file was analyzed. Figure 3-14 shows the raw images generated 
from the scanner for two of the microarray slides.  
 
Initial microarray scans displayed a ‘blotchy’ pattern on the first few microarrays.  
This could be due to the formation of bubbles during the hybridization step, which 
may interfere with the probe binding to the target. Spots on these blotches were 
removed if they do not fulfil the quality control tests as highlighted in Section 2.4.6.2. 
Such blotchy patches will affect the data quality generated, and many of these spots 
were removed from the final analysis, resulting in a lower number of genes that 
appeared in the final list. After several attempts, a ‘clean’ pattern was finally obtained, 
and is shown in Figure 3-14B, and these were used for downstream data analyses.  
 
Figure 3-15 shows the landmark spots used for image orientation. The number of 
spots found at the corners marks the orientation positions of the slide. These spots can 
be correlated with Figure 3-16, which shows the distribution of negative and positive 
control spots on the microarray slides. Spots marked with (+)Pro25G denote positive-
control spots, (-)3xSLv1 denote negative-control spots, while QC spots are for the 







[A]  [B]  
Figure 3-14. Raw scans of HWN1 [A] and AWN2 [B]. Initial microarray scans [A] 
displayed a ‘blotchy’ pattern on the microarray.  This could be due to the formation of 
bubbles during the hybridization step. AWN2 [B] showed the best hybridization 
pattern with an absence of any patches.   
 
 
Top of slide 
 
 
Bottom of slide 
 
Figure 3-15. Landmark spots for slide orientation are circled. The number of green 




Figure 3-16. Map of control spots on Agilent’s Human 1A Oligo Microarray. 
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3.6.5   Microarray Image Analysis 
The positions of the spots on the images were determined by placing a grid for spot 
locations over the image, as shown in Figure 3-17. GenePix Pro was then able to 
automatically fit every single grid spot over the spot on the image. This allowed the 
software to determine the pixel intensity within (foreground) and outside (background) 
the spot. Before differentially regulated spots can be identified, various other 
manipulations like normalization and quality control tests have to be carried out.  
 
After the pixel intensities have been determined, the software will proceed to match 
them with the spot identities and generate a statistical database. Visual analysis can be 
carried out by comparing the colour saturation and intensities. As shown in Figure 3-
18, differentially regulated genes and amount of expression can be picked out by 
visually analyzing the image. For the case where RNA from virus-infected cells were 
labelled with Cy5 (red) and RNA from control cells were labelled with Cy3 (green), 
the spot will be red if the RNA from the infected population is in abundance. If the 
RNA from the control population is in abundance, the spot will be green. If infected 
and control RNA samples bind equally, the spot will be yellow. If neither binds, it 
will not fluoresce and appear black. Thus, from the fluorescence intensities and 
colours for each spot, the relative expression levels of the genes in the sample and 
control populations can be estimated. For a closer analysis of an individual spot, the 
feature viewer can be used to examine the spot features, as shown in Figure 3-19. 


















Figure 3-17. The microarray image is fitted with a grid of spots, thus allowing the 
software to determine the positions of the spots and calculate their signal intensities. 
Spots with a vertical line across denote defective spots as marked out by the slide 


















Figure 3-18. A sample section of a microarray image, showing differentially 
regulated genes and bad spots which are omitted from analysis. The diameter of each 
spot is 135 microns. The above section was taken from HWN2.  
 
 
Figure 3-19. The feature viewer shows the statistics 
for a single spot. For example, the Cy5 intensity (top) 
is 2631 and the Cy3 intensity (middle) is 2401. When 
the 2 wavelengths are combined, the spot turns up 
yellow, with a differential expression ratio of 1.096. 
This gene has approximately equal spot intensities and 
is therefore equally expressed.  
 







However, before any meaningful information can be gleaned from the mass of data, 
the intensities for the 2 fluorescent dyes need to be normalized (see Section 2.4.6.3), 
which corrects for any biases due to the dyes.  
 
A regression method of normalization can be carried out, which tries to equalize the 
total intensity counts of the two dyes. Figure 3-20 shows the intensity curves before 
and after normalization. Assuming that the global genomic expression remained 
constant before and after infection, the total ratio of the Cy3 versus Cy5 should be 
approximately equal to one. Therefore, after normalization, the green and red curves 
in Figure 3-20 were approximately equal. A more common method is to utilize 
Lowess normalization, whereby the values between the 2 dyes are brought together in 
an intensity dependent manner. Figure 3-21 shows a typical M-A plot of the 
microarray spots showing the effects after undergoing Lowess normalization. The 
slight bend of the smoother (trend line) suggested subtle-intensity dependent 
differential dye bias was present when different dyes were used. A dye-swap 
duplicate was therefore an essential step here, since incorporation of Cy3 or Cy5 
modified nucleotide analogues have been known to manifest a difference in gene-
specific incorporation efficiency due to sequence-specific artefacts (Tseng et al., 2001) 
and dye biases (Holloway et al., 2002). 
 
After normalization, the spots were then ready to be analyzed. Figure 3-22 shows a 
scatter plot of all the spots. This provided a convenient visual of the differentially 
regulated spots. There were spots that lie far away from the regression line. Spots that 







Figure 3-20. The 
Intensity Distribution 
curves for Cy3 (green) 
and Cy5 (red) are 
plotted out. The top 
graph shows the curves 
before normalization. 
After normalization, 
the counts ratio 
between the 2 dyes are 
approximately equal to 
1, and the green and 
red curves are 
approximately equal, 
as shown by the graph 
below. The graphs 
were for sample 
HWN1.  
Before Normalization  




Figure 3-21. Intensity-based normalization using the Lowess method. Each spot on the graph 
corresponds to one feature on the microarray. Spots that are on the zero line are not 
differentially regulated. The top and middle panel shows the plot from a dye swap experiment. 
A dye bias is detected from the opposite directions of the deviated smoother curve (trend line). 






Figure 3-22. A scatter plot of the total intensities of every spot on a log graph. The regression line is 
shown in green. Spots that deviate greatly from this line (Log2 ratios > ±1) are considered to be 
differentially expressed.  
 
 













3.6.6   Differentially Regulated Genes in West Nile Virus-Infected A172 Cells 
A172 cells were found to be more permissive to WNV infection compared to HeLa 
cells, and this is easy to fathom as A172 cells are of CNS origins, and are thus the 
natural targets for the WNV. To understand the pathogenesis of brain tissue infected 
with WNV, an analysis of the global transcriptomics on infected-A172 cells alone 
was carried out. 
 
A total of 173 cellular genes were identified by ArrayTools to be differentially 
expressed in the A172 cells after WNV infection, out of which 57 genes were found 
to be up-regulated and 116 genes were down-regulated. These genes can be found 
listed in Appendix 6, and they are sorted according to the magnitude of their fold 
change.  
 
Instead of just sorting these genes into their functional groups, EASE (Hosack et al., 
2003) was used to identify specific functional groups of genes (or gene ontology) that 
were found to be highly enriched in occurrence, compared to the whole human 
genome. The basis for selection is a significance value of less than 0.01 on the 
Fisher’s exact P-value test. Thirty-nine of the 57 up-regulated genes and 41 of the 
116 down-regulated genes were picked out by EASE, and these are listed in Tables 3-
6 (a and b) according to their P-values.  
 
Functional classes that were found to be enriched in the upregulated genes included 
immune defense, response to external stimulus and pathogens, and apoptosis (Table 
3-6a). Genes relating to ubiquitin cycle, transcription regulation and other 
physiological processes were also identified by EASE. Functional classes that were 
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downregulated were not commonly observed in a virus infection system (Table 3-6b). 
For instance, genes relating to the mitochondria, ribosomes and protein biosynthesis 
were found to be highly over-represented in down regulation. Genes which have a 
putative relevance to influence virus infection are briefly mentioned below.  
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Table 3-6a.  List of upregulated functional groups in WN(S)V-infected A172 cells at 
24 h post-infection. 
 





OAS3 2.32 2'-5'-oligoadenylate synthetase 3, 100kDa 
GBP5 2.47 guanylate binding protein 5 
OASL 3.46 2'-5'-oligoadenylate synthetase-like 
HLA-C 2.20 major histocompatibility complex, class I, C 
INDO 3.38 indoleamine-pyrrole 2,3 dioxygenase 
IFITM1 12.00 interferon induced transmembrane protein 1 (9-27) 
G1P2 9.50 interferon, alpha-inducible protein (clone IFI-15K) 
IFIT2 3.76 interferon-induced protein with tetratricopeptide repeats 2 
MX2 3.17 myxovirus (influenza virus) resistance 2 (mouse) 
IFIT1 10.74 interferon-induced protein with tetratricopeptide repeats 1 
IFITM2 3.04 interferon induced transmembrane protein 2 (1-8D) 
immune defense 
response 1.35E-11 
IFI27 4.03 interferon, alpha-inducible protein 27 




SOD2 2.12 superoxide dismutase 2, mitochondrial 
CEB1 2.33 cyclin-E binding protein 1 
ubiquitin cycle 0.000871 
FLJ13855 2.05 hypothetical protein FLJ13855 
MAZ 2.02 MYC-associated zinc finger protein 
TBX3 2.32 T-box 3 (ulnar mammary syndrome) 
KLF2 2.62 Kruppel-like factor 2 (lung) 
ZFP36L2 2.16 zinc finger protein 36, C3H type-like 2 
NT5C3 2.33 5'-nucleotidase, cytosolic III 
transcription 
regulator activity 0.0026 
EGR1 4.79 early growth response 1 
KIF22 2.02 kinesin family member 22 
RBPSUHL 2.43 recombining binding protein suppressor of hairless (Drosophila)-like DNA binding 0.00528 
SSA1 2.29 Sjogren syndrome antigen A1  
CXCL10 2.10 chemokine (C-X-C motif) ligand 10 
CXCL11 2.31 chemokine (C-X-C motif) ligand 11 





PTX3 3.44 pentaxin-related gene, rapidly induced by IL-1 beta 
TNFSF14 2.19 tumor necrosis factor (ligand) superfamily, member 14 
BIRC3 2.24 baculoviral IAP repeat-containing 3 
NFKBIA 4.13 nuclear factor of kappa light polypeptide gene enhancer 
TRAF1 2.01 TNF receptor-associated factor 1 
apoptosis 0.00947 
IFNB1 2.79 interferon, beta 1, fibroblast 
LAP3 2.73 leucine aminopeptidase 3 
KCNH6 2.21 potassium voltage-gated channel, subfamily H, member 6 
TFPI2 5.34 tissue factor pathway inhibitor 2 
physiological 
process 0.00957 
CHRND 2.30 cholinergic receptor, nicotinic, delta polypeptide 
RIG-I 4.19 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 
Others   




Table 3-6b.  List of downregulated functional groups in WN(S)V-infected A172 cells 
at 24 h post-infection. 
 





FDPS -2.10 farnesyl diphosphate synthase  
LTA4H -2.02 leukotriene A4 hydrolase macromolecule biosynthesis 5.84E-09 
TPI1 -2.17 triosephosphate isomerase 1 
ATP5G1 -2.64 ATP synthase, mitochondrial F0 complex, subunit c, isoform 1 
ATP5C1 -3.82 ATP synthase, mitochondrial F1 complex, gamma polypeptide 1 
ATP5J -2.11 ATP synthase, mitochondrial F0 complex, subunit F6 
UQCRB -2.11 ubiquinol-cytochrome c reductase binding protein 
COX5B -2.13 cytochrome c oxidase subunit Vb 
SLC25A6 -2.02 solute carrier family 25 (mitochondrial carrier) 
ATP5B -2.17 ATP synthase, mitochondrial F1 complex, beta polypeptide 
ATP5A1 -2.21 ATP synthase, mitochondrial F1 complex, alpha subunit, isoform 1 
SDHC -2.31 succinate dehydrogenase complex, subunit C 
ATP5O -2.00 ATP synthase, mitochondrial F1 complex, O subunit  
PRDX5 -2.74 Peroxiredoxin 5 
BNIP3L -2.49 BCL2/adenovirus E1B 19kDa interacting protein 3-like 
COX6B -2.41 cytochrome c oxidase subunit VIb 
ATP5F1 -2.43 ATP synthase, mitochondrial F0 complex, subunit b, isoform 1 
Mitochondrion 2.22E-07 
COX7B -2.21 cytochrome c oxidase subunit VIIb 
RPS3A -3.33 ribosomal protein S3A 
RPLP0 -2.16 ribosomal protein, large, P0 
RPL4 -2.30 ribosomal protein L4 
RPL41 -2.03 ribosomal protein L41 
RPS24 -2.51 ribosomal protein S24 
RPL7A -2.03 ribosomal protein L7a 
RPS3A -3.04 ribosomal protein S3A 
RPL5 -2.97 ribosomal protein L5 





RPL26L1 -2.12 ribosomal protein L26-like 1 
NACA -2.17 nascent-polypeptide-associated complex alpha polypeptide 
EIF3S5 -2.88 eukaryotic translation initiation factor 3, subunit 5 epsilon, 47kDa 
SRP9 -3.27 signal recognition particle 9kDa 
EIF4G2 -2.11 eukaryotic translation initiation factor 4 gamma, 2 
protein bio-
synthesis 1.63E-06 
EEF2 -2.60 eukaryotic translation elongation factor 2 
CAPZA2 -2.12 capping protein (actin filament) muscle Z-line, alpha 2 
CNN3 -2.50 calponin 3, acidic 
MYH6 -3.00 myosin, heavy polypeptide 6, cardiac muscle, alpha 
cytoskeletal 
(actin) binding 0.00111 
DSTN -2.13 destrin (actin depolymerizing factor) 
RAC1 -2.87 ras-related C3 botulinum toxin substrate 1 
ARF4 -2.30 ADP-ribosylation factor 4 





ARHI -2.73 ras homolog gene family, member I 
EEF1G -3.29 eukaryotic translation elongation factor 1 gamma 
S100A4 -2.53 S100 calcium binding protein A4  
HDAC3 -2.52 histone deacetylase 3 
PFN2 -2.42 profilin 2 
PRDX3 -2.27 Peroxiredoxin 3 
KRT15 -2.18 keratin 15 
Others   
LASP1 -2.14 LIM and SH3 protein 1 
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Of the genes found in the immune defense class, OAS3 and MX2 have known 
antiviral properties. OAS3 catalyzes the 2', 5' oligomers of adenosine in order to bind 
and activate RNase L, while MX2 is a member of both the dynamin family and the 
family of large GTPases. Genes like CXCL10 and CXCL11 belong to the CXC 
subfamily of chemokines that modulates the immune response. Other immune related 
genes that showed an increase in expression include HLA-C, which codes for the 
MHC-I, and PTX3, which is an acute phase protein. Both INDO and FOSL1 genes 
have an effect on the regulation of cell proliferation and transformation. A number of 
interferon-induced proteins (e.g. IFIT1, IFI27, IFITM1) were found to be up-
regulated, but their functions are not known, and may suggest novel roles in 
inhibiting virus replication. SOD2 gene codes for superoxide dismutase, which is 
involved in protection from free radicals.  
 
Many of the genes in the transcription regulation group relates to growth regulation. 
Examples include EGR1 and ZFP36L2 genes. CEB1 gene belongs to the ubiquitin 
cycle functional group and also helps to regulate growth. Genes associated with 
apoptosis were also found to have increased in expression. These include TNFSF14, 
TRAF1 and NFKBIA genes, which are proapoptotic, and BIRC3 gene, which codes 
for a baculoviral inhibitor of apoptosis proteins (IAP). SAT is an enzyme that 
catalyzes the N(1)-acetylation of spermidine and spermine, and may also be involved 
in apoptosis (Babbar et al., 2003). 
 
Genes whose proteins are able to bind DNA include KIF22, which is a kinesin that 
has been found to assist in the transport of organelles by also binding to microtubules 
(Shiroguchi et al., 2003) The RBPSUHL gene is a transcription factor to activate 
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transcription in concert with Epstein-Barr virus nuclear antigen-2 (EBNA2) 
(Minoguchi et al., 1997).  
 
Other genes of interest included TFPI2, which is a serine protease inhibitor belonging 
to the physiological processes functional category. RIG-I belongs to the DEAD box 
family of proteins and encodes for RNA helicases.  
 
Genes associated with cell metabolism was found to be greatly decreased. FDPS is 
involved in the isoprene biosynthetic pathway that provides the cell with cholesterol, 
ubiquinone, dolichol, and other nonsterol metabolites. TPI1 is a triosephosphate 
isomerase and its deficiency has been implicated in neurodegenerative diseases (Olah 
et al., 2002).  
 
Many genes associated with the mitochondria were also found to be reduced in 
expression. SDHC, COX5B, 6B, and 7B are genes involved in the mitochondrial 
respiratory chain. Some mitochondrial genes involved in cellular protection were also 
found to be down-regulated. These were PRDX5 gene, which is an antioxidant 
enzyme, and BNIP3L gene, which plays a role in apoptosis and tumour suppression. 
PRDX3 gene, which paradoxically was not classified together in this functional class, 
was found to be downregulated and is required for normal mitochondria function 
(Wonsey et al., 2002). A host of genes relating to ATP synthase, which is involved in 
proton transport, were also found to be down-regulated.  
 
The ribosomal proteins represent the next significant functional category that was 
down-regulated, consisting of 10 ribosomal proteins belonging to both large and 
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small subunits. RPL5 protein binds 5S rRNA to form a stable complex called the 5S 
ribonucleoprotein particle (RNP), which is necessary for the transport of 
nonribosome-associated cytoplasmic 5S rRNA to the nucleolus for assembly into 
ribosomes. One of the genes, RPS3A, belongs to the S3AE family of ribosomal 
proteins and down regulation of this gene was previously found to be involved in 
cellular differentiation (Goodin & Rutherford, 2002). 
 
Protein biosynthesis represents the next functional class that was found to be down 
regulated. Translation initiation and elongation factors (EIF3S5, EIF4G2, and EEF2) 
were found to be represented in this class. The EEF2 gene is an essential factor for 
protein synthesis by promoting the GTP-dependent translocation of the nascent 
protein chain from the A-site to the P-site of the ribosome. The EEF1G gene encodes 
a subunit of the elongation factor-1 complex, which is responsible for the enzymatic 
delivery of aminoacyl tRNAs to the ribosome. NACA protein, which is part of a 
heterodimeric complex of alpha- and beta-subunits that prevents mistargeting of 
nascent polypeptide chains to the endoplasmic reticulum membranes, also belongs to 
this class.  
 
Actin binding proteins were also found to be highly represented. Genes in this class 
include DSTN which helps in actin depolymerization, CAPZA2 which is a capping 
protein at the barbed end of an actin filament, and CNN3 which plays a role in the 
cellular organization of actin filaments. Genes represented in the small GTPase 
mediated signal transduction group appear to regulate a diverse array of cellular 
activities. Of interest is the RAC1 gene which regulates cytoskeletal reorganization 
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(Shin et al., 2004), and both ARF4 and ARFD1 which plays a role in the formation of 
intracellular transport vesicles and vesicular trafficking. 
 
Genes that were not classified into functional categories, but were found to be of 
interest in this study, are also listed. The HDAC3 gene codes for histone deacetylase 
3 that plays a critical role in transcriptional regulation, cell cycle progression, and 
developmental events. Down expression of HDAC3 has been implicated in increasing 
cell permissiveness to human cytomegalovirus (Murphy et al., 2002). The S100A4 
gene is a member of the S100 family of proteins containing 2 EF-hand calcium-
binding motifs, and involved in the regulation of a number of cellular processes such 
as cell cycle progression and differentiation. It has also been recently found to affect 
F-actin polymerization (Belot et al., 2002), in association with PFN2 gene, which is 
also down regulated. Other genes that were associated with the cytoskeleton, which 
were also similarly down regulated, include KRT15 which is a cytokeratin involved 
in intermediate filament formation, and LASP1 which is involved in cytoskeletal 
organization and cell motility (Butt et al., 2003).  
 
3.6.7   Differentially Regulated Genes between West Nile Virus-Infected A172 
and HeLa Cells 
A comparative study between A172 and HeLa cells was performed to determine the 
molecular mechanisms that might explain the difference in permissiveness of the two 
different cell lines to WN(S) virus infection. Differences in host gene expression 
patterns between the two cells lines during infection are very likely to have an effect 
on the efficiency of virus replication. On the other hand, similarities in host genes 
expression patterns between the two cell lines will have the same effects on the virus 
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ability to replicate within the cells, and are therefore not listed. For example, signs of 
apoptosis can be detected in both A172 and HeLa cells, and genes related to apoptosis 
were upregulated in both cell lines. Apoptosis genes therefore do not show 
differences in expression patterns between the two cell lines, and are therefore not 
detected by the software during analysis.  
 
ArrayTools identified 300 cellular genes that showed a 2-fold difference in 
expression between the two cell lines. For example, if a gene shows a +½  fold 
increase in A172 cells but shows a –½  fold decrease in HeLa cells, this gene will be 
identified as showing a 2-fold difference between the two cells lines. After clustering 
of these genes into their specific functional groups and uploaded into EASE, 46 of 
these genes belonging to 4 functional classes were found to be over-represented, 
based on a significance value of less than 0.01 on the Fisher’s exact P-value test. 
These genes are listed in Table 3-7. The individual changes in gene expression within 
the cell lines are shown, before the fold change between both cells lines are calculated.  
 
Genes relating to intracellular structure and transport were highly represented. Genes 
from the hexose metabolism group were also present. This was surprising as these 
genes are highly invariable and are known as housekeeping genes. As in Table 3-6b 
on A172 cells only, genes relating to protein metabolism and RNA processing were 
again found to be significantly differentially regulated. The possible relevance of 





Table 3-7.  List of differentially expressed genes between WN(S)V-infected A172 
and HeLa cells.  
 
Classification Symbol Gene Name A172 HeLa Fold 
DNAH3 dynein, axonemal, heavy polypeptide 3 1.06 -0.53 3.02 
TUBA2 tubulin, alpha 2 0.85 -0.62 2.76 
STX4A syntaxin 4A (placental) 0.68 -0.44 2.17 
C15orf22 integral type I protein 0.40 -0.64 2.06 
ARFGAP3 ADP-ribosylation factor GTPase activating protein 3 0.23 -0.91 2.21 
IPO8 importin 8 0.11 -1.55 3.14 
SLC25A6 solute carrier family 25, member 6 -0.01 -1.17 2.24 
ANK3 ankyrin 3 -0.02 -1.11 2.12 
PSAP prosaposin 0.16 -1.74 3.72 
FRMD4A FERM domain containing 4 0.11 -3.11 9.31 
KLC2L kinesin light chain 2-like 1.34 -0.84 4.53 
CKAP4 cytoskeleton-associated protein 4 0.81 -0.46 2.40 
KRTAP2 keratin associated protein 2-1 0.57 -1.03 3.03 
KRTHA3B keratin, 3B 0.36 -0.76 2.18 
K-ALPHA-1 tubulin, alpha 0.36 -0.93 2.45 
ACTN4 actinin, alpha 4 0.23 -1.00 2.34 
NXF5 nuclear RNA export factor 5 -0.10 1.32 0.37 
TEKT3 tektin 3 0.18 2.37 0.22 
CENPJ centromere protein J -0.16 1.01 0.45 
PFN2 profilin 2 -0.84 0.50 0.40 


















ACTG1 actin, gamma 1 -0.33 0.89 0.43 
ENO1 enolase 1, (alpha) 0.53 -1.14 3.20 
ALDOA aldolase A, fructose-bisphosphate 0.42 -0.74 2.24 











SUCLG2 succinate-CoA ligase, GDP-forming 0.00 -1.01 2.01 
SRM spermidine synthase 0.32 -0.80 2.18 
INDO indoleamine-pyrrole 2,3 dioxygenase 2.98 -0.07 8.28 
WARS tryptophanyl-tRNA synthetase 1.75 0.44 2.47 
EEF1A2 eukaryotic translation elongation factor 1 alpha 2 -0.06 -1.09 2.04 
EEF1G eukaryotic translation elongation factor 1 gamma -0.53 -1.66 2.18 
TUFM Tu translation elongation factor, mitochondrial 0.56 -0.76 2.50 
RPLP2 ribosomal protein, large P2 -0.19 -1.82 3.09 
RPL10L ribosomal protein L10-like -0.51 -1.79 2.43 












RPS13 ribosomal protein S13 -0.60 0.58 0.44 
SNRPB small nuclear ribonucleoprotein polypeptides B and B1 0.65 -1.08 3.33 
FNBP3 formin binding protein 3 0.60 -0.54 2.19 
TRA2A transformer-2 alpha 0.40 -0.67 2.10 
SF3B5 splicing factor 3b, subunit 5, 10kDa 0.36 -0.96 2.49 
SURF6 surfeit 6 (localize to nucleolus) 0.19 -0.98 2.25 
RNASE6 ribonuclease, RNase A family, k6 -0.37 0.75 0.46 













A172, HeLa = gene expression fold change of infected cells vs. mock-infected cells, expressed in Log2. 
Fold = gene expression fold change of infected-A172 cells vs. infected-HeLa cells.  
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3.6.8   Confirmation of Expression Changes by Quantitative Real-Time PCR 
(qRT-PCR) Analysis.  
 
The qRT-PCR was performed on a fresh set of RNA from that used for the 
microarray experiments to confirm the microarray results. This was to ensure that the 
genes identified were truly differentially expressed due to the virus infection. Genes 
for qPCR were chosen such that a broad spectrum of functional classes was 
represented. From Table 3-8, confirmation tests on qPCR corroborated with 
microarray results, thereby verifying the accuracy of the statistical analyses. Two 
genes (DUSP1 and DNAJB1) that showed less than 2-fold change on the microarray, 
were found to be differentially expressed to a greater extent, thus substantiating the 
sensitivity of the microarray tests. Fold changes from qRT-PCR were observed to be 
mostly of a higher magnitude compared to microarray results, and this may be due to 




Table 3-8. Comparison of gene expression changes between microarray and qRT-
PCR 
 







ARHI ras homolog gene family -2.72 -2.55 
ATP5J ATP synthase, mitochondrial F0 complex -2.11 -2.60 
CEB1 hect domain and RLD 5 2.32 42.22 
DNAJB1 DnaJ (Hsp40) homolog, subfamily B -1.97 -2.14 
DUSP1 dual specificity phosphatase 1 1.92 5.66 
EGR1 early growth response 1 4.79 8.57 
EIF4G2 eukaryotic translation initiation factor 4 gamma, 2 -2.11 -7.77 
FLJ13855 hypothetical protein FLJ13855 2.05 3.85 
FOSL1 FOS-like antigen 1 2.08 6.50 
IFITM1 interferon induced transmembrane protein 1 (9-27) 12.03 527.61 
LTA4H leukotriene A4 hydrolase -2.02 -8.10 
RPL5 ribosomal protein L5 -2.97 -9.03 
RPL7A ribosomal protein L7a -2.03 -3.42 
RPLP0 ribosomal protein, large, P0 -2.15 -1.52 





4.0   RESULTS – Progressive Host Interactions with West Nile Virus 
during Infection 
 
In Chapter 3, results of the microarray studies between A172 and HeLa cells were 
presented. A ‘snap-shot’ of the host gene regulation of the infected cells was obtained 
for 24 h p.i., which corresponds to the late phase of infection or peak virus production. 
As A172 cells were found to be more suitable for WN(S)V infection, it was used for 
further studies. In this chapter, the results of a time-course study on the changes in 
global transcriptomics on A172 cells are presented. The aim is to determine the 
aberrations in gene expression as the virus infection progressed. The time points used 
were 1½ h, 6 h, 12 h, 18 h, and 24 h p.i. The choice of these time points allows us to 
understand the changes in host gene response starting from the early to the late phases 
of infection. 
 
4.1   Preparation of Samples for Microarray Studies 
As the quality of scanned images resulting from the use of Amersham’s kits and 
hybridization stations tend to yield inconsistent results, it was decided to switch to 
Agilent Technologies’ recommended kits that are more appropriate to the microarray 
slides used here. As it was difficult to assess if the inconsistency was with the probe 
labelling or hybridization step, both of these methods were changed and a detailed 
description of these can be found in Section 2.4.5.  
 
Table 4-1 gives the values of the quantity of total RNA in the samples used in this 
procedure. The samples were obtained from A172 cells infected after 1.5 h, 6 h, 12 h, 
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and 18 h p.i. Mock-infected control cells were prepared concurrently at the same 
timings. Microarray results from the 24 h p.i. time-point were used from the previous 
section for the microarray analysis here. As the use of the Linear Amplification kit 
generates cRNA (instead of cDNA), the amount of product generated was measured 
in terms of the concentration of cRNA (instead of quantity of CyDye). The product 
quantities are listed in Table 4-2. Figure 4-1 shows a microarray image obtained by 
using the protocol from Agilent Technologies. As can be seen, images generated by 
using this protocol are generally of a much higher quality. It shows a wider dynamic 
range in spot intensities, with clear background and absence of any blotchy patterns.  
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Table 4-1: Quantity and Purity of RNA samples.  












A1.5WNC1 Cy5 0.624 0.293 1.248 62.4 2.13 






A1.5WNC2 Cy3 0.738 0.369 1.476 73.8 2.00 





A6WNC1 Cy5 0.853 0.436 1.706 85.3 1.96 





A6WNC2 Cy3 0.820 0.420 1.640 82.0 1.95 






A12WNC1 Cy5 1.329 0.653 2.658 132.9 2.04 






A12WNC2 Cy3 0.853 0.410 1.706 85.3 2.08 






A18WNC1 Cy5 1.047 0.478 2.094 104.7 2.19 






A18WNC2 Cy3 0.805 0.394 1.610 80.5 2.04 
Sample: A – A172, WNV – Virus infected sample, WNC – Control sample, (1.5, 6, 12, 18) – 
represents the number of h p.i. (24 h p.i. was not carried out as the raw microarray results were 
obtained from the previous section.) 
 
A260/A280: UV Absorbance readings. 
Concentration = A260 X 40 X dilution factor (50) 
Yield = Concentration X volume (50) 
Purity = A260/A280 
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Table 4-2: Quantity of cRNA generated.  
Sample A260 [cRNA] (µg/µl)  






A1.5WNC1 0.058 46.4 






A1.5WNC2 0.089 71.2 





A6WNC1 0.055 44.0 





A6WNC2 0.066 52.8 






A12WNC1 0.026 20.8 






A12WNC2 0.021 16.8 






A18WNC1 0.026 20.8 






A18WNC2 0.026 20.8 
Sample: A – A172, WNV – Virus infected sample, WNC – Control sample, (1.5, 6, 12, 18) – 
represents the number of h p.i. (24 h p.i. was not carried out as the raw microarray results were 
obtained from the previous section.) 
 
A260: UV Absorbance readings. 




   
Figure 4-1. A scanned microarray image obtained by using the protocol from Agilent 




4.2   Data Transformation from the Raw Data 
After the microarrays were scanned and the spot intensities measured for all the slides, 
the raw data files were fed into the MIDAS software (Saeed et al., 2003) from the 
Institute of Genomic Research (TIGR, USA). This software carries out the 
preliminary data processing to normalize the spot intensities, compare the consistency 
of the spot intensities between replicates and flip-dye duplicates, as well as to filter 
out differentially regulated genes from each microarray slide. As the preliminary data 
transformation carried out was the same for all the slides, data from the A12WN 
slides will be presented here as the representative sample. The data generated from 
the other microarray slides show similar trends.  
 
As before, the first step in data transformation involved the normalization of the spot 
intensities using the Lowess method. Figures 4-2 and 4-3 show the effects of the 
normalization on the spot intensities using this method. After normalization, all the 
spots were centred on the zero line. The further away the spot was from the zero line, 





Figure 4-2. Pre-Lowess normalization for A12WN1. 
 
 
Figure 4-3. Post-Lowess normalization for A12WN2. 
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After normalization, the data between the flip-dye experiments were compared for 
consistency. The ratio of the spot intensity between the two different dyes should be 
about the same when flipped in the two microarray slides, and the spots should fall 
close to the diagonal line when plotted on graph plot (shown in red spots). However, 
if the spot shows a difference of greater than 2 standard deviations from the mean, 
then the spots will be filtered out (shown in blue spots). Figure 4-4 shows the typical 
graph generated from this filtering process. Spots shown in red falls within the 2 
standard deviations, and were therefore carried over to the next stage of data analyses. 
Table 4-3 shows the results of all the slides from this process. During the flip-dye 
consistency checking process, the values from both slides were combined and a single 
data file was generated per pair of duplicate experiments.  
 
 
Figure 4-4.  Flip-dye consistency checking of spots.  
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Following the flip-dye consistency checking, the data was filtered for differentially 
regulated genes. This was performed using the Slice Analysis function within MIDAS. 
In this case, differentially regulated genes are based on their z-score, which is defined 
as 1.50 standard deviations away from the mean of the intensities. These genes are 
marked in red in Figure 4-5. As can be seen in the graph plot, spots with low 
intensities show a wider spread compared to spots with high intensities. This wider 
spread is attributed to the higher error rates due to ratio comparisons of low values. 
The z-score method therefore allows the identification of differentially regulated 
genes of more than 2-fold change in a more accurate manner. The number of genes 
that passed this test is also listed in Table 4-3.  
 
 
Figure 4-5. z-score slice analysis showing differentially regulated genes (in red) for 


















A1.5WN 16691 15762 5.57% 0.335 1904 
A6WN 17050 16194 5.02% 0.238 1955 
A12WN 16005 15008 6.23% 0.289 1855 
A18WN 16881 15220 9.84% 0.604 1394 
A24WN 16043 15211 5.19% 0.303 1785 
 
4.3   Analysis of the Microarray Data 
After the differentially regulated genes for the five time points had been identified, 
they were loaded into TIGR’s MultiExperiment Viewer (TMEV) for more advanced 
data analyses. Hierarchical clustering, K-means clustering, as well as t-tests were 
performed to identify specific trends in the gene expression during a WNV infection 
in human brain cells. Approximately 240 genes that were differentially regulated in at 
least 3 out of the 5 time points were used in these analyses. Genes that were 
differentially regulated in 2 or less of the time points were disregarded in this study, 
as they were not considered to be sufficiently significant. 
 
4.3.1   Analyses using Hierarchical Clustering 
The first method used was hierarchical clustering. Figure 4-6 shows an overview of 
the tree structure after hierarchical clustering was performed, while Figure 4-7 shows 
the enlarged top portion of the tree structure. A red cell denotes an upregulation of the 
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gene and a green cell denotes a downregulation. The intensity of the colour represents 
the magnitude of the fold-change, which can be compared with the colour bar at the 
top. A black cell denotes an insignificant change in expression and no numerical 
value is given to that gene. The tree node structures of the clustering can be observed 
at the top and left side of the figure, while the identities of the genes (GenBank 
accession) are listed on the right. 
 
In this analysis, both the genes and experiments were both subjected to the 
hierarchical clustering algorithm. From the top of Figure 4-7, the experiments were 
observed to be clustered in the sequential time points. From the tree nodes, the 
algorithm indicated that the genes regulated in the first 3 time points (1.5 h, 6 h, and 
12 h p.i.) were relatively different from the last 2 time points (18 h and 24 h p.i.). This 
is not coincidental as it represents the early/middle phase and the late phase of a virus 
infection, respectively. Clustering of the experimental time points had therefore 
helped to verify the validity of the microarray experiments.  
 
Based on the expression values, the genes were clustered into 9 separate groups. The 
number of genes in each group and the average movements of the expression values 
over time are displayed in the centroid graphs (Figure 4-8). However, upon 
observation of the expression graphs in Figure 4-9, many of the genes within the 
clusters were found to be expressed in a rather inconsistent manner. Some of the 
genes did not follow the trend line (in pink) closely. Analyses of the genes in each 
cluster were therefore difficult as there was great variability in the gene expression 
















Figure 4-6 (left). An overview of 
the tree structure from the 
hierarchical clustering analysis. 
 
Figure 4-7 (below). An expanded 



















Figure 4-8. Centroid graphs of the 9 clusters from hierarchical clustering. The number of genes in 
each cluster is shown on the top left hand corner. The line shows the general trend of the gene 





Figure 4-9.  Expression graphs of the 9 clusters from hierarchical clustering. The individual lines 
show the expression pattern of each gene. Overall, the gene expression patterns clustered using 
hierarchical clustering is not consistent within each cluster, as many of them do not follow the trend 
line (in pink) closely.  
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4.3.2   Analyses using the Self-Organizing Tree Algorithm (SOTA) 
The SOTA algorithm constructs a binary tree (dendrogram) in which the terminal 
nodes are the resulting clusters. From the results, 11 clusters were produced, and the 
general trend across these clusters is shown in the SOTA dendrogram (Figure 4-10). 
It displays the generated tree with the expression image of each resulting cluster’s 
centroid gene. The text to the right of the centroid expression image includes the 
cluster number, the number of genes within the cluster, and the cluster diversity (or 
the mean gene to centroid distance). The centroid graphs and the expression graphs of 
the 11 clusters are shown in Figures 4-11 and 4-12, respectively.  
 
When comparing the graphs with those obtained for hierarchical clustering, the 
clusters obtained from SOTA were less haphazardly arranged. The gene expression 
patterns in the SOTA clusters followed the centroid graphs rather closely, with the 
exception of clusters 1, 3 and 11 (figure 4-12). The better clustering in SOTA could 
be due to the creation of 2 extra clusters, and thus allowing the better fit in the 
grouping of genes. 


































Figure 4-12. Expression graphs of the 11 clusters from SOTA analysis. The clusters are 
numbered sequentially from the top left to the bottom right. The genes in cluster 1, 3 and 11 do 
not seem to group together consistently, and do not follow the trend line (in pink) closely. 
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4.3.3   Analysis using K-Means Clustering 
K-means clustering represents another popular algorithm often used in clustering 
genes in microarray experiments. In this case, the number of clusters can be specified 
and the algorithm will try to fit the genes into these groups. In order to determine the 
ideal number of clusters to be generated, another algorithm was used. The Figures of 
Merit (FOM) algorithm helps to measure the extent of fit for a group of genes in 
different number of clusters. The graph generated by FOM analysis is shown in 
Figure 4-13. As the number of clusters increases, the fit of the genes within the 
cluster becomes tighter and less haphazard, and therefore the value of the adjusted 
FOM decreases. A compromise must be obtained between the FOM value and the 
number of 
clusters, as too 
many clusters 
make analyses 
difficult. From the 
FOM graph, a 
good choice for 
the number of 
clusters would be 





Figure 4-13. Figures of Merit (FOM) graph. 
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K-means clustering was therefore carried out by specifying the algorithm to generate 
either 8 or 10 clusters. The results of these analyses are shown in Figures 4-14 to 4-
17. As can be seen from the graphs, K-means clustering algorithm appeared to 
produce better clustering results of the genes compared to hierarchical clustering and 
SOTA, with less of the haphazard arrangements seen in the previous methods.  As the 
clustering of the genes appeared to be more coherent in the 10 clusters, subsequent 
analyses of gene regulation will utilize the data generated from that set. The 
disadvantage of using K-means is that the tree structures between the different 
clusters cannot be visualized (as compared to the clustering graphs in Figures 4-7 and 
4-10). However, this is an insignificant consequence as the goal is to achieve reliable 


















Figure 4-14.  Centroid graphs of the 8 clusters from K-means clustering. 
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Figure 4-17. Expression graphs of the 10 clusters from K-means clustering. 
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4.3.4   Analyses using T-Test Statistics 
 By using the statistical one-sample 
t-test to analyze the results, genes 
which are statistically different 
from a mean value of zero 
expression at p <0.05, will be 
clustered into one group. This will 
identify genes which were either 
continually upregulated or 
downregulated throughout the 
study. Forty-six genes were 
identified in this process, and the 
hierarchical tree structure is shown 
in Figure 4-18. The expression 
graph of the same set of genes is 
shown in Figure 4-19. As can be 
seen in the hierarchical tree, these 
46 genes can be divided into 2 main subgroups. Those in red are consistently 
upregulated through the time series, whereas those in green (the second node) are 
consistently downregulated. The first 5 genes can be further subdivided from the rest 
of the upregulated genes, as their expression at 18 h and 24 h were exceedingly high.  
Figure 4-18. Hierarchical tree of statistically 













4.4   Identifying Trends in Gene Expression 
From the centroid and expression graphs obtained from the various clustering 
algorithms, certain gene expression trends during the course of the virus infection can 
be identified.  
 
The most obvious group of genes was those which were upregulated for all the 5 
time-points during the study. This group of genes includes those found in SOTA 
(clusters #5, 6, 7 and 8), K-means 8-clustering (cluster #6), and K-means 10-
clustering (clusters #9 and 10). A representative expression graph with genes that are 
consistently upregulated is shown in Figure 4-20. The genes from all these clusters 
were combined, and repetitive genes present in 2 or more clusters were removed. 
Forty-five genes were identified using this method, and these are listed in Appendix 









To identify the ontology group that was over represented in this upregulated cluster, 
these 45 genes were loaded into EASE. The immune response functional group (15 
genes) was highly significant with a Fisher’s Exact value of 7.38E-10, and these are 
highlighted in yellow.  
 
On the other hand, genes which were constantly downregulated were much fewer. 
Only the t-test analysis was able to cluster this group of genes (Figure 4-19). These 17 
Figure 4-20. An expression graph of constantly upregulated genes throughout 
the course of WNV infection. (GpI).  
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genes are listed in Appendix 8, and are labelled as GpII. When these were loaded into 
EASE, no significant ontology group was found with a Fisher’s Exact value of < 0.05. 
These constantly downregulated genes were thus quite diverse in functions.  Figure 4-
21 shows an expression graph for GpII. 
 
The next group of genes to explore was those which were upregulated initially, but 
were later downregulated as the course of infection progresses. Two clusters from K-
means clustering fit this profile. The first group was downregulated just after 6h p.i. 
Figure 4-21. An expression graph of genes that are constantly downregulated 
throughout the course of an infection. (GpII) 
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(GpIII), while the second group was downregulated after 18h p.i. (GpIV). Their 




Figure 4-22. An expression graph of genes that were initially upregulated, but were 
downregulated after 6 h p.i. (GpIII) 
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Twenty-three genes were clustered into GpIII. The ontology group that was found to 
be over-represented by EASE belongs to the cell cycle regulation group with a 
Fisher’s Exact value of 0.014. These genes are highlighted in yellow in Appendix 9.  
Thirty-eight genes were clustered into GpIV. Genes belonging to transcription and 
nucleic acid metabolism ontology group were found to be significantly over-
represented with a Fisher’s Exact value of 0.0282. These genes are highlighted in 
yellow in Appendix 10.  
 
Figure 4-23. An expression graph of genes that were initially upregulated, 
but were downregulated after 18 h p.i. (GpIV) 
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The next group of genes was those whose expression levels increased as the infection 
progressed, and this cluster is labelled as GpV. Clusters belonging to this group are 
represented in Figure 4-24, and they were obtained from SOTA (cluster #11) and K-
means (cluster #7). Interestingly, these genes were downregulated during the initial 
phase of infection, but became upregulated after 18h p.i.  
 
 
Figure 4-24. An expression graph of genes that were initially downregulated, 
but were upregulated after 18 h p.i. (GpV) The expression pattern of this group 
is the exact opposite of Gp IV.  
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Twenty-seven genes were represented in GpV. Genes belonging to the cellular 
physiological processes and proteins integral to plasma membrane ontology groups 
were found to be significantly over-represented with a Fisher’s Exact value of 0.0224 
and 0.0263, respectively. These genes are highlighted in yellow in Appendix 11.  
 
The last group of genes shows a peculiar pattern of expression. These genes were 
initially downregulated at 1.5 h p.i., but became upregulated at 6 h, and finally 
returned to be downregulated for the next three time-points (12 h, 18 h, and 24 h). 
Genes whose expression patterns belonging to this group (GpVI) are represented in 
Figure 4-25, and they are obtained from SOTA (cluster #4) and K-means (cluster #2).  
 
Fifty-one genes were represented in GpVI. Three ontology groups were found to be 
significantly enriched in this group, and these genes belong to the endoplasmic 
reticulum, mitochondrion and cytoskeletal protein binding functional groups. These 
genes are also highlighted in yellow in Appendix 12.  
 







Figure 4-25. An expression graph of genes that were consistently downregulated, 
except at 6 h p.i. (GpVI) 
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Table 4-4. Summary of the 6 groups from microarray analysis.  
Groups Gene Expression Trend 
Number 
of Genes 
Significant Gene Ontologies 
I Constantly upregulated 45 Immune response 
II Constantly downregulated 17 None 
III 
Downregulation after 6hr 
of infection 
23 Regulation of cell cycle 
IV 




Nucleic acid metabolism 
V 
Upregulation after 18hr of 
infection 
27 
Cellular physiological processes 
Integral to plasma membrane 







5.0   DISCUSSION 
 
5.1   Cytopathic Effects of West Nile (Sarafend) Virus Infection 
West Nile (Sarafend) virus [WN(S)V] infection in HeLa (cervical adenocarcinoma) 
and A172 (glioblastoma) cells resulted in two outcomes. Although cytopathic effects 
(CPE, Figure 3-2) can be observed in HeLa cells, they were not extensive and they 
produced lower virus yields. This was confirmed by studies using plaque assays, 
quantitative PCR, and immunofluorescence microscopy. Dunster and colleagues 
(1990) had also reported similar findings. It was found that the WNV became 
attenuated in just six passage cycles, with a 4 X 103 fold reduction in virus yield. It 
can therefore be deduced that HeLa cells are not readily permissive to WNV infection. 
Its less permissive nature may lead to novel inhibitory mechanisms to WNV 
infections. 
 
In contrast, WNV infection in A172 (glial) cells showed advanced CPE within 24hr 
(Figure 3-4). Plaque assay studies showed a 100-fold increase in virus yields from 
infected-A172 cells compared to infected-HeLa cells (Section 3.3). The intracellular 
levels of the virus was also about 4-times more in A172 cells, as determined by 
immunofluorescence and quantitative PCR studies (Section 3.4 and 3.5).  This was 
not surprising as WNV is neurotrophic, thereby causing encephalitis. Neuronal 
degeneration, neuronophagia, spongy degeneration, and focal haemorrhages have 
been observed in the thalamus, cerebrum, cerebellum, medulla oblongata and cervical 
spinal cord of humans infected with the WNV (Sampson et al., 2000). The WNV 
cellular receptor αVβ3 integrin, was found to be expressed in equal amounts in both 
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A172 and HeLa cells (Chu and Ng, in press), and therefore virus entry should not be 
the limiting factor. 
 
This study was therefore conducted in two parts to investigate in detail the differential 
host responses during WNV infection. The first part of the study was to investigate 
the mechanisms for an apparent attenuation in virus replication in HeLa cells. West 
Nile (Sarafend) virus was allowed to infect the A172 and HeLa cell samples for 24 
hours (see Section 2.2.2), after which, the cells were harvested for subsequent 
analysis. Twenty-four hours was chosen to ensure that the virus had undergone a full 
replication cycle and represented peak virus production. As A172 cells were found to 
be more permissive for WNV infection, the second part of the study was to 
investigate the host cell response at various time points (1.5 h, 6 h, 12 h, 18 h, and 24 
h p.i.). This will allow the study of virus-host interactions at various stages of the 
virus replication.  
 
5.2   Global Transcriptomic Analysis using Microarrays 
Genomic expression studies on host-virus interactions using microarrays have the 
advantage of producing a huge volume of data (6MB of raw data per slide) in a single 
experiment. This mean that time spent in the lab per data point collected has become 
very small. However, a standard approach to analyze microarray data is still absent as 
methods in experimental techniques and in data analysis are continually being 
improved.  
 
Microarray analysis is a complex system and is affected by a number of experimental 
factors, including target preparation, physical deposition of the targets, slide 
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chemistry, probe chemistry, hybridization, and detection of the fluorescent signal 
(Worley, 2000). Problems inherent to the technologies have raised important issues 
on how to apply adequate statistical tests. As a consequence, statistical approaches to 
microarray research in the life sciences are not yet as routine as they are in other 
sciences (Nadon and Shoemaker, 2002). The difficulties stem primarily from the 
myriad of potential sources of random and systematic error in the microarray process, 
and the absence of a systematic method for data analysis. Indeed, the same analyses 
performed using BRB ArrayTools and TIGR’s MeV can produce different sets of 
results. And as also shown in the Results Section 4.3, utilization of different 
clustering algorithms can produce a range of different results.  
 
In an attempt to address these issues, microarray experiments in this study was carried 
out in a meticulous manner. Three types of quality control values were used to verify 
data quality: (1) A series of metrics reported by the image analysis software to ensure 
that the spots that were quantified appeared to be good spots, (2) A series of controls 
on the microarray to ensure that hybridization had occurred correctly. These will 
indicate how specific and efficient the hybridization had been, (3) Analysis of the 
data from duplicate targets to indicate how good the overall data was and whether the 
results obtained were statistically meaningful (Amersham, 2002).  
 
A lower limit of detection threshold must be set for each scanned microarray, such 
that spots with intensities below the lower limit are discarded. For this study, a more 
stringent lower limit was utilized. The lower limit was defined as three standard 
deviations of the pixel intensities on the negative control spots. This value was higher 
than the mean pixel intensities of the negative control spots, and thus, led to higher 
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stringency. The raw data generated in the Appendices therefore show a higher 
confidence of accuracy.  
 
Direct incorporation of Cy3 or Cy5 modified nucleotide analogues have been known 
to introduce a gene or sequence-specific artefact (Tseng et al., 2001). This difference 
in gene-specific incorporation efficiency manifests itself in a way that some genes 
produce consistently larger signals when labelled with one dye compared to the other. 
It has also been reported that Cy3- or Cy5- conjugated nucleotides are bulky, which 
makes their incorporation using standard enzymes very inefficient. In addition, rates 
of incorporation can differ between dyes, potentially resulting in dye biases 
(Holloway et al., 2002). This type of experimental artefact can be most efficiently 
identified and flagged by exchanging dyes on samples (Bilban et al., 2002). This 
procedure was carried out in this study.  
 
Even for the normalization step, there are variations in how this can be carried out. 
Linear normalization of the data, where all the data points in the microarray are 
adjusted to one common value, is usually carried out. However some 
bioinformaticians had disputed that this was not accurate, and non-linear 
normalization should be carried out instead (Tseng et al., 2001). Another method is to 
normalize against a putative housekeeping gene or a group of such genes (Hess et al., 
2001). There are a few other methods for normalization. Bilban and colleagues (2002) 
and Quackenbush (2002) have written exhaustive articles on the various aspects of 
normalizing microarray data. It is noteworthy to point out that since there are various 




However, different methods of normalization are very likely to produce different set 
of results. Hoffmann and colleagues (2002) employed four different normalization 
methods for detection of differentially expressed genes on a prototype dataset. They 
found that the number of genes detected as differentially expressed differs by a factor 
of about three. This means that some genes that are truly differentially regulated will 
escape detection, and false positives will end up being detected. The dataset produced 
in this study must therefore be rigorously tested in a statistical manner.  For this study, 
non-linear normalization using the Lowess algorithm was adopted (Yang et al., 
2002b), as it is the most 
commonly used and accepted 
form of normalization.  
 
Microarray studies are often not 
an end to itself, as there is a need 
to validate the large data sets that 
are generated (Chuaqui et al., 
2002). Molecular ‘gold-standard’ 
techniques such as qRT-PCR or 
northern blots are often used to 
validate the results (Rajeevan et 
al., 2001). These are termed lab-
based confirmation of microarray 
data. Another method of 
validation is the in silico analysis 
where array results are compared 
Fig 4-1. Key issues for validation of microarray data. The top 
panel lists the front-end quality control needed to facilitate 
successful downstream validation of microarray experiment 
results. The middle panel lists the minimum statistical steps 
required before follow-up studies. The bottom panel diagrams 
validation methods currently used to evaluating array results. 
These methods are used to address both independent confirmation 
of data and universality of the results (Chuaqui et al., 2002). 
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with information available in the literature and in public or private expression 
databases. This provides the opportunity to validate data without further 
experimentation (Chuaqui et al., 2002). Figure 4-1 shows the various techniques for 
microarray data validation. Both these methods of validation were carried when 
analyzing the microarray results. The in silico method of validation is particularly 
important in the face of a myriad of genes to analyse. However, due to the high 
number of genes involved in this study, it was not possible to carry out an exhaustive 
analysis of each gene individually. Some genes whose functions have yet to be 
characterized also served to limit the understanding of host-virus interactions.  
 
5.3   Global Transcriptomic Comparison between HeLa and A172 Cells 
5.3.1   Aberrations in Host Response in A172 Cells Lead to Observed 
Cytopathology 
It is noted that the factors governing the development of neurological disease, host 
immune response, the pattern of clinical features and outcomes are poorly understood 
in those infected with neurotropic flaviviruses (Solomon and Winter, 2004). 
Therefore, studying the host response of A172 cells to WNV infection might provide 
some insights into the molecular mechanisms involved in mediating the 
neuropathogenicity observed in damaged neuronal cells. Genes which were 
differentially regulated were grouped into their functional groups and listed in Table 
3-6.  
 
Apoptosis is a commonly observed outcome when the virus replicates within the host 
cells. This active and highly conserved process of cellular self-destruction serves to 
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limit the spread of the virus. Apoptosis had also been shown to be a major pathway of 
death in mouse neuronal cells infected with another flavivirus, the dengue virus 
(Despres et al., 1996). In this study, a group of genes causing apoptosis were found to 
be upregulated, and may help to shed some light on the pathways linking virus 
replication to apoptosis. These genes include the tumor necrosis factor superfamily 
(TNFSF14), nuclear factor of kappa light chain gene (NFKBIA), TNF receptor-
associated factor (TRAF1) and spermidine/spermine N1-acetyltransferase (SAT). The 
SAT gene was recently shown to be a new mechanism in inducing apoptosis (Babbar 
et al., 2003).  
 
Another cause of pathological effects is due to the activation of the innate antiviral 
immune response pathways. Presence of double-stranded RNA (dsRNA) replication 
complexes from viral origins are amongst the first inducers of the immune response, 
and subsequently plays a role in the transcriptional activation of the IFN-α/β (or type-
I IFN) pathways (Samuel, 2001). In this study on glioma cells, the activation of 
numerous interferon-induced proteins (such as IFIT1, IFIT2, IFI27, IFITM1, IFITM2, 
G1P2) lend support to this mechanism. 
 
However, most in vitro studies of WNV infections were carried out on cells with no 
immunological functions. It was therefore difficult to examine the host cell response 
in native states. Glial cells are advantageous in this study as they are immune cells of 
CNS origins. More importantly, activated glial cells have macrophagic activity and 
are primed to respond to the presence of the virus, therefore allowing the display of 
immune-mediated neuropathology that is reflective of the native conditions in the 




In view of this, glial cells can also activate the type-II (IFN-γ) pathway and modulate 
the immune response by regulating cellular trafficking of various types of leukocytes, 
including macrophage activation and stimulation of specific T-cell cytotoxic 
immunity (Salmaggi et al., 2002). An example of this activation was the observation 
that the HLA-C gene coding for the major histocompatibility complex class I (MHC-I) 
antigens was found to be upregulated in the A172 cells. Peptides derived from 
endogenous intracellular proteins are generally bound by the MHC-I molecules for 
presentation, thus paving the way for cell cytotoxicity in cellular immunity (Cheng et 
al., 2004). This observation thus helped to verify the accuracy of the results. In 
another study on mice, the killing of target infected cells by CD8(+) T cells may 
explain the severe neurological pathology often observed in WNV infections 
(Shrestha and Diamond, 2004).  
 
In addition, indoleamine 2,3 dioxygenase (INDO) was observed to be upregulated in 
the A172 cells during the infection. The INDO gene regulates catabolism of 
tryptophan and is also induced by IFN-γ (Du et al., 2000). Increased INDO 
production by glial cells was found to cause neuronal injury, particularly 
neuroinflammatory diseases like encephalitis (Grant & Kapoor, 2003). The INDO 
was also found to be essential for the cytolytic activity of NK cells (Kai et al., 2004), 
and may be another mechanism for neuronal death in WNV-infected cells. 
Intervention of INDO activity is a target to alleviate or prevent neuronal damage 




The pentaxin-related gene (PTX3) is a gene that is induced by acute inflammatory 
stimuli (Polentarutti et al., 2000) in the brain, and this gene was also found to be 
upregulated in this study. This has recently been implicated in local tissue damage 
from various pathological factors (Bussolati et al., 2003), with the attraction of 
inflammatory cells, resulting in an aggressive response. The PTX3 gene was also 
found to be rapidly produced in macrophages and was implicated in the pathogenesis 
of endothelial cells in atherosclerosis (Rolph et al., 2002) and in causing the 
amplification of inflammation in innate immunity (Bottazzi et al., 1997). 
 
A major group of genes relating to the mitochondria was found to be significantly 
downregulated. Mitochondrial dysfunction due to respiratory-chain dysfunction and 
free-radical formation have been associated with neurodegenerative diseases, such as 
Huntington's disease, Parkinson's disease and Friedreich ataxia (Schapira, 1998). 
These neurological symptoms can also be observed in WNV-infected patients (Burton 
et al., 2004) and could be the mechanism for the observed severe neurological 
dysfunction in the CNS.  
 
Genes belonging to the energy synthesis pathways, consisting of the mitochondrial 
respiratory Kreb’s cycle genes and ATP synthase genes, were decreased significantly. 
These included succinate dehydrogenase (SDHC), cytochrome c oxidase (COX5B 
and COX6B), and various genes of the ATP synthase complex (ATP5G1, ATP5C1, 
ATP5J, ATP5B, ATP5A1, ATP5O, and ATP5F1). The SDHC gene belongs to the 
complex II of the electron transport chain while COX genes codes for the terminal 
enzyme contributing to a proton electrochemical gradient. Mitochondrial ATP 
synthase catalyzes ATP synthesis by utilizing the electrochemical gradient. Decreased 
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or loss of energy production from the downregulation of these genes as well as 
overproduction of free radicals is possibly the cause of severe neurodegeneration 
(Eng et al., 2003).  
 
Besides being involved in respiratory functions, some mitochondrial genes are 
involved in cellular protection. Two of the peroxiredoxin family of antioxidant 
enzymes (PRDX5 and PRDX3), which help to eliminate hydrogen peroxide, were 
found to be down-regulated in the infected cells. This may lead to increased oxidative 
stress induced by reactive oxygen species (ROS), thus creating a proinflammatory 
condition that resulted in CNS pathology (Krapfenbauer et al., 2003), and 
encephalitis in WNV infections. Downregulation of the PRDX3 gene was also 
implicated in the pathogenesis of Alzheimer's disease and Down’s syndrome (Kim et 
al., 2001).  
 
More interestingly, downregulation of yet another gene has been associated with 
Alzheimer’s disease and Down’s syndrome. Nascent polypeptide-associated complex 
(NACA) helps to target nascent translated polypeptides to the ER membrane. 
Decreased NACA may therefore result in the mistargeting, mistranslation, and 
proteolysis of proteins, and might be involved in the pathology of neurodegenerative 
diseases (Kim et al., 2002). This gene was also found to be similarly downregulated 
in the WNV-infected A172 cells.  
 
Aberrations in expression of genes with putative roles in neuropathology observed in 




Besides the differentially regulated genes which are the putative cause of WNV 
pathology mentioned above, other genes observed in the mircoarray results has 
corroborated with previous findings involved in the host response during a virus 
infection. Examples of these include the upregulation of 2'-5'-oligoadenylate 
synthetase 3 (OAS3) which activates RNaseL (Presti et al., 2001) in an attempt to 
catalyze the breakdown of the virus genome (Samuel, 2001; Lucas et al., 2003). 
Another gene coding for the kinesin motor protein (KIF22) was also upregulated. 
Kinesins are microtubule-dependent molecular motors that transport organelles within 
cells, and are essential for the transport of WNV structural proteins to the plasma 
membrane (Chu & Ng, 2002a,b).  
 
Table 5-1. List of differentially regulated genes involved in pathogenesis. 
Gene Symb Gene Name Fold Change
OAS3 2'-5'-oligoadenylate synthetase 3, 100kDa 2.32 
OASL 2'-5'-oligoadenylate synthetase-like 3.46 
HLA-C major histocompatibility complex, class I, C 2.20 
INDO indoleamine-pyrrole 2,3 dioxygenase 3.38 
KIF22 kinesin family member 22 2.02 
PTX3 pentaxin-related gene, rapidly induced by IL-1 beta 3.44 
TNFSF14 tumor necrosis factor (ligand) superfamily, member 14 2.19 
NFKBIA nuclear factor of kappa light polypeptide gene enhancer 4.13 
TRAF1 TNF receptor-associated factor 1 2.01 
SAT spermidine/spermine N1-acetyltransferase 2.18 
COX5B cytochrome c oxidase subunit Vb -2.13 
COX6B cytochrome c oxidase subunit VIb -2.41 
SDHC succinate dehydrogenase complex, subunit C -2.31 
PRDX5 Peroxiredoxin 5 -2.74 
PRDX3 Peroxiredoxin 3 -2.27 
ATP5G1 ATP synthase, mitochondrial F0 complex, subunit c, isoform 1 -2.64 
ATP5C1 ATP synthase, mitochondrial F1 complex, polypeptide-γ 1 -3.82 
ATP5J ATP synthase, mitochondrial F0 complex, subunit F6 -2.11 
ATP5B ATP synthase, mitochondrial F1 complex, polypeptide-β -2.17 
ATP5A1 ATP synthase, mitochondrial F1 complex, α-subunit, isoform 1 -2.21 
ATP5O ATP synthase, mitochondrial F1 complex, O subunit  -2.00 
ATP5F1 ATP synthase, mitochondrial F0 complex, subunit b, isoform 1 -2.43 
NACA nascent-polypeptide-associated complex alpha polypeptide -2.17 
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5.3.2   Differences in Host Response in Different Cells May Lead to Lower Virus 
Yields 
Besides studying the changes in gene expression between infected and mock-infected 
A172 cells at 24 hours p.i., a comparison was made with the less-permissive HeLa 
cells. The virus yield in HeLa cells was a 100-fold lower compared to A172 cells 
(Figure 3.5), while intracellular virus level was 4-fold lower as determined by 
quantitative PCR and immunofluoresnce microscopy (Tables 3-2 and 3-3). The 
differences in host-responses between the two types of cells were examined to 
determine the molecular mechanisms that might act to limit the replication of the 
virus in the less permissive HeLa cells. The list of genes which showed a difference 
in expression between the two cell types, and identified by EASE as significantly 
over-represented, are listed in Table 3-7.  
 
Genes relating to intracellular transport functions was the predominant group found to 
be differentially regulated. Cytoskeletal structural constituents DNAH3 is a dynein 
protein that binds to microtubules to facilitate the transport of vesicles along the 
microtubules. Kinesin proteins (KLC2L) are also motor proteins running along 
microtubules, and was also found to be similarly regulated. TUBA2 and K-ALPHA-1 
genes code for the tubulin subunit that polymerizes to form the microtubular 
complexes. Trafficking of the viral E and C proteins was previously shown to be 
transported along the microtubules towards the plasma membrane (Chu and Ng, 
2002b), and microtubules are also involved in the trafficking of internalized virus 
found within endocytic vesicles (Chu and Ng, 2004). Upregulation of these genes in 
A172 cells over HeLa cells may therefore facilitate virus entry and production, 
resulting in greater virus yield in A172 cells. On the other hand, the protein tektin 3 
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(TEKT3) was found to be upregulated in HeLa cells. Tektin facilitates the 
maintenance of microtubule stability and rigidity (Roy et al., 2004). The presence of 
this protein in higher amounts in HeLa cells may help to limit the spread of the virus 
within the cells, as transportation along these microtubular tracks are hindered.  
 
Ankyrin (ANK3) is a protein that helps to link the integral membrane proteins to the 
underlying spectrin-actin cytoskeleton and play key roles in activities such as cell 
motility, activation, contact, and the maintenance of specialized membrane domains. 
The function of actinin (ACTN4) is to cross-link and bundle actin filaments at the 
plasma membrane (Honda et al., 1998).  Actin filaments play an essential role during 
the initial penetration of the virus across the plasma membrane during entry (Chu and 
Ng, 2004), and also for the virus maturation process during the release of virions from 
the plasma membrane (Chu et al., 2003). Indeed, these genes were found to be 
upregulated in A172 cells compared to HeLa cells, thereby facilitating the virus entry 
and extrusion process observed. On the contrary, greater amounts of profilin were 
found in HeLa cells (2.5-fold more) and may therefore limit the yield of the virus. 
Profilin (PFN2) is involved in the regulation of actin polymerization by binding to 
charged actin-monomers and acts as a sequestering protein, thus modifying actin 
dynamics (Paavilainen et al., 2004).  
 
The West Nile virus was recently found to enter a cell through the αVβ3 integrin 
receptor (Chu and Ng, in press). FRMD4A is a FERM domain containing protein that 
mediates intermolecular interactions, including the binding and activation of the β-
subunit of integrins via the talin FERM domain (Calderwood et al., 2002). There was 
a 9-fold repression of this activating protein in HeLa cells, compared to A172 cells. 
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Inactivation of the integrin receptor in HeLa cells could explain the low intracellular 
levels of viral RNA and proteins observed, since only a small number of virus 
particles may be able to enter the cell successfully.   
 
After virus attachment to the receptor, the virus is internalized by a clathrin-mediated 
endocytic pathway within the endosomal and lysosomal vesicles. Fusion of the 
enveloped virus with the lysosomal membrane occurs at low pH, resulting in the 
expulsion of the viral nucleocapsids into the cytoplasm around the vicinity of the ER 
(Chu and Ng, 2004). Syntaxin 4A (STX4A) facilitates the docking and fusion of 
vesicles onto membranes for the transport of intracellular materials through the t-
SNARE proteins (Wyman et al., 2003). ADP-ribosylation factors (ARFs) are critical 
in the vesicular trafficking pathway, whose activity is controlled by GTPase-
activating proteins (GAPs) such as ARFGAP3. Both STX4A and ARFGAP3 function 
in the transport of substances between intracellular compartments mediated by 
transporting vesicles, and were found to be upregulated in A172 cells compared to 
HeLa cells. Prosaposin (PSAP) is the precursor of four sphingolipid activator proteins 
that are localized within lysosomes in a pH-dependent process (de Alba et al., 2003), 
and may facilitate in virus uptake. Indeed, expression of prosaposin was found to be 
repressed in HeLa cells which may limit the permissiveness of the cell to the virus.  
 
In addition to the genes involved in virus transport and packaging, genes belonging to 
the hexose metabolism family were also involved, particularly in glycolysis. Both 
aldolase (ALDOA) and glucose-6-phosphate dehydrogenase (G6PD) are 
housekeeping genes and thus their expression should not vary much under various 
physiological conditions. However, the expression of these genes was found to be 
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repressed in HeLa cells. On the other hand, A172 cells did not show much change in 
the regulation of these genes. In a study on the tick-borne encephalitis (TBE) virus, 
which is another flavivirus, glucose uptake was markedly increased after infection by 
the virulent strain rather than the attenuated strain of the virus (Starek and Babkova, 
1976). The glycolytic activity was higher in cells with actively replicating viruses. A 
repression in glycolytic enzymes in HeLa cells observed in this study might therefore 
be a novel mechanism in inhibiting virus replication.  
 
Genes belonging to the protein biosynthesis functional group is also implicated in 
causing the differences in permissiveness observed. The first subgroup of genes is 
involved in the generation of nascent peptides. Translation elongation factors (EFs) 
are involved in the enzymatic delivery of aminoacyl-tRNAs to the ribosome, whereas 
aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate 
amino acid. These genes were all found to be upregulated in A172 cells compared to 
HeLa cells. Of the three EFs detected, translation elongation factor 1 (EEF1A2) is 
known to interact with the 3' stem-loop region of WNV (Blackwell and Brinton, 1997) 
and closely related Dengue virus (De Nova-Ocampo et al., 2002) RNA to facilitate 
viral RNA replication. EF-1 also plays a role in actin re-organization (Ejiri, 2002; Liu 
et al., 2002), which will affect virus entry, maturation and extrusion as mentioned 
above.  EF-1 delta is known to decrease the metabolism of host cells to the virus’s 
advantage by reducing the efficiency of translation of cellular mRNA, but not viral 
mRNA in HIV infections (Xiao et al., 1998). Taken together, a decreased level of EF-
1 in HeLa cells has the potential to impact the ability of WN virus to replicate 
efficiently inside the host. Further study on the roles of elongation factors in 
influencing virus replication is under study.  
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Ribosomal genes were also detected by EASE and they come under the protein 
biosynthesis group. Two large ribosomal proteins (RPLP2 and RPL10L) were greatly 
upregulated in A172 cells, while two small ribosomal proteins (RPS13 and RPS24) 
were upregulated in HeLa cells. This pattern of regulation is interesting although the 
effect of these proteins on WNV replication is not clear. However, it is believed that 
this is a significant finding as the capsid protein of the virus was found to localize to 
the nucleolus in the initial phase of infection through a novel nuclear localization 
signal (Wang et al., 2002). The function of the nucleolus is not only for ribosome 
biogenesis (Shaw and Jordan, 1995), but the peri-nucleolar compartment has been 
implicated in RNA metabolism (Huang et al., 1998). The interaction of the capsid 
protein with the nucleolus may therefore give rise to observed findings. It is 
noteworthy to mention that the localization of viral structural proteins to the nucleus 
can result in the induction of cytopathic effects and subsequent disease pathogenesis 
in the host cells (Hoyt et al., 2004).  
 
To provide further credence to the observation above, the protein importin 8 (IPO8) 
which mediates the nuclear import of proteins with a classical nuclear localization 
signal by binding to the nuclear pore complex, was found to be greatly repressed in 
HeLa cells. This mechanism of capsid protein entry was also observed in 
polyomavirus JC virus (Qu et al., 2004). The capsid protein may therefore mediate 
the RNA processing activities within the nucleus, as it is the only viral protein found 
to enter the nucleus. Indeed, the surfeit-6 (SURF6) gene, which encodes a nucleolar-
matrix protein with nucleic-acid binding properties (Magoulas and Fried, 2000), was 
found to be regulated in a similar fashion in this study. Even though the WNV is a 
positive-strand RNA virus and thus replicates exclusively in the cytoplasm, these 
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viruses are known to use the nucleus and/or nuclear components in order to facilitate 
their replicative processes (Hiscox, 2003). The findings here that genes involved in 
RNA processing within the nucleus, are also differentially regulated in cells with 
different permissiveness to a WNV infection, strongly supports the view that the 
nucleus is involved in viral replication.  
 
Many of the genes in the RNA processing group code for protein products that are 
involved in nuclear RNA splicing, via the spliceosome complex in the nucleus. These 
include genes like SNRPB, FNBP3, SF3B5, SF4 and TRA2. As many of the genes 
relating to mRNA splicing mechanism were differentially regulated between the two 
host cells, it suggested that the host cell is adjusting its RNA processing activities not 
only for protein production, but also in response to the virus infection. Utilization of 
host splicing factors to mediate virus replication has been documented in other RNA 
viruses (Caputi et al., 2004; Gruffat et al., 2002; Momose et al., 2001), but this is the 
first observation for a flavivirus. In the time course study of WNV infection in A172 
cells, splicing factor, arginine/serine-rich 1 (SFRS1) was found to be downregulated 
after 18h (Appendix 10), and thus lends support to the importance of spliceosome in a 
flavivirus infection. SFRS1 has been found to be be pivotal in the posttranscriptional 
regulation of late gene expression of human papillomavirus type 16 (McPhillips et al., 
2004). The interaction of WNV with the nucleus is however still not well understood, 
and the functional significance of these interactions remains to be determined. 
Perturbation of the host cell nuclear functions by the capsid protein may promote an 




5.4   Progressive Global Transcriptomic Analysis of A172 Cells During 
WNV Infection 
As previous studies and analyses were carried out at 24h post-infection, microarray 
studies on various time points during a WNV infection cycle were also carried out to 
determine the host-response changes at various stages of the WNV infection. Five 
different time points (i.e. 1.5h, 6h, 12h, 18h, and 24h) were used in this study, to 
capture the gene expression patterns at the early, middle, and late phases of infection. 
Various clustering methods were performed to find the best fit for the hundreds of 
genes being analyzed. Interesting trends in gene expression patterns during the course 
of WNV infection were identified, and these are presented in Section 4.4. A summary 
of the 6 clusters obtained is listed in Table 4-4. 
 
Group I consists of genes whose expression were constantly upregulated throughout 
the course of the WNV infection. Forty-five genes were found to belong to this group, 
of which the immune response genes were found to be significantly over-represented 
by EASE (Appendix 7).  As discussed in Section 5.3.1 above, activation of the 
immune response genes is the natural host response when it encounters a pathogen. It 
was detected as early as 1.5h after inoculation, and upregulation of these genes were 
maintained till the late phase of infection. The interplay between these immune-
related genes is highly complex, and is made more complicated with the activation of 
both IFN-α/β and IFN-γ (type I and II, respectively) pathways. Some of the genes 
relating to the immune functions that were clustered in this group were already 
highlighted above, and these include the interferon-induced genes (IFITM1, IFIT1, 
IFIT2, and IFI27), 2’,5’-oligoadenylate synthetase (OASL), and pentaxin gene 
(PTX3), which together may lead to the cytopathology observed in A172 cells.  
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Other genes of significance in this group include the N-myc (and STAT) interactor 
gene (NMI), bradykinin receptor B1 (BDKRB1), and protein C receptor (PROCR), 
all of which are involved in the inflammatory response of the host cells. Induction of 
these genes leads to local vasodilation, extravasation of plasma into intercellular 
spaces and accumulation of white blood cells and macrophages, thereby causing the 
observed symptom of encephalitis in patients infected with WNV.  
 
Interestingly, genes which are antagonistic to the immune function were also found to 
be upregulated. Interleukin-18 binding protein (IL18BP) is activated by IFN-γ 
(Paulukat et al., 2001) and prevents the binding of IL-18 to its receptor, thus 
inhibiting IL18-induced IFN-γ production (Novick et al., 1999). Serine (or cysteine) 
proteinase inhibitor, or C1 inhibitor (SERPING1) inhibits activated C1r and C1s of 
the first complement component and thus regulates complement activation. These 
antagonistic functions serve to regulate the immune response, in view of the presence 
of a pro-inflammatory environment. To fully understand the immune-related effects 
and its relationship to the pathophysiology of infected cells, further studies are needed 
to be carried out in this area. 
 
Seventeen genes were clustered into Group II, which were all constantly 
downregulated during the course of the WNV infection. Even though the functions of 
some genes are listed in Appendix 8, no specific ontology group was found to be 
significantly over-represented by EASE. Therefore, even though 3 genes relating to 
cell proliferation were found to be downregulated, it does not necessarily signify that 
the process of cell multiplication is totally shut down. The same is true for all 5 
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categories listed. Nevertheless, some of these constantly downregulated genes are of 
significance in the virus replication process.  
 
Coatomer protein complex, zeta (COPZ1), is a protein involved in intracellular 
transport, and is closely associated with the Golgi apparatus and the clathrin vesicle 
coat. Downregulation of this gene constantly is interesting, as the virus is known to 
enter the cell through a clathrin-mediated endocytic pathway (Chu and Ng, 2004). 
Further studies in the genes related to the ER and Golgi apparatus might help to 
further elucidate the relationship of these organelles with virus replication. Two genes 
relating to carbohydrate metabolism, alpha glucosidase II alpha subunit (GANAB) 
and succinate dehydrogenase complex (SDHC), were also found to be down-
regulated. The significance of a downregulation in carbohydrate metabolism and 
respiration has been discussed in Section 5.3.  
 
Genes that were upregulated at the early phase of infection (i.e. at 1.5h p.i.), but were 
subsequently downregulated after the mid-phase of infection (6 h p.i.) were found in 
Group III (Figure 4-21). There were 23 genes in this group, and the dominant gene 
ontology group belongs to cell cycle regulation. Of the 4 genes relating to the cell 
cycle regulation, NHP2 non-histone chromosome protein 2-like 1 (NHP2L1) is also 
part of the ribosome, and is intricately linked to the nucleolus and spliceosome 
complex (Leung and Lamond, 2002). Cell cycle genes appeared in a significant 
number of instances throughout this study, but the patterns of expression has been 
sporadic. The relationship of these genes on WNV infection is not clear, but it is 
noted that changes in cell cycle regulation has been reported in other virus systems 
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such as cytomegalovirus (Hertel and Morcarski, 2004) and HIV (Mannioui et al., 
2004).  
 
Genes in Group IV were initially upregulated, but were found to be downregulated 
after 18 h post-infection during the late phase of infection (Figure 4-22). Eight genes 
belonging to nucleic acid metabolism were significantly over-represented as 
determined by EASE, with six of these genes also belonging to the DNA-dependent 
transcription regulation ontology group.  It was noted that after 18 hours post-
infection, the WNV entered the late phase of infection with peak virus production (Ng 
et al., 2001). While the host-cells were still viable at this stage of the virus replication 
process, it was observed that various cellular genes can be downregulated through 
regulating the activity of the transcription factors. Of these genes, YY1 transcription 
factor (YY1) is of interest as accumulation of this protein within the nucleus during 
the course of a virus infection was found to decrease virus yield in vaccinia virus 
(Slezak et al., 2004).   
 
Also of interest is the presence of 2 kinesin (KIF3C and RAB6KIFL) and nexilin (F-
acting binding; NEXN) genes which were also found to be upregulated during the 
early/mid phases of infection, but were downregulated after 18h. As discussed in 
Section 5.3.2, kinesins are an important group of motor proteins involved in the 
intracellular transport of viral proteins. Upregulation of these genes initially will 
therefore facilitate in viral proteins transport, but downregulation of the motor 
proteins at the late phase of infection may denote that most of the viral particles have 




Genes in Group V show the exact opposite in expression pattern from Group IV. 
They were downregulated during the initial phases of infection, but were upregulated 
after 18h post-infection (Figure 4-23). There are 27 genes in this group, and 2 
ontology groups belonging to cellular physiological processes and integral membrane 
proteins were found to be significantly over-represented by EASE.  
 
Three genes from the cellular physiological processes group were found to be of 
interest here. Death-associated protein kinase 3 (DAPK3) and pleckstrin homology-
like domain (PHLDA2) genes are both involved in apoptosis, and both were found to 
be upregulated after 18 h p.i. DAPK3 induces morphological changes in apoptosis 
when it is overexpressed in mammalian cells through a nuclear pathway (Kawai et al., 
2003), while PHLDA2-induced apoptosis is Fas-mediated (Qian et al., 1997). The 
role of apoptosis in WNV infection and other genes involved in cell death were also 
discussed in Section 5.3.1. Laminin alpha 1 (LAMA1) is involved in basement 
membrane formation through the formation of glycoproteins and helps in the 
regulation of cell adhesion. This gene was found to be upregulated after 18h p.i., and 
was also similarly found to be heavily upregulated in cells afflicted with Alzheimer’s 
disease and playing a role in its pathophysiology (Palu and Liesi, 2002).  
 
In the integral membrane proteins groups, interleukin 27 receptor (WSX1) was also 
upregulated after 18h p.i. WSX1 binds to IL-27 and is important for the activation of 
STAT1 in the immune response (Takeda et al., 2003). In yet another link to 
Alzheimer’s Disease, low density lipoprotein-related protein (LRP1) which is 
involved in the transport of amyloid-β, was also found to be upregulated after 18h p.i. 
(Deane et al., 2004).  
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The gene expression pattern in Group VI is rather unique when compared to the rest 
of the groups. The genes were all downregulated during the WNV infection, except at 
6 h p.i. whereby they were upregulated (Figure 4-24). Interestingly, this group has the 
most number of genes (i.e. 51 genes) and 3 functional groups were found to be 
significantly over-represented by EASE.  
 
Genes belonging to the endoplasmic reticulum group were highly represented. 
Reticulon 4 (RTN4), or NOGO protein, is involved in membrane trafficking. 
Upregulation of this gene in neurons has been implicated in epilepsy (Bandtlow et al., 
2004) and in inducing apoptosis (Qi et al., 2003). Emopamil-binding protein (EBP) is 
an integral membrane protein of the endoplasmic reticulum involved in the trafficking 
of drugs (Hanner et al., 1995) and possesses sterol-isomerase activity (Braverman et 
al., 1999). Another gene involved in sterol metabolism is the sterol regulatory 
element binding transcription factor 1 (SREBF1).  The nascent transcription factor is 
localized at the ER before entering the nucleus to bind at the sterol regulatory 
element-1 (SRE1) (Wang et al., 1994). Kinesin-associated protein 3 (KIFAP3) is 
concentrated around the ER, and can serve as an adapter to kinesin II in the transport 
of vesicles along microtubules (Shimizu et al., 1996). The SEC23 interacting protein 
(SEC23IP) has been shown to cause disorganization of the endoplasmic reticulum-
Golgi intermediate compartment and Golgi apparatus, which suggests its role in the 
early secretory pathway (Tani et al., 1999).  
 
The upregulation of these ER related genes at 6h p.i. is highly significant as the 
trafficking of the uncoated viral RNA genomes to the ER and subsequent virus 
maturation occurs at the mid-early phase of infection (Chu and Ng, 2004). The genes 
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are therefore important for virus uptake and maturation. Another gene that is involved 
in intracellular protein transport is the sorting nexin 3 (SNX3) gene through the 
endocytic process (Haft et al., 1998).  
 
Genes involved in the cytoskeletal structures include tropomyosin 3 and tropomyosin 
4 (TPM3 and TPM4), which are molecular motors that bind to actin filaments. 
Interestingly, actin dynamics may be mediated by the abl-interactor 1 (ABI1) gene, 
which was also upregulated at 6h p.i. ABI1 increases actin polymerization activity 
and is involved in Rac-dependent lamellipodia protrusion (Innocenti et al., 2004). 
Such lamellipodia protrusions were also observed in the WNV-infected cells (Lee and 
Ng, 2004).  
 
Genes relating to the mitochondria were also again highly represented. Defects in 
mitochondrial function have implications in neuropathology, and this was discussed 
in Section 5.3.1. However, the mitochondria genes listed in Group VI were different 
from those above, albeit with similar functions. Succinate-CoA ligase (SUCLA2), 
isocitrate dehydrogenase 1 (IDH1), cytochrome c oxidase (COX6C), surfeit 1 
(SURF1) and ATP synthase (ATP5F1) are all involved in the respiratory chain. These 
genes were upregulated at 6h p.i., but were again downregulated at the late phase of 
infection. The change in metabolic activity at this time point of infection is therefore 
be interesting. Abberations in SURF1 and COX genes have been shown to cause 
Leigh syndrome and brain damage (Moslemi, et al., 2003). Sterol carrier protein 2 
(SCP2) is involved in the transfer of sterols between plasma membranes, lysosomes, 
peroxisomes, mitochondria, and the endoplasmic reticulum, and also helps in the 
protection against oxidative damage (Dansen et al., 2004).  
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5.5   Conclusion 
Genes relating to the apoptosis and the immune response were constantly highlighted 
in this study. This was naturally so given the nature of the assault suffered by the host 
cells during a virus infection. However, there were other functional classes which 
were also highly significant in this study. These included the interplay between the 
cytoskeletal structures and intracellular transport genes in mediating virus replication 
and maturation. Genes involved in the nucleolar, spliceosome, ribosomal and protein 
synthesis functional groups were also highly significant and warrant further analysis. 
Defects in mitochondrial function and its effects on cellular metabolism were also 
significant. Finally, many of these genes were observed to be related to the 
pathophysiology of other neuronal diseases like Parkinson’s and Alzheimer’s diseases, 
and may represent a common pathway in the degeneration of the cells in the CNS.  
 
The results of this extensive study on the global analyses of WNV-host interaction 
have been interesting, and displayed a complex network of host responses that may 
affect the virus replication during the infection process. This has helped to provide 
new insights into the pathogenesis of the diseases. The use of glial A172 cells, which 
are brain cells with immune functions, has shed some important insights into the 
molecular mechanisms behind the observed neuronal pathology.  The use of the less 
permissive HeLa cells has also helped in our understanding on which host factors are 
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Appendix 1: Media for Tissue Culture of Cell Lines 
 
a) Dulbecco’s Modified Eagle’s Medium (DMEM): Growth Medium for HeLa  
and A172 Cells 
Item Amount Source 
DMEM Powder 17.3 g Sigma, USA 
NaHCO3 2.2 g Merck, Germany 
Foetal Calf Serum (FCS) 100 ml Hyclone, Switzerland 
Type 1 Reagent Grade Water (NANOpure) 900 ml Barnstead, USA 
1 bottle of DMEM powder was dissolved in 900 ml of NANOpure water. 2.2 g of 
NaHCO3 was then added and the pH adjusted to 7.2. Sterilization of media was 
carried out by filtration through a 0.22 µm filter (Sterivex G-S, Millipore, USA). The 
media was then stored in aliquots at 4°C. FCS was added as required before use. 
 
b) Medium 199: Growth Medium for Vero Cells 
Item Amount Source 
M199 Powder 11.0 g Sigma, USA 
NaHCO3 2.2 g Merck, Germany 
Foetal Calf Serum (FCS) 100 ml Hyclone, Switzerland 
Type 1 Reagent Grade Water (NANOpure) 900 ml Barnstead, USA 
1 bottle of DMEM powder was dissolved in 900 ml of NANOpure water. 2.2 g of 
NaHCO3 was then added and the pH adjusted to 7.2. Sterilization of media was 
carried out by filtration through a 0.22 µm filter (Sterivex G-S, Millipore, USA). The 




c) 10X Phosphate Buffered Saline [(PBS) (pH7.4)] 
Item Amount Source 
NaCl 80.0 g Merck, Germany 
KCl 2.0 g Merck, Germany 
KH2PO4 2.0 g Merck, Germany 
Na2HPO4 11.5 g Merck, Germany 
Type 1 Reagent Grade Water (NANOpure) 1000 ml Barnstead, USA 
To prepare 10X PBS stock solution, the specified items were added to 900 ml of 
NANOpure water and the pH adjusted to 7.4. The solution was topped up to 1 litre 
and then autoclaved at 121°C for 15 min. The stock solution was then stored at room 
temperature. To prepare the working 1X PBS, the stock solution was diluted 1:10 
with NANOpure water. The solution was then autoclaved at 121°C for 15 min and 
subsequently stored at 4°C.  
 
d) Trypsin/Versene (ATV) Solution 
Item Amount Source 
NaCl 80.0 g Merck, Germany 
KCl 4.0 g Merck, Germany 
D-glucose 10.0 g Analar, UK 
NaHCO3 5.8 g Merck, Germany 
Trypsin 5.0 g Difco, New Zealand 
Versene (EDTA) 2 g Sigma, USA 




The items were added to 100 ml of NANOpure water and the mixture was heated to 
30°C with occasional shaking (for 3-4 hr) to dissolve the trypsin. The solution was 
then filtered through a 22 µm filter (Sterivex G-S, Millipore, USA). Ten ml of this 




Appendix 2: Reagents for Plaque Assay 
 
a) Virus Diluent 
Item Amount Source 
Hank’s Balanced Salt Solution 11.0 g Sigma, USA 
10% Bovine Serum Albumin 1 ml CSL, Australia 
NaHCO3 2.2 g Merck, Germany 
Type 1 Reagent Grade Water (NANOpure) 99 ml Barnstead, USA 
All items were dissolved in the water to give 100 ml. The solution was sterilized by 
filtration through a 0.22 µm filter unit (Sterivex G-S, Millipore, USA). Storage was at 
4°C. 
 
b) Maintenance Medium (DMEM) for HeLa and A172 Cells 
Item Amount Source 
DMEM Powder 17.3 g Sigma, USA 
Foetal Calf Serum 20 ml Hyclone, Switzerland 
NaHCO3 2.2 g Merck, Germany 
Type 1 Reagent Grade Water (NANOpure) 980 ml Barnstead, USA 
1 bottle of DMEM powder was dissolved in 980 ml of water, and 2.2 g of NaHCO3 
was then added. The pH was adjusted to 7.2 and sterilization was carried out by 
filtration through a 0.22 µm filter (Sterivex G-S, Millipore, USA). The media was 






c) Maintenance Medium (M199) for Vero Cells 
Item Amount Source 
M199 Powder 11.0 g Sigma, USA 
Foetal Calf Serum 20 ml Hyclone, Switzerland 
NaHCO3 2.2 g Merck, Germany 
Type 1 Reagent Grade Water (NANOpure) 980 ml Barnstead, USA 
1 bottle of M199 powder was dissolved in 980 ml of water, and 2.2 g of NaHCO3 was 
then added. The pH was adjusted to 7.2 and sterilization was carried out by filtration 
through a 0.22 µm filter (Sterivex G-S, Millipore, USA). The media was then stored 
in aliquots at 4°C. FCS was added as required prior to use. 
 
d) Overlay Medium 
Item Amount Source 
M199 Powder 11.0 g Sigma, USA 
Foetal Calf Serum 40 ml Hyclone, Switzerland 
NaHCO3 4.4 g Merck, Germany 
Type 1 Reagent Grade Water (NANOpure) 460 ml Barnstead, USA 
The reagents were dissolved in the water to produce a 2X concentrate nutrient 
medium. Two hundred ml of this 2X concentrate medium was added to an equal 




e) 1% Crystal Violet Staining Solution 
Item Amount Source 
Crystal Violet Powder 1.85 g BDH, UK 
37% Formaldehyde  250 ml Merck, Germany 
PBS 120 ml see Appendix 1(c) 
 
f) 2.5% Carboxymethyl-Cellulose Solution 
Item Amount Source 
Sodium salt of Carboxymethyl-Cellulose 2.5 g CalBiochem, USA 
Type 1 Reagent Grade Water (NANOpure) 100 ml Barnstead, USA 
2.5 g of sodium salt of carboxymethyl-cellulose (Aquacide II, CalBiochem, USA) 
was added to 100 ml of the water. The solution was mixed, autoclaved for 15 min at 
121°C and stored at 4°C. 
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Appendix 3: Reagents for Genomic Expression Studies 
 
a) Diethylpyrocarbonate (DEPC) Treated ddH2O 
Item Amount Source 
Diethylpyrocarbonate (DEPC) 1.0 ml Sigma, USA 
Type 1 Reagent Grade Water (NANOpure) 999 ml Barnstead, USA 
To make 1 litre of DEPC treated (RNase-free) water,  1ml of DEPC was added to 999 
ml of water. The treated water was incubated overnight at room temperature with 
stirring. The water was then autoclaved at 121°C for 15 min. 
 
b) Formaldehyde-Agarose (FA) Gel 
Item Amount Source 
Agarose  1.2 g Merck, Germany 
10x FA Gel Buffer 10 ml see Appendix 3i 
37% (12.3M) Formaldehyde  1.8 ml Sigma, USA 
Ethidium Bromide (10µg/ml) 1 µl see Appendix 3j 
DEPC Water 90 ml see Appendix 3a 
The agarose and 10x FA gel buffer was mixed and topped up to 100 ml with DEPC 
water. It was then swirled and microwaved until completely dissolved. Formaldehyde 





c) 1x Formaldehyde-Agarose (FA) Gel Running Buffer 
Item Amount Source 
10x FA Gel Buffer 100 ml see Appendix 3i 
37% (12.3M) Formaldehyde 20 ml Sigma, USA 
DEPC Water 880 ml see Appendix 3a 
Store at room temperature after preparation.  
 
d) 5x RNA Loading Buffer 
Item Amount Source 
Bromophenol Blue 16 µl Sigma, USA 
Formamide 3.084 ml Sigma, USA 
37% (12.3M) Formaldehyde 720 µl Sigma, USA 
100% Glycerol 2 ml Merck, Germany 
500mM EDTA, pH8.0 80 µl Merck, Germany 
10x FA Gel Buffer 4 ml See Appendix 3i 
DEPC Water to 10 ml see Appendix 3a 
Store at -20°C after preparation.  
 
e) 2.5M NaOH 
Item Amount Source 
NaOH 20.0 g Merck, Germany 






f) 2M HEPES free acid 
Item Amount Source 
4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES) 
95.3 g Merck, Germany 
DEPC Water 200 ml see Appendix 3a 
 
g) Wash Solution 1 
Item Amount Source 
20x SSC 300 ml Sigma, USA 
Triton X-102 0.5 ml Supplied with kit. 
DEPC Water 700 ml see Appendix 3a 
Mix the items in a nuclease-free graduated cylinder. Pass it through a 0.22 µm filter 
(Sterivex G-S, Millipore, USA) and store at room temperature. 
 
h) Wash Solution 2 
Item Amount Source 
20x SSC 5 ml Sigma, USA 
10% Triton X-102 0.5 ml Supplied with kit. 
DEPC Water 995 ml see Appendix 3a 
Mix the items in a nuclease-free graduated cylinder. Pass it through a 0.22 µm filter 







i) 10x FA Gel Buffer 
Item Amount Source 
200mM 3-[N-morpholino]propanesulfonic 
acid (MOPS) (free acid) 
41.86 g Sigma, USA 
50mM Sodium acetate 4.1 g Merck, Germany 
10mM EDTA 2.9 g Merck, Germany 
DEPC Water to 1000 ml see Appendix 3a 
Mix the above items with a magnetic stirrer. pH to 7.0 with NaOH.  
 
j) Ethidium Bromide (EtBr) 
Item Amount Source 
Ethidium Bromide (EtBr) 0.2 g Sigma, USA 
DEPC Water 20 ml see Appendix 3a 
EtBr was dissolved in 20 ml of DEPC water by stirring with a magnetic stirrer at 







Appendix 4: Reagents for Immunofluorescence 
 
a)  10% Bovine Serum Albumin (BSA) 
Item Amount Source 
Bovine serum albumin powder, Fraction V 10 g Gibco BRL, USA 
PBS 100 ml see Appendix 1c 
Glycerol 9 ml Merck, Germany 
The solution was aliquoted and stored at –20°C. To obtain 0.1% BSA, 1 ml of 10% 
BSA was diluted in 100 ml of PBS.  
 
b)  Mountant 
Item Amount Source 
1,4-Diazabicyclo[2.2.2]octane (DABCO) 1 g Sigma, USA 
0.1 M Tris-HCl (pH 7.6) 1 ml Merck, Germany 
Glycerol 9 ml Merck, Germany 
The mountant was aliquoted and then stored at –20°C. 
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Appendix 5: List of Oligonucleotides 
 
 Gene Symbol Sequence (5'-3') 




envelope protein WN(S)E (-) ACTAAACGGGGGTTCGAGTT 
   




transferase 1 HPRT1 (-) GGTCCTTTTCACCAGCAAGCT 
   




protein 1 IFITM1 (-) AGGTGTGTGGGTATAAACTGCT 
   




2 TFPI2 (-) AGGTGAAAGCATCACAGGTTCT 
   
DNAJA1 (+) GAAGGCATGGACATTGATGACC 
  DnaJ (Hsp40) homolog, subfamily 
A, member 1 DNAJA1 (-) TGGGGGATCTTGCTTCTTTCG 
   
DUSP1 (+) CTTAGCGTCAAGACATTTGCTG 
  Dual specificity phosphatase 1 DUSP1 (-) TGTGTCGTCGGGAATAATACTG 
   




member I ARHI (-) CTCCTCTTCAAATGCCAATGTT 
   
YWHAZ (+) TGGTACATTGTGGCTTCAAAAG 
  14-3-3 zeta 
YWHAZ (-) CTACACCTGTGACTGGAACCAA 
   
FLJ13855 (+) CCTGGCTTTGTTGCTTCTCTAT 
  Hypothetical protein FLJ13855 FLJ13855 (-) TAAATCTGGAAGTACGGGGAGA 
   
HERC5 (+) TCAACAACAACAGAGGATTTGG 
  Cyclin-E binding protein 1 HERC5 (-) CTTCATCCCTCTTTCCTGCTTA 
   
RPS12 (+) TGTTCTGACTGCTGACAATTCC 
  40S ribosomal protein S12 RPS12 (-) GGCAGTCTTCAGAACCTCTTGT 
   
RPL7 (+) TAAGAAGCGAATTGCTTTGACA 
  Ribosomal protein L7 RPL7 (-) AAATGGGTGGTCTTTTTCTTCA 




Appendix 6: List of Differentially Regulated Genes in A172 Cells at 
24 h Post-Infection 
 
GB Acc Fold Change Gene Name 
J04164 12.00 interferon induced transmembrane protein 1 (9-27) 
X03557 10.74 interferon-induced protein with tetratricopeptide repeats 1 
M13755 9.50 interferon, alpha-inducible protein (clone IFI-15K) 
AF095154 6.42 C1q-related factor 
BC007922 5.57 interferon stimulated gene 20kDa 
BC005330 5.34 tissue factor pathway inhibitor 2 
X52541 4.79 early growth response 1 
AF038963 4.19 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 
BC002601 4.13 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 
X67325 4.03 interferon, alpha-inducible protein 27 
M14660 3.76 interferon-induced protein with tetratricopeptide repeats 2 
AF080246 3.53 chromosome 22 open reading frame 1 
AJ225089 3.46 2'-5'-oligoadenylate synthetase-like 
X63613 3.44 pentaxin-related gene, rapidly induced by IL-1 beta 
BC027882 3.38 indoleamine-pyrrole 2,3 dioxygenase 
M30818 3.17 myxovirus (influenza virus) resistance 2 (mouse) 
X57351 3.04 interferon induced transmembrane protein 2 (1-8D) 
U23070 2.97 putative transmembrane protein 
AB006746 2.94 phospholipid scramblase 1 
V00546 2.79 interferon, beta 1, fibroblast 
AK002148 2.75 hypothetical protein FLJ11286 
AF061738 2.73 leucine aminopeptidase 3 
AF134053 2.62 Kruppel-like factor 2 (lung) 
BC009353 2.50 HL-60-induced differentiation immediate-early protein 
AK026672 2.50 hypothetical protein FLJ39885 
AF288815 2.47 guanylate binding protein 5 
AB024964 2.43 recombining binding protein suppressor of hairless (Drosophila)-like 
BC013292 2.33 5'-nucleotidase, cytosolic III 
AB027289 2.33 cyclin-E binding protein 1 
AF063613 2.32 2'-5'-oligoadenylate synthetase 3, 100kDa 
BC012532 2.31 chemokine (C-X-C motif) ligand 11 
X55019 2.30 cholinergic receptor, nicotinic, delta polypeptide 
M62800 2.29 Sjogren syndrome antigen A1 (52kDa, ribonucleoprotein autoantigen SS-A/Ro) 
AF070674 2.24 baculoviral IAP repeat-containing 3 
AF311913 2.21 potassium voltage-gated channel, subfamily H (eag-related), member 6 
BC004489 2.20 major histocompatibility complex, class I, C 
AB023206 2.20 angiomotin like 2 
AF064090 2.19 tumor necrosis factor (ligand) superfamily, member 14 
M77693 2.18 spermidine/spermine N1-acetyltransferase 
BC005010 2.16 zinc finger protein 36, C3H type-like 2 
X07834 2.12 superoxide dismutase 2, mitochondrial 
AF376770 2.12 Member of the gamma-glutamyltranspeptidase family 
U41315 2.11 makorin, ring finger protein, 4 
AF442151 2.11 viperin 
BC010954 2.10 chemokine (C-X-C motif) ligand 10 
BC015692 2.09 Protein containing two PDZ, DHR, or GLGF domains 
X67330 2.09 Protein of unknown function 
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BC016648 2.08 FOS-like antigen 1 
AL713764 2.06 tissue inhibitor of metalloproteinase 2 
BC013161 2.06 28kD interferon responsive protein 
AK027372 2.05 hypothetical protein FLJ14466 
BC015890 2.05 hypothetical protein FLJ13855 
AK001176 2.04 Protein of unknown function 
AK000707 2.03 hypothetical protein FLJ20700 
AB017335 2.02 MYC-associated zinc finger protein (purine-binding transcription factor) 
U19261 2.01 TNF receptor-associated factor 1 
AJ315767 2.00 O-linked N-acetylglucosamine (GlcNAc) transferase  
X83218 -2.00 ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit  
AF283772 -2.01 ribosomal protein L15 
BC007850 -2.02 solute carrier family 25 
J03459 -2.02 leukotriene A4 hydrolase 
BC017820 -2.03 ribosomal protein L41 
M36072 -2.03 ribosomal protein L7a 
BC030135 -2.04 SH3 domain binding glutamic acid-rich protein like 3 
AJ132583 -2.04 aminopeptidase puromycin sensitive 
U15008 -2.07 small nuclear ribonucleoprotein D2 polypeptide 16.5kDa 
AF348700 -2.09 ubiquitin A-52 residue ribosomal protein fusion product 1 
BC010004 -2.10 farnesyl diphosphate synthase  
U73824 -2.11 eukaryotic translation initiation factor 4 gamma, 2 
BC005230 -2.11 ubiquinol-cytochrome c reductase binding protein 
AF217963 -2.11 melanoma antigen, family D, 1 
BC001178 -2.11 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 
AK000373 -2.11 hypothetical protein FLJ20366 
AJ251760 -2.11 GNAS complex locus 
AK000575 -2.12 host cell factor C1 regulator 1 (XPO1 dependant) 
BC017360 -2.12 ribosomal protein L26-like 1 
BC005338 -2.12 capping protein (actin filament) muscle Z-line, alpha 2 
AB011173 -2.12 KIAA0601 protein 
S65738 -2.13 destrin (actin depolymerizing factor) 
BC006229 -2.13 cytochrome c oxidase subunit Vb 
BC012460 -2.14 LIM and SH3 protein 1 
AB011159 -2.14 NCK-associated protein 1 
BC003655 -2.16 ribosomal protein, large, P0 
BC003409 -2.17 ovarian carcinoma immunoreactive antigen 
M10036 -2.17 triosephosphate isomerase 1 
BC016512 -2.17 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 
AY034001 -2.17 nascent-polypeptide-associated complex alpha polypeptide 
S73591 -2.17 thioredoxin interacting protein 
BC004975 -2.17 cyclin I 
X07696 -2.18 keratin 15 
BC022510 -2.20 ADP-ribosylation factor domain protein 1, 64kDa 
AF020038 -2.20 isocitrate dehydrogenase 1 (NADP+), soluble 
AF035737 -2.20 general transcription factor II, i 
D14710 -2.21 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 
BC015887 -2.21 WD repeat and SOCS box containing protein 2 
Z14244 -2.21 cytochrome c oxidase subunit VIIb 
BC017100 -2.22 ring finger protein 130 
M83248 -2.22 secreted phosphoprotein 1 
BC030828 -2.22 EGF-like repeats and discoidin I-like domains 3 
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U00968 -2.23 sterol regulatory element binding transcription factor 1 
BC010114 -2.23 ribosomal protein L23 
AF283772 -2.25 ribosomal protein L15 
AL136693 -2.25 cytochrome b reductase 1 
Z49861 -2.25 histone 3, H3 
BC007062 -2.27 peroxiredoxin 3 
AJ242586 -2.28 arginyl aminopeptidase (aminopeptidase B) 
D50369 -2.28 Ubiquinone binding protein 
AK027426 -2.29 signal peptidase 12kDa 
BC017396 -2.30 prostatic binding protein 
BC007748 -2.30 ribosomal protein L4 
BC016325 -2.30 ADP-ribosylation factor 4 
D49737 -2.31 succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa 
BC015041 -2.36 vesicle amine transport protein 1 homolog (T californica) 
AF169650 -2.36 High mobility group protein 1 
X14420 -2.36 collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) 
U88895 -2.37 Putative protein encoded by human endogenous retrovirus H (HERV-H) 
AF109873 -2.39 CREBBP/EP300 inhibitory protein 1 
BC001015 -2.41 cytochrome c oxidase subunit VIb 
BC002964 -2.42 profilin 2 
BC005143 -2.42 cytoskeleton related vitamin A responsive protein 
BC006262 -2.42 Protein containing a reeler domain 
AF037364 -2.43 paraneoplastic antigen MA1 
BC016350 -2.43 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 
AL132665 -2.49 BCL2/adenovirus E1B 19kDa interacting protein 3-like 
BC010514 -2.50 clusterin  
AB053293 -2.50 Rho GTPase activating protein 18 
BC025372 -2.50 calponin 3, acidic 
M31520 -2.51 ribosomal protein S24 
BC000614 -2.52 histone deacetylase 3 
BC017875 -2.52 Cyclophilin A 
BC016300 -2.53 S100 calcium binding protein A4  
M82809 -2.53 annexin A4 
Z11793 -2.54 selenoprotein P, plasma, 1 
AB062450 -2.55 NIMA (never in mitosis gene a)-related kinase 7 
M61199 -2.55 sperm specific antigen 2 
Z11692 -2.60 eukaryotic translation elongation factor 2 
X76534 -2.63 glycoprotein (transmembrane) nmb 
AJ277724 -2.64 histone deacetylase 8 
AL080089 -2.64 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c, isoform 1 
AK000265 -2.68 EPS8-like 1 
U41766 -2.69 a disintegrin and metalloproteinase domain 9 (meltrin gamma) 
U96750 -2.73 ras homolog gene family, member I 
AF124993 -2.74 peroxiredoxin 5 
AJ330246 -2.77 Member of the galactosyltransferase family 
BC003352 -2.79 tumor protein, translationally-controlled 1 
X78669 -2.84 reticulocalbin 2, EF-hand calcium binding domain 
AJ132694 -2.87 ras-related C3 botulinum toxin substrate 1  
BC000490 -2.88 eukaryotic translation initiation factor 3, subunit 5 epsilon, 47kDa 
M90354 -2.93 basic transcription factor 3, like 1 
D84295 -2.96 tetratricopeptide repeat domain 3 
U14966 -2.97 ribosomal protein L5 
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AF100615 -2.97 mortality factor 4 like 1 
Y13286 -2.97 GDP dissociation inhibitor 2 
X57347 -2.99 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 
D00943 -3.00 myosin, heavy polypeptide 6, cardiac muscle, alpha 
M84711 -3.04 ribosomal protein S3A 
Z83737 -3.06 histone 1, H3j 
BC008850 -3.10 ribosomal protein L7 
M60746 -3.18 histone 1, H3e 
BC008443 -3.27 signal recognition particle 9kDa 
BC031012 -3.29 eukaryotic translation elongation factor 1 gamma 
BC001708 -3.33 ribosomal protein S3A 
BC003623 -3.33 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 
BC017701 -3.40 hypothetical protein DKFZp434L142 
AF348078 -3.48 G protein-coupled receptor 91 
AK025643 -3.50 Ribosomal protein S12 
U96876 -3.70 insulin induced gene 1 
BC000931 -3.82 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 
X83550 -3.95 histone 1, H3i 
BC007552 -4.15 H3 histone family 3B 
AK025927 -4.33 hypothetical protein MGC8721 
AF023860 -4.47 Protein with strong similarity to cyclophilin A  




Appendix 7: List of genes that were constantly upregulated during 
WNV infection. (GpI) 
 GB Acc Symbol Gene Name 
Immune response 
X03557 IFIT1 interferon-induced protein with tetratricopeptide repeats 1 
M14660 IFIT2 interferon-induced protein with tetratricopeptide repeats 2 
J04164 IFITM1 interferon induced transmembrane protein 1 (9-27) 
X67325 IFI27 interferon, alpha-inducible protein 27 
AJ225089 OASL 2'-5'-oligoadenylate synthetase-like 
AF110801 IL18BP interleukin 18 binding protein 
BC011171 SERPING1 serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) 
BC032589 B2M beta-2-microglobulin 
M28827 CD1C CD1C antigen, c polypeptide 
Y00636 CD58 CD58 antigen, (lymphocyte function-associated antigen 3) 
M30818 MX2 myxovirus (influenza virus) resistance 2 (mouse) 
Immune response: inflammation 
X63613 PTX3 pentaxin-related gene, rapidly induced by IL-1 beta 
U32849 NMI N-myc (and STAT) interactor 
AJ238044 BDKRB1 bradykinin receptor B1 
BC014451 PROCR protein C receptor, endothelial (EPCR) 
Others: organogenesis 
AF022654 SHOX2 short stature homeobox 2 
BC009983 MAB21L2 mab-21-like 2 (C. elegans) 
U05237 FALZ fetal Alzheimer antigen 
U41901 LSAMP limbic system-associated membrane protein 
X73902 LAMC2 laminin, gamma 2 
Others: signal transduction 
AK027780 GPR34 G protein-coupled receptor 34 
BC002601 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 
BC012513 ARHE ras homolog gene family, member E 
U37547 BIRC2 baculoviral IAP repeat-containing 2 (apoptosis inhibitor) 
Others 
AB014515 N4BP1 Nedd4 binding protein 1 
AB027289 LOC51191 cyclin-E binding protein 1 
AF099011 EHD1 EH-domain containing 1 
AJ131890 POLL polymerase (DNA directed), lambda 
AK000146 FLJ20139 CGI-30 protein 
AK000644 FLJ20637 hypothetical protein FLJ20637 
AK021416 LGP2 likely ortholog of mouse D11lgp2 (DEAD box) 
AK024401 ABCB8 ATP-binding cassette, sub-family B (MDR/TAP), member 8 
AK025485 C10orf2 progressive external ophthalmoplegia 1 
AK026672 FLJ39885 hypothetical protein FLJ39885 
AL080121 DKFZP564O0823 DKFZP564O0823 protein 
AL512725 MIDN midnolin 
BC001946 BRUNOL4 bruno-like 4, RNA binding protein  
BC005361 PSMA4 proteasome (prosome, macropain) subunit, alpha type, 4 
BC006392 CNP 2',3'-cyclic nucleotide 3' phosphodiesterase 
BC013161 IFRG28 28kD interferon responsive protein 
BC029162 MGC35440 hypothetical protein MGC35440 
J04056 CBR1 carbonyl reductase 1 
L13852 UBE1L ubiquitin-activating enzyme E1-like 
M77693 SAT spermidine/spermine N1-acetyltransferase 
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Appendix 8: List of genes that were constantly downregulated during 
WNV infection. (GpII) 
GB Acc Symbol Gene Name 
Cell proliferation 
D16431 HDGF hepatoma-derived growth factor (high-mobility group protein 1-like) 
S67334 PIK3CB phosphoinositide-3-kinase, catalytic, beta polypeptide 
X13916 LRP1 low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) 
Transport 
AF151878 LOC51644 coatomer protein complex, subunit zeta 1 ( clathrin adaptor complex) 
Transcription 
AB007874 ZNF297B zinc finger protein 297B 
AK027559 SIN3A SIN3 homolog A, transcriptional regulator (yeast) 
Signal transduction 
BC008770 GPR56 G protein-coupled receptor 56 
S67334 PIK3CB phosphoinositide-3-kinase, catalytic, beta polypeptide 
U07151 ARL3 ADP-ribosylation factor-like 3 
AB007144 DAPK3 death-associated protein kinase 3 
D16431 HDGF hepatoma-derived growth factor (high-mobility group protein 1-like) 
Carbohydrate metabolism 
D42041 G2AN alpha glucosidase II alpha subunit 
D49737 SDHC succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa 
Others 
AB064272 DPCR1 diffuse panbronchiolitis critical region 1 
AF153605 AIG-1 androgen-induced 1 
BC008796 DIPA hepatitis delta antigen-interacting protein A 
BC033193 MGC30208 hypothetical protein MGC30208 




Appendix 9: List of genes which are downregulated after 6hr of 
WNV infection. (GpIII) 
GB Acc Symbol Gene Name 
Regulation of cell cycle 
AF155235 NHP2L1 NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) 
AF480461 ZAK sterile alpha motif and leucine zipper containing kinase AZK 
AL360166 NME1 non-metastatic cells 1, protein (NM23A) expressed in 
D16431 HDGF hepatoma-derived growth factor (high-mobility group protein 1-like) 
Others: Regulation of transcription 
AB023221 FBXL11 F-box and leucine-rich repeat protein 11 
AJ224901 ZNF198 hypothetical protein BC008631 (with zinc-finger motif) 
BC005342 NSBP1 nucleosomal binding protein 1 
BC006143 MAFG v-maf musculoaponeurotic fibrosarcoma oncogene homolog G 
Others: G-protein coupled receptor protein signaling pathway 
BC008770 GPR56 G protein-coupled receptor 56 
U07151 ARL3 ADP-ribosylation factor-like 3 
Others 
BC033193 MGC30208 hypothetical protein MGC30208 
BC010436 MGC16028 MGC16028 similar to RIKEN cDNA 1700019E19 gene 
BC014887 FLJ12270 hypothetical protein FLJ12270 (with 8 WD domains) 
M55172 AGC1 aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified by monoclonal antibody A0122) 
D50371 ATP5I ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e 
AK023995 FLJ12442 hypothetical protein FLJ12442 
BC002461 BNIP2 BCL2/adenovirus E1B 19kDa interacting protein 2 (anti-apoptotic) 
AB014548 SCC-112 SCC-112 protein  
AB064272 DPCR1 diffuse panbronchiolitis critical region 1 
AB018306 KIAA0763 KIAA0763 gene product 
AK001568 FLJ10706 hypothetical protein FLJ10706 
AJ007714 AASS aminoadipate-semialdehyde synthase 




Appendix 10: List of genes which are downregulated after 18hr of 
WNV infection. (GpIV) 
GB Acc Symbol Gene Name 
Nucleic acid metabolism 
BC005266 PRIM1 primase, polypeptide 1, 49kDa 
D21851 LARS2 leucyl-tRNA synthetase 2, mitochondrial 
Transcription regulation 
AB018351 TOX thymus high mobility group box protein TOX 
AF022654 SHOX2 short stature homeobox 2 
AF507946 ZNF23 zinc finger protein 23 (KOX 16) 
M76541 YY1 YY1 transcription factor 
X89887 HIRA HIR histone cell cycle regulation defective homolog A (S. cerevisiae) 
Y07867 PIR Pirin 
Others: Response to external stimulus 
BC004168 FKBPL FK506 binding protein like 
M28827 CD1C CD1C antigen, c polypeptide 
M29893 RALA v-ral simian leukemia viral oncogene homolog A (ras related) 
Others: transport 
AF035621 KIF3C kinesin family member 3C 
AK025790 RAB6KIFL kinesin family member 20A 
AK057954 NEXN nexilin (F actin binding protein) 
AK027543 MSTP028 potassium channel tetramerisation domain containing 10 
Others 
M69040 SFRS1 splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) 
AK023971 FLJ13909 hypothetical protein FLJ13909 
BC005004 FLJ10156 hypothetical protein FLJ10156 
BC009424 BANP BTG3 associated nuclear protein 
AK023137 MGAT4B mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isoenzyme B 
AL136910 FIP1L1  FIP1 like 1 (S. cerevisiae) 
BC001376 SCAMP2 secretory carrier membrane protein 2 
BC001409 MGC2963 hypothetical protein MGC2963 
AF132940 LOC51604 phosphatidylinositol glycan, class T 
BC003353 MGC5309 hypothetical protein MGC5309 
AK022617 IMP-1 IGF-II mRNA-binding protein 1 
AL512725 MIDN midnolin 
AF179786 ERU162 Eulemur rubriventer olfactory receptor 
J03459 LTA4H leukotriene A4 hydrolase 
BC029162 MGC35440 hypothetical protein MGC35440 
AK056357 FLJ31795 hypothetical protein FLJ31795 
BC011990 C20orf30 chromosome 20 open reading frame 30 
BC008440 LOC51074 likely ortholog of mouse monocyte macrophage 19 
BC003098 HSD17B4 hydroxysteroid (17-beta) dehydrogenase 4 
BC005004 FLJ10156 hypothetical protein FLJ10156 
BC003099 DPH2L1 DPH2-like 1 (S. cerevisiae) 
AK025485 PEO1 progressive external ophthalmoplegia 1 




Appendix 11: Genes which are upregulated after 18hr of WNV 
infection. (GpV) 
GB Acc GenName 
Cellular physiological processes 
AB007144 DAPK3 death-associated protein kinase 3 
AF035444 PHLDA2 pleckstrin homology-like domain, family A, member 2 
X58531 LAMA1 laminin, alpha 1 
AB040884 OSBPL8 oxysterol binding protein-like 8 
AL136635 RAB1B RAB1B, member RAS oncogene family 
M62302 GDF1 growth differentiation factor 1  
X61118 LMO2 LIM domain only 2 (rhombotin-like 1) 
Integral to plasma membrane 
AF053004 WSX1 interleukin 27 receptor, alpha 
Y16187 ECEL1 endothelin converting enzyme-like 1 
AB015355 SLC11A2 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 
BC011403 GABRA5 gamma-aminobutyric acid (GABA) A receptor, alpha 5 
X13916 LRP1 low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) 
Others 
AB002370 KIAA0372 KIAA0372 
AB020667 UBCE7IP5 likely ortholog of mouse ubiquitin conjugating enzyme 7 interacting protein 5 
AB023166 CIT citron (rho-interacting, serine/threonine kinase 21) 
AF249872 FATE fetal and adult testis expressed transcript protein 
AJ006266 AND-1 WD repeat and HMG-box DNA binding protein 1 
AK023799 KIAA1271 KIAA1271 protein 
AK027372 FLJ14466 hypothetical protein FLJ14466 
AL136917 TUFT1 tuftelin 1 
AL390173 DKFZp547I224 hypothetical protein DKFZp547I224 
BC001430 RPP20 POP7 (processing of precursor, S. cerevisiae) homolog 
BC001784 HSU15552 acidic 82 kDa protein mRNA 
BC032512 MGC15631 hypothetical protein MGC15631 
M26167 PF4V1 platelet factor 4 variant 1 
--- --- Protein containing four C2H2 type zinc finger domains 




Appendix 12: Genes which show upregulation only at 6hr during 
WNV infection. (GpVI) 
GB Acc Symbok Gene Name 
Endoplasmic reticulum 
AF132048 RTN4 reticulon 4 
BC001549 EBP emopamil binding protein (sterol isomerase) 
U00968 SREBF1 sterol regulatory element binding transcription factor 1 
BC028679 KIFAP3 kinesin-associated protein 3 
AF215935 P44S10 proteasome regulatory particle subunit p44S10 
AK001135 SEC23IP SEC23 interacting protein 
Cytoskeletal functions 
AK023385 TPM3 tropomyosin 3 
AK023385 TPM4 tropomyosin 4 
U87166 ABI1 abl-interactor 1  
BC028679 KIFAP3 kinesin-associated protein 3 
Mitochondrion  
AB035863 SUCLA2 succinate-CoA ligase, ADP-forming, beta subunit 
AF020038 IDH1 isocitrate dehydrogenase 1 (NADP+), soluble 
BC000187 COX6C cytochrome c oxidase subunit VIc 
BC016350 ATP5F1 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 
M75883 SCP2 sterol carrier protein 2 
Z35093 SURF1 surfeit 1 
U31930 DUT dUTP pyrophosphatase 
Others: Intracellular transport 
BC015179 SNX3 sorting nexin 3 (involved in protein trafficking) 
BC001255 NCBP2 nuclear cap binding protein subunit 2, 20kDa 
BC019944 SLC20A1 solute carrier family 20 (phosphate transporter), member 1 
AK001135 SEC23IP SEC23 interacting protein 
X57347 YWHAQ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (14-3-3), theta polypeptide 
Others: Transcription regulation 
BC013998 PITX2 paired-like homeodomain transcription factor 2 
L03411 RDBP RD RNA binding protein 
X70394 ZNF146 zinc finger protein 146 
Others: Protein metabolism 
AF283772 RPL15 ribosomal protein L15 
AK000734 FLJ20727 ubiquitin specific protease 47 
BC000848 UBE2Q ubiquitin-conjugating enzyme E2Q (putative) 
BC009839 SKP1A S-phase kinase-associated protein 1A (p19A) 
M64174 JAK1 Janus kinase 1 (a protein tyrosine kinase) 
U73824 EIF4G2 eukaryotic translation initiation factor 4 gamma, 2 
Others: Signal transduction 
BC004186 GNB1 guanine nucleotide binding protein (G protein), beta polypeptide 1 (for signal transduction) 
AF061243 MP1 pitrilysin metalloproteinase 1 
BC005219 NRAS neuroblastoma RAS viral (v-ras) oncogene homolog 
Others 
AB002370 KIAA0372 KIAA0372 (contains multiple tetratrico peptide repeat domains) 
AB011173 KIAA0601 KIAA0601 protein (flavin containing amine oxidase family) 
AF226052 FLJ20432 hypothetical protein FLJ20432 
AF272973 EAF1 ELL associated factor 1 
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AF342736 BBS2 Bardet-Biedl syndrome 2 
AK024552 PAIP2 hypothetical protein BC007764 
AY007103 HSPC195 CXXC finger 5 
BC003409 OCIA ovarian carcinoma immunoreactive antigen 
BC005004 FLJ10156 hypothetical protein FLJ10156 
BC005968 APACD ATP binding protein associated with cell differentiation 
BC008070 HSPC182 HSPC182 protein 
BC008440 LOC51074 likely ortholog of mouse monocyte macrophage 19 
BC008796 DIPA hepatitis delta antigen-interacting protein A 
BC011990 C20orf30 chromosome 20 open reading frame 30 
BC017701 DKFZp434L142 hypothetical protein DKFZp434L142 
BC022508 GPM6A glycoprotein M6A 
X76534 GPNMB glycoprotein (transmembrane) nmb 
BC025296 ODC1 ornithine decarboxylase 1 
U81607 AKAP12 A kinase (PRKA) anchor protein (gravin) 12 
 
 
 
 
 
